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INTRoDuCTIoN
Integrating the picture . . . in medical terms: a comprehensive analysis of an individual phenotype. 
The word “phenotype” stems from the old Greek “phainein”, to bring to light, and “typos”, impres-
sion. Depending on the scope of the observer, the beating heart literally brings to light seemingly 
endless impressions. The motor of life has attracted and inspired numerous poets and visual artists 
throughout the history of mankind (Figure 1).
Doctors and scientists have a broad arsenal to collect impressions of the heart, ranging from 
interrogation of the patient (“anamnesis”) to the use of high-technology diagnostics for cardiac 
imaging. Despite all available tools, it remains challenging in daily clinical practice to integrate all 
these impressions to understand the cardiac phenotype of an individual and thereby solve his or 
her problem.
In the studies that served as the basis for this thesis, the hearts of experimental animals and humans 
with ventricular hypertrophy due to different types of hemodynamic overload were phenotyped 
in vivo. To this aim, aspects of mechanical, contractile and electrical function, and dynamically 
altering myocardial structure were assessed over time.
Our understanding of overload-induced cardiac remodeling is far from complete. A decade ago, 
Charles J. Homcy, MD, addressed the complexity of unravelled mechanisms by wondering meta-
phorically ‘how many switches and how many wires’ would contribute to ‘signaling hypertrophy ’ 
[61].
‘Signaling hypertrophy: how many switches and how many wires’
Charles J. Homcy, 1998 [61]
This issue still remains to be fully elucidated. It becomes clear after analyzing the data collected 
in this thesis that overload-induced cardiac disease is characterized by a multitude of different 
aspects encompassing structural and functional myocardial remodeling processes with mutual 
interrelations and sharing potentially common primary stimuli. In order to consider and integrate 
all relevant aspects of the overloaded cardiac phenotype, we propose to designate a common 
denominating term, cardiac mechanomyopathy. This neologism allows to summarize all the remod-
eling processes as a common pathophysiological entity, thereby meeting its complex nature and 
aiding to unravel common underlying mechanisms. Importantly, the term indicates a primary role 
of mechanical stimuli for myocardial remodeling.
In this thesis, we focused on mechanical forces imposing on the heart as potential stimuli for 
hypertrophic remodeling due to cardiac hemodynamic overload. Although this can occur in the 
absence of mechanical forces, there is cumulating evidence that during hemodynamic overload 
mechanical forces play a primary role as stimuli for myocardial remodeling (Table 1). The identifica-
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Chapter 1    INtRoDUCtIoN
tion of these primary stimuli will improve our understanding and advance novel mechanism-based 
diagnostic and therapeutic strategies in individual patients.
In the remainder of this Introduction the clinical relevance of cardiac phenotyping in hemody-
namic overload is explained. A brief history is given of the heart and circulation, and the historic 
recognition that certain disease states cause cardiac overload and hypertrophy. Many aspects of 
the cardiac phenotype have long been known but are still not elucidated mechanistically today. 
Figure 1  The heart. Artwork by Aaron (7 years), Eline (5 years) and Marit Donker (3 years). From left to right.
For full colour illustration, see page 221.
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PRO’s
Hypertrophy occurs in almost all cardiovascular diseases and related animal models in which a form of •	
hemodynamic overload is present, e.g., arterial hypertension, valvular heart disease etc., and can be (at 
least partially) reversed upon withdrawal of overload. Hypertrophy can be considered a universal response 
to cardiac overload [17,44,99,110,137-139]. Hypertrophy can be induced by direct mechanical stimulation in 
cardiomyocyte preparations in vitro. Stretching cardiomyocyte preparations stimulates protein synthesis, 
induces altered gene expression without involvement of neural or humoral factors, yielding similar results as 
in vivo experiments [17,19,39,44,79,83,86,94,107,108,117,125,130,137,146]. In addition, different degrees and 
directions [132] of stretch, and the timing of its action within the cardiac cycle [151], result in differential 
hypertrophic responses, which supports primary mechanical influences on phenotypic hypertrophic changes. 
These aspects of phenotypical determination of cardiomyocyte hypertrophy can be observed in vivo, i.e., 
pressure overload results in predominant cellular thickening (addition of sarcomeres in parallel), and volume 
overload in predominant cellular lengthening (addition of sarcomeres in series).
Direct non-mechanical hypertrophic stimuli, e.g., G protein - coupled receptor agonists (endothelin-1, angio-•	
tensin II, phenylephrine), which can induce hypertrophy in the absence of mechanical factors in vitro also 
play a role in vivo in cardiac disease with hemodynamic overload [18,56,93,100,116,118,129,134]. These non-
mechanical stimuli are often directly coupled to mechanical stimuli acting as initiators for their release.
Hypertrophy can be induced by hemodynamic overload in vivo even after adrenoreceptor blockade or sympa-•	
thectomy [21]. Also, in isolated hearts increased hemodynamic load increases protein synthesis [78].
CON’s
Hypertrophy can be induced by direct agonist activation in the absence of mechanical stimuli in cardio-•	
myocyte preparations in vitro, e.g., G protein - coupled receptor agonists (endothelin-1, angiotensin II, 
phenylephrine), growth factors (IGF-I, TGFβ), cytokines (TNFα) and hormones (thyroid hormone, insuline) 
[129,134,135]. It should be realized that the specific effect of a given hypertrophic stimulus may be the result 
of a complex combined action of various different pathways depending on spatial and temporal abundance 
of relevant proteins in the cell in question. These aspects are not necessarily determined by mechanical forces 
but depend on the inherent synchronization and integration of different hypertrophic pathways [130].
Hypertrophy is importantly mediated by many other different stimuli, e.g., metabolic stress, ischemia, oxida-•	
tive stress and inflammation [106,136].
Hypertrophy can be induced by genetic modifications in experimental models under normal loading condi-•	
tions by either constitutive overexpression of hypertrophy-promoter genes or knock out of hypertrophy-
repressor genes.
Hypertrophy can occur in humans with genetic defects under normal loading conditions, i.e., mutations of •	
cytoskeletal/ sarcomeric proteins.
Table 1  PRO’s and CON’s. Protagonistic and antagonistic views on the primary role of mechanical forces as stimuli for hypertrophic 
myocardial remodeling during hemodynamic and mechanical overload.
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In the following sections current controversies in the phenotyping of ventricular hypertrophy are 
discussed. An overview is provided of modern diagnostic modalities and molecular techniques that 
generate detailed insights on mechanosensing and mechanotransduction, and mechano-electrical 
links. The need for an integrated approach towards cardiac mechanomyopathy has led to the aims 
of the present thesis.
Clinical background
Cardiac hypertrophy is commonly defined as an increased myocardial mass of the ventricle. 
Although hypertrophy can affect both the left (LV) and the right ventricle, LV hypertrophy (LVH) 
poses a much greater problem because it affects more patients. In the general population the 
prevalence of LVH has been estimated to range between 15 and 20% using different diagnostic 
modalities such as electrocardiography, echocardiography, magnetic resonance imaging (MRI) and 
autopsy [75,90,104]. In patients with cardiovascular disease like arterial hypertension, valvular 
heart disease and myocardial infarction, the prevalence of LVH is considerably higher than in the 
general population and reaches up to 100%.
Epidemiological studies have shown that cardiac hypertrophy is associated with a high cardiovas-
cular morbidity and mortality independent of its cause [75,88,89,145]. This is largely due to the fact 
that sustained overload will finally result in irreversible pump failure. In addition, the hypertrophied 
heart has an increased propensity to develop potentially fatal ventricular arrhythmias, by which the 
relative risk of sudden arrhythmogenic death is highest in patients with a well-preserved functional 
capacity [1,141-143,154].
In The Netherlands, the impact of the problem of LVH can best be illustrated with data from 
Statistics Netherlands1 and the Netherlands Heart Foundation: In 2004, a total of 136,553 people 
died in The Netherlands, i.e., 374 per day. Of these, 45,445 died of cardiovascular disease, i.e., 33% 
of the total mortality. Of the latter group, 15,272 people died of cardiovascular disorders in which 
ventricular hypertrophy is generally prevalent and might play a pathological role [2].
Historical notes
William Harvey (1578-1657) was the first to describe in 1628 that the circulation consists of two 
separate closed circuits connected to the heart, the pulmonary and the systemic circulation; and 
he recognized that the heart acts as a pump enabling blood flow in arteries and veins throughout 
the body [55]. Harvey’s description formed the basis for subsequent findings on the link between 
blood-flow abnormalities and cardiac enlargement, with John Mayow (1634-1679) in 1674 being 
among the first to publish a case of cardiac overload due to LV inflow obstruction, most likely mitral 
stenosis, and right-ventricular enlargement [33,95]. Mayow speculated already on distending forces 
1 Centraal Bureau voor de Statistiek
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as potential stimulus for cardiac dilatation. Giovanni Maria Lancisi (1654-1720) was among the first 
who distinguished cardiac dilatation in situations of regurgitant blood flow and hypertrophy in 
situations of narrowing of the aortic orifice [150].
The causal relation between hemodynamic overload and cardiac enlargement was put forward by 
Giovanni Battista Morgagni (1682-1771) in 1761 [101]. The history of different classifications of 
cardiac enlargement is rather extensive and has been excellently reviewed and summarized by Katz 
[76]. In 1801 Jean-Nicolas Corvisart (1755-1821) distinguished in more detail ventricular hyper-
trophy and dilatation, which led to a general acceptance in the nineteenth century that different 
patterns of cardiac enlargement are the consequence of distinct hemodynamic abnormalities. 
Réné-Joseph-Hyacinthe Bertin (1767-1828) refined Corvisart’s concept and classified ventricular 
hypertrophy as ‘eccentric’ and ‘concentric’ and also related the morphologic pattern to its prog-
nostic significance. In this tradition, Francois Aran (1817-1861), was among the first to describe 
a compensated form of ventricular hypertrophy [5]. In the same period, Austin Flint (1812-1886) 
recognized many compensatory, beneficial aspects of overload-induced ventricular hypertrophy 
and opposed these findings to the deleterious sequelae of ventricular dilatation [37]. Intuitively, 
Austin Flint associated hypertrophy and heart failure with an abnormal mechanical load, yet it 
lasted about 100 years before these thoughts were supported by calculation of mechanical forces 
acting in the myocardial wall [49,62,128], as outlined below. John Milner Fothergill (1841-1888) was 
then able to link patterns of ventricular hypertrophy to the underlying mechanical forces, i.e., ‘in 
the distending force . . . hypertrophy is always combined with dilatation of the cardiac chambers; in 
obstruction to be overcome . . . there is pure hypertrophy, usually without dilatation’ [40]. Along with 
Austin Flint, Fothergill recognized many of the beneficial aspects of certain forms of hypertrophy.
A major step forward in the understanding of cardiac pump failure and the transition from compen-
sated hypertrophy to failure was the work of William Osler (1849-1917). He was among the first 
to describe the natural history of different types of overload and differentiated three stages of 
disease: development, full compensation and broken compensation [111]. A historical step forward 
in terms of mechanistic understanding was the recognition of James Mackenzie (1853-1925) that 
myocardial abnormalities are the major underlying cause of heart failure [92].
Then, hemodynamic and geometric assessment, i.e., intracardiac pressures and volumes, became 
increasingly important in heart-failure research as introduced by Otto Frank, Ernest H. Starling and 
Carl J. Wiggers around 1900 [41,133,149]. Owing to the introduction of cardiac catheterization, the 
ideas of Austin Flint and Fothergill on cardiac (de-)compensated hypertrophy and dilatation could 
be mechanistically confirmed by the calculation of wall stress [49,62,128].
Thus, based on historical notes, mechanical influences on cardiac structure, contractile function 
and hemodynamics have long been addressed. In addition, electrophysiological alterations due to 
mechanical influences imposed on the heart have already been described more than 200 years ago. 
Already in 1765 it was recognized that the heart’s function is sensitive to mechanical forces, when 
Akenside reported on the occurrence of arrhythmias after a traumatic cardiac injury [3]. In 1882, 
Riedinger reported on ‘commotio cordis’ as a trigger for arrhythmic events in the absence of tissue 
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trauma [114]. In 1915, it was Bainbridge who recognized a mechanically-induced increase in heart 
rate [10], and in 1920 Schott reported on the ‘pre-cordial percussion’ as an effective therapy of 
Stokes-Adams attacks, which is still an element of resuscitation protocols today [131]. Finally, these 
and other observations led to the concept of mechano-electrical feedback, originally described by 
Kaufmann in 1967 as ‘mechano-elektrische Rückkoppelung’ [77].
Phenotyping ventricular hypertrophy
‘everyone thinks they know what “cardiac hypertrophy” is: a reactive increase in cardiac size/
myocardial mass in response to hemodynamic stress that, in humans, predisposes to early death 
[89]. Yet, the term “hypertrophy” has become one of the most misused and inaccurate terms in the 
cardiovascular basic science literature because of its nonspecificity and, as typically used, lack of 
mechanistic implication. . . . we reflect on the appropriate meanings of terms and criteria that can 
be used to accurately describe cardiac enlargement and myocardial growth, with the anticipation 
that rigorous mechanistic description of such phenotypes will result in a more coherent apprecia-
tion of the parallel and redundant processes that result in “myocardial hypertrophy.” ‘ 
Gerald W. Dorn II, 2003 [32]
The ventricular geometry of hypertrophied hearts is classically divided into eccentric and concen-
tric forms based on their macroscopic structural shape [4,49,115]. The former is characterized by a 
proportional increase of ventricular cavity and wall, whereas the latter is dominated by a substantial 
and disproportional wall thickening in the virtual absence of chamber enlargement. The traditional 
paradigm is that eccentric hypertrophy occurs as a result of volume overload and its cellular basis 
is cardiomyocyte lengthening due to the serial addition of sarcomeres. It is opposed to a concentric 
geometry which results from pressure overload and exhibits an increase of the cardiomyocyte cross 
sectional area due to a parallel addition of sarcomeres [47,49,4]. Grossman and co-workers were 
among the first to describe the potential mechanical stimuli responsible for these differences in 
hypertrophic remodeling. They postulated that systolic stress imposed on the myocardium leads 
to wall thickening and concentric hypertrophy, which in turn could reduce or even normalize the 
systolic stress in a feedback loop. In volume overload Grossman et al. found that diastolic stress 
was likely responsible for eccentric hypertrophy, whereby the heart “grew” in a nearly physiological 
way, but was not able to normalize the hypertrophy-stimulating mechanical forces [48,49]. These 
findings were derived from group comparisons between normal control patients, patients with 
pressure overload and patients with volume overload. In that way Grossman et al. were purely 
descriptive as they based their conclusions exclusively on observations on systolic and diastolic LV 
wall stresses which partly differed among the groups. It was Karl Weber who added an important 
dimension to the discussion on load-dependent patterns of cardiac remodeling. Weber et al. studied 
extracellular-matrix remodeling and myocardial fibrosis in overload-induced cardiac disease and 
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emphasized the relevance of the extracellular matrix for myocardial stiffness and contractile func-
tion [34,148].
The clinical applicability of terms as ‘eccentric’ and ‘concentric’ LVH is of limited value. The differ-
entiation of just these two types of LVH oversimplifies the many faces myocardial hypertrophy 
can have in humans with cardiovascular disease. Moreover, clinical studies have indicated that 
the pattern of hypertrophy may provide only little additional information beyond the assessment 
of LV mass itself [85,147]. In addition, there is no geometry-specific therapy for eccentric volume-
overload-induced versus concentric pressure-overload-induced hypertrophy.
In disease, human hearts are exposed to complex mechanical loading conditions, often over long 
stretches of time, which results in a diversity of (mal)adaptational myocardial remodeling. Adequate 
characterization is complicated by an often unknown duration of the disease with varying ventric-
ular loading over time, ongoing functional and structural myocardial remodeling, interference of 
therapeutic interventions, and genetic constitution. A lot of these aspects are beyond the scope of 
currently used clinical diagnostic techniques.
In order to advance more individualized, rational therapies, risk stratification and prognostic 
judgments, there is a need for a more detailed, mechanism-based phenotypic description of the 
hypertrophied ventricular myocardium in clinical medicine. Novel diagnostic approaches should be 
directed towards mechanistic understanding of underlying cellular remodeling processes and the 
causal stimuli involved [32].
Phenotyping ventricular mechanical overload
It has been recognized for many decades that cardiac overload is the principal stimulus for ventric-
ular hypertrophy and associated myocardial remodeling in numerous cardiovascular diseases. Yet, 
a detailed identification of the primary stimuli that regulate hypertrophic ventricular remodeling 
at the level of the myocardium remains elusive. Much evidence points to a prominent role of 
mechanical factors as primary stimuli for cardiac hypertrophy [38,49,105,123]. It has also become 
clear that besides mechanical influences, neural- and neurohumoral stimulation, growth hormones, 
cytokines, alterations of metabolism and energy consumption all contribute to myocardial remod-
eling during ventricular hypertrophy [68,69,102,123,124,127].
Cardiac mechanical load is the integrated sum of distinct elementary quantities and can basically 
be quantified in terms of stress and strain. This terminology is derived from physics, where stress 
s (kPa=dyne/ cm2 x 104) is defined as a force acting on the surface of an object, and strain e (-) as 
the resultant deformation of this object. Strain e (-) is dimensionless and expressed as the length 
of the object after the deformation relative to its unstressed baseline length. By definition, positive 
strain represents lengthening or expansion of an object, and negative strain indicates shortening 
or compression.
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Quantification of LV myocardial stress
Direct measurement of stress imposed on the myocardium can be performed by insertion of tech-
nical devices, so called “force gauges”, into the tissue. These gauges are able to detect the stress 
indirectly through deformation of a compliant element within the gauge. Yet, the invasiveness of this 
approach limits reliable measurement of stress due to local tissue damage and can only be applied 
under basic experimental conditions. Currently, there is no clinically-feasible method to measure LV 
myocardial stress. Novel approaches to non-invasively determine stress are described in this thesis. 
This is made possible by mathematical modeling of cardiac mechanics, as reviewed by McCulloch 
and Mazhari [98]. In computer models of cardiac mechanics, the heart is assumed to have a certain 
geometric shape and myocardial material properties [6-8,22-25,29,50,51,66,73,96-98]. Geometric 
assumptions of the LV range from simple thin-walled spheres or cylinders to more realistic thick-
walled truncated ellipsoids. The most realistic models apply the three-dimensional finite element 
method of the heart, which is rather difficult to handle. In all models, the myocardium is assumed 
to be a continuous, homogenous, elastically deformable and incompressible material. In addition 
to assumptions on LV shape and myocardial structure, data on LV cavity pressure are incorporated. 
Ideally, the “model input data” on LV dimensions and pressure are simultaneously recorded to allow 
for proper synchronization of these two interrelated quantities to calculate myocardial stress and 
strain.
Most of the models published in the literature calculate LV wall stress. However, while widely 
used, this has inherent limitations. It is dependent on the site and direction of measurement, and 
absolute values generated using different models are not comparable since they do not represent 
true myocardial stress when compared to in-vitro/ intramyocardial recordings [7]. Nguyen et al. 
supported this notion by showing that fiber stresses differ significantly from wall stresses [105]. 
Calculation of (myo)fiber stress is preferable to LV wall stress since it represents more accurately 
the stresses within the myocardium. This is supported by a better comparability between calculated 
absolute myofiber stresses in vivo and in vitro [30], as outlined in Chapter 3. Moreover, calcula-
tion of fiber stress is found to be superior to estimates of wall stress in patients with abnormal 
ventricular geometry [46].
Quantification of LV myocardial strain
The invasive gold standard for direct measurement of strain is the intramyocardial application 
of sonomicrometric piezoelectric crystals. Although this technique is used in acute and chronic 
experiments to validate non-invasive modalities assessing strain, it is limited by local tissue reac-
tion and is not applicable to humans due to its invasiveness.
Non-invasive assessment of strain is possible using different approaches, including computer 
modeling, Doppler echocardiography and MRI [59]. Computer modeling of cardiac mechanics has 
recently been reviewed [98] and is shortly discussed above. The clinical applicability is limited 
due to the use of complex algorithms. Recent technical developments in echocardiography allow 
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assessment of regional myocardial deformation by strain and strain-rate imaging [26,27]. To this 
aim, tissue-Doppler imaging using real-time echocardiography is applied.
Assessment of strain and strain rate (i.e., the temporal derivative of strain being a measure of 
rate of deformation) by tissue-Doppler imaging (TDI) is mainly regarded as a method to measure 
regional systolic myocardial function [57], i.e., either LV long-axis shortening strain (longitudinal 
strain), short-axis thickening strain (radial strain) or short-axis shortening strain (circumferen-
tial strain). This technique provides continuous information on changes in regional dimensions. 
Important limitations are the inherent angle dependency of the ultrasound beam relative to the 
myocardial wall and the necessity of sufficient image quality, which is critical for the application 
of this imaging modality [26,59,84,144]. Magnetic Resonance Imaging (MRI) tagging is currently 
accepted as the non-invasive diagnostic reference modality to assess myocardial strain [113]. The 
clinical use of MRI tagging as a measure of regional contractility is still limited. The data analysis 
is time consuming and overall relatively costly in comparison to echocardiographic techniques. 
Moreover, MRI is not available at the bedside. This precludes its use for many routine purposes in a 
clinical setting [16,59,91,113,152].
Importance of assessing LV myocardial stress and strain
From in-vitro and in-vivo studies in animal models and humans with mechanical overload it is 
well recognized that more than two mechanical stimuli, as classically described [49], are caus-
ally involved in hypertrophic ventricular remodeling [60]. The traditional assumptions as e.g., the 
dominant role of systolic load during pressure-overload hypertrophy have not been unequivocally 
supported: Nguyen et al. [105] suggested that end-diastolic stress is more likely the stimulus for 
pressure overload hypertrophy than peak systolic stress. This in-vivo finding indicates that the 
causal role of mechanical stimuli for hypertrophy is much more complex than the traditionally 
assumed dichotomy of concentric versus eccentric hypertrophic patterns as proposed by Grossman 
et al., who suggested that hypertrophy develops to normalize systolic but not diastolic wall stress 
[49]. Many mechanical stimuli are likely involved as hypertrophic stimuli, which deserves further 
analysis as pointed out by Holmes [60]. In-vitro experiments have been performed to clarify this 
complexity. In cardiomyocyte preparations, it has been shown that the spatial orientation [132] of 
externally applied mechanical load, with respect to the cellular axes and its timing within the cardiac 
cycle [151], differentially influence the biological responses of cardiomyocytes. Also, external loads 
as applied to passively stretched cardiomyocytes [94], should be contrasted to internal loads as 
occurring in field-stimulated actively contracting cells [70]. In the light of this in-vitro information, 
many temporal and spatial aspects of myocardial load may form relevant stimuli for hypertrophic 
ventricular remodeling as recently reviewed [60,109]. Importantly, stress and strain act at the 
cellular level within the ventricular wall and determine myocardial remodeling [65]. The identifica-
tion of mechanical stimuli responsible for different aspects of these remodeling processes will likely 
increase mechanistic understanding. The translation of these basic insights into clinical practice 
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would allow the development of diagnostic, prognostic and therapeutic strategies focusing on the 
underlying mechanisms involved in hypertrophic remodeling.
Mechanosensing and mechanotransduction
It is well-established that mechanical forces directly imposed on cardiomyocytes in vitro evoke 
various cellular responses [123], as illustrated in Figure 2. In addition, in-vivo studies in animal 
models and humans with cardiac overload have described numerous effects on the myocardium. 
The underlying molecular cascades have been studied extensively and different major pathways, 
including hormones, vasoactive substances, cytokines which are involved in the induction of 
myocardial hypertrophy have been reported in the literature, as recently reviewed [17,19,20,28, 
31,35,36,39,43,44,48,53,54,61,63,65,67,70,80,86,118,137]. However, mechanistic insights about 
cellular mechanotransduction are still scarce and it is currently unclear how mechanical signals are 
sensed and transduced by cardiomyocytes [8,9].
Mechanotransduction can be defined as ‘the process of converting physical forces into biochemical 
signals and integrating these signals into the cellular responses’ [65] or as ‘the biochemical response 
of cells to mechanical stimulation’ [86]. It should be noted that many authors describe these 
phenomena as mechanosensing [11]. In the literature, the distinction between the terms mecha-
notransduction and mechanosensing is not always clear and differences are often ill-defined. 
Mechanosensing should be reserved only for the initial, proximal cellular response to an externally 
applied force [80].
Although it is currently unknown how a cardiomyocyte actually senses mechanical load, i.e., stress 
and strain, much evidence suggests a direct load-sensing mechanism as reviewed by Omens [109]. 
However, a cellular load-sensor is not definitely identified. Various cellular components have been 
implicated in mechanosensing and -transduction. It is likely that the cell is capable of detecting 
stress indirectly as strain by the deformation of cellular elements. Several cytoskeletal elements 
and downstream protein cascades have been characterized as relevant for mechanotransduction. 
Furthermore, direct functional connections between membrane-bound mechanosensors and the 
nucleus have been reported which have been considered to regulate transcription [45,67,71,118-
122,140].
Mechano-electrical links
It has long been recognized that mechanical forces can influence the electrical function of the heart 
as mentioned above (see Historical notes). The contemporary knowledge of mechano-electrical 
phenomena has recently been summarized and extensively reviewed [82]. Clinical and experimental 
aspects of mechano-electrical links during chronic hemodynamic overload and ventricular hyper-
trophy are described in Chapter 2 [82]. Importantly, chronic mechano-electrical phenomena must 
be distinguished from acute effects. The latter applies to electrophysiological effects of acute 
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Figure 2  Mechanosensing and mechanotransduction in cardiomyocytes. Simplified scheme incorporating major cardiomyocyte 
mechanosensing and mechanotransduction elements reported in the literature [11-15,34-36,39,52,58,63,67,74,80,81,86,87,103,107-
109,112,117-122,126,134,137,138,153]. Note miniaturized schemes on top: illustration of mechanical forces, i.e., stress and strain, 
imposed on cardiomyocyte that dynamically alter the cellular shape in all directions. This may result in increased broadening and/or elonga-
tion of the cell within the cardiac cycle. Abbreviations: Akt/PKB, Akt, protein kinase B; CaMK, Ca2+/ calmodulin-dependent protein kinase, 
or CaM kinase; CT-1, cardiotrophin; DAG, diacylglycerol; ERK, extracellular signal-regulated kinases, mitogen-activated protein kinases; 
FAK, focal adhesion kinase; GATA-4, cardiac transcription factor, zinc finger-containing transcription factor; HDAC, histone deacetylase; 
IGF1, insuline-like growth factor; IL1β, interleukin; IP3, inositol 1,4,5-trisphosphate; JNK, C-Jun N-terminal kinases, mitogen-activated 
protein kinases; KCNE1, or minK, β-subunit of I
Ks
 channel (slowly-activating delayed-rectifier K+ channel); KCNQ1, or KvLQT1, β-subunit 
of I
Ks
 channel; MAPK, mitogen-activated protein kinases; MEF2, cardiac transcription factor; MSC, mechanosensitive channels including 
stretch-activated ion channels; MLP, muscle LIM protein; Na
v
, voltage-gated sodium channels; NFAT, nuclear factor of activated T-cells, 
cardiac transcription factor; NF-κB, nuclear factor-kappa B; Nkx 2.5, cardiac transcription factor, vertebrate homologue of tinman trans-
cription factor; p38, mitogen-activated protein kinase; PKC, protein kinase C; PLC, phospholipase C; T-cap, telethonin; TGFβ, transforming 
growth factor beta. 
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stretch onto the myocardium [42], which have been well documented and found to be princi-
pally based on the action of stretch-activated ion channels [64,120]. Chronic mechano-electrical 
phenomena, have also been described under the term electrical remodeling. Electrical remodeling 
could be defined as a ‘persistent change in the electrophysiological properties of myocardium’ [72] 
and it is mostly used to describe long-term remodeling of ion channels and other electrogenic ion 
transporters. The mechanisms that link mechanics to electrical remodeling in a chronic setting are 
still largely unexplored and deserve further investigation as outlined in Chapter 2 [82].
AImS oF THE THESIS
In the studies conducted for this thesis, we investigated mechanical overload-induced ventricular 
hypertrophy by integrating functional and structural aspects of the remodeling heart over time.
To this aim, we developed novel approaches and techniques that allow to 1) quantify mechanical 
forces acting on the ventricular myocardium by minimally-invasive, and eventually non-invasive 
means, 2) sample ventricular myocardial tissue from in-situ beating hearts in chronic experiments, 
and thereby 3) integrate mechanical, functional and molecular-biological data to gain more mech-
anistic insights on mechano-functional and mechano-structural links. Finally, we have translated 
our experimental experience and insights into clinical studies.
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Electro-mechanical remodeling 
in hypertrophy
Chapter 2
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ABSTRACT
This chapter describes clinical and experimental aspects of electro-mechanical remodeling during 
long-term hemodynamic overload leading to hypertrophy. The putative role of mechanical stimuli 
to induce molecular-electrophysiologic changes is discussed. The chapter focuses primarily on the 
remodeling of ventricular repolarization and its relation to arrhythmogenesis. First, we provide a 
brief overview of ventricular arrhythmias and sudden cardiac death (SCD) in the general population 
emphasizing how electrophysiologic changes in the setting of chronic hemodynamic overload can 
adversely influence these deleterious events.
Boek_Donker_v5.indb   38 21-7-2008   10:21:22
39
Chapter 2    ElECtRo-MECHANICAl REMoDElING IN HyPERtRoPHy 
Cl INICAl ImPACT oF VENTRICulAR ARRHy THmIAS AND SuDDEN 
CARDIAC DEATH
SCD is responsible for 300,000 to 400,000 victims per year in the United States [1]. In the Maas-
tricht area in The Netherlands, with 182,000 inhabitants, the yearly incidence of out-of-hospital 
sudden cardiac arrest (death rate, 93%) at the age of 20 to 75 years is approximately 1 per 1000 
people [2]. More than 90% of these fatalities occur in patients with coronary artery disease or 
cardiomyopathies. In the remaining 5% to 10%, no evidence of structural heart disease can be 
found.
Ventricular arrhythmias are the most frequent cause of sudden death. Often, they are the first 
manifestation of cardiovascular disease. In a study of patients with sudden arrhythmic death 
(documented on an ambulatory electrocardiographic [ECG] recorder), ventricular tachyarrhythmias 
were the terminal event in 83% of the cases, whereas bradyarrhythmias occurred in 17% [3]. Three 
forms of tachyarrhythmia were distinguished: (1) primary ventricular fibrillation (10% of the 83%); 
(2) monomorphic ventricular tachycardia or flutter precipitating ventricular fibrillation (75%); and 
(3) polymorphic ventricular tachycardia, including torsades de pointes (15%) [3]. An example of the 
latter, from our own registry, is shown in Figure 1. Fortunately, most often ventricular arrhythmias 
have less detrimental consequences.
Patients with chronic pathologic overload of the heart (e.g., caused by hypertension, valvular 
disease, chronic ischemia, and infarction) are at increased risk for fatal arrhythmias [4,5] and 
prone to develop overt heart failure [6,7]. There is an increase in the frequency and complexity 
of ventricular ectopy with the progression of heart failure [8]. Total mortality correlates with left 
ventricular (LV) function and the presence of complex ventricular ectopy [9]. However, a clear 
correlation between SCD and LV contractile function or ventricular ectopy has not been found. 
In fact, data from the Vasodilator Heart Failure Trial (Val-HeFT) Study [10] and the Metoprolol 
Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Trial [11] suggest that death 
is disproportionately sudden in patients with more modest myocardial dysfunction.
Figure 1 shows an example of sudden arrhythmic death in a patient with compensated ventricular 
hypertrophy. The recordings are from an 81-year-old woman with a long-term history of severe 
aortic stenosis, moderate aortic incompetence, and hypertension leading to concentric LV hyper-
trophy. Aortic valve replacement was strongly recommended but was refused by the patient. Her 
last medication comprised enalapril, furosemide, carbamazepine, and venlafaxine. She had been 
in a vital condition with no clinical signs of circulatory decompensation and a normal ejection 
fraction of 63% just days before the fatal event.
Pathologic ventricular hypertrophy has long been recognized as an independent risk factor for SCD 
[4,6]. However, the mechanisms of proarrhythmia in conditions with chronic hemodynamic overload 
are complex. Even in patients with the same pathology, different mechanisms of tachyarrhythmia 
prevail. In our patient, the presence of a myocardial substrate with electrical and structural altera-
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tions (e.g., fibrosis) must be assumed (based on the recordings shown and literature data). The 
generation of ventricular ectopic beats, triggering the tachycardia, indicated an arrhythmogenic 
milieu that was possibly influenced by myocardial ischemia, autonomic dysbalance, local conduc-
tion disturbances, and/or the side effects of venlafaxine (with a known proarrhythmic risk; for more 
information, see the University of Arizona Health Sciences Center Web site at: www.torsades.org) 
Figure 1  Sudden arrhythmic death in a patient with compensated ventricular hypertrophy. Top, Twelve-lead electrocardiograms (ECG) in 
1997 and 2001 (weeks before death), showing sinus rhythm with normal QT intervals. From 1997 to 2001, the electrical axis changed from 
horizontal to intermediate, whereas high voltages in the precordial leads and a strain pattern of the ST-T segments developed, compatible 
with significant hypertrophy. Bottom left, Echocardiogram recorded a few days before the fatal event. Cardiac contractile performance 
was overall good. Bottom right, Ambulatory ECG showing the sudden onset of polymorphic ventricular tachycardia degenerating into 
ventricular fibrillation at 05:32 AM. (Courtesy of Joep L.R.M. Smeets, MD, PhD, Department of Cardiology, Academic Hospital Maastricht, 
Netherlands).
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and furosemide (with a risk for hypokalemia). This case exemplifies the importance of a substrate 
and triggers for the occurrence of polymorphic ventricular tachycardia in hypertrophy.
ElECTRICAl REmoDElINg IN CHRoNIC CARDIAC oVERloAD
General remarks
The poor understanding of arrhythmias in cardiac hypertrophy and failure has instigated numerous 
studies, both experimental and clinical. A common finding is the presence of structural and elec-
trical reconstitution of the overloaded myocardium. Many of the molecular safeguards of electrical 
stability undergo functional or expressional alterations, or both, often by genetic reprogramming. 
Collectively, these alterations are termed electrical remodeling.
Electrical remodeling is a key characteristic of normal development, expressing functional adap-
tation to increasing hemodynamic demands during cardiac growth (e.g., see Reference 12). In 
congenital and acquired heart disease, when hemodynamic load exceeds physiologic limits, the 
plasticity of the (mal)adaptive response systems determining electrical stability is challenged. The 
growing list of molecules affected in such conditions comprises ion channels and transporters, 
components of the Ca2+-handling machinery, and structural proteins of the myocytes and inter-
stitium [13]. Importantly, their alterations may already be significant in an early stage of overload, 
when contractility is still adequate to maintain cardiac output at (near-)normal levels. This might 
explain, at least in part, why a relatively high proportion of patients with compensated or mildly 
decompensated myocardial function is susceptible to arrhythmias and SCD.
A hallmark of electrical remodeling in hypertrophy and failure, independent of the cause, is prolon-
gation of the ventricular action potential (for excellent reviews, refer to Tomaselli and coworkers [5, 
13]). For the human heart, action potential prolongation occurs both in compensated hypertrophy 
[14] and in terminal heart failure [15,16]. In the three-dimensional structure of the heart, regional 
differences in action potential duration (across the ventricular wall, between the ventricles, and 
from base to apex) may exaggerate during hypertrophy [17,18] and failure, [19,20] and predis-
pose to ventricular arrhythmias. Conversely, a reduction in electrophysiologic gradients may also 
be proarrhythmic (see Chapter 22)1. Changes in repolarization may present as perturbations of 
the normal epicardial to endocardial direction of recovery from electrical activation, which can 
turn arrhythmogenic [21]. QT-interval labilities in patients with ischemic and nonischemic dilated 
cardiomyopathy, [22] and other disorders with hypertrophy or failure, are another indication that 
the substrate for arrhythmias is related, at least in part, to impaired repolarization. Importantly, the 
1 Cardiac Mechano-Electric Feedback and Arrhythmias: From Pipette to Patient. 2005 
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presence of severe repolarization abnormalities can be hidden under a “normal” action potential 
morphology and duration, or a “normal” QT interval in the surface ECG. In such conditions, a 
modest challenge of electrical stability can evoke profound proarrhythmic responses.
Repolarization lability in cardiac hypertrophy and failure is commonly based on K+-channel down-
regulation [23,24] and altered Ca2+ homeostasis [25]. These changes may have a gene-transcriptional 
basis, [26,27] although some reports indicate the additional importance of post-transcriptional 
alterations [28]. Information about the exact time course of electrical changes and underlying 
molecular mechanisms is scarce. Also, the identity of mechanical or biochemical stimuli that trigger 
electrical remodeling is largely unknown.
Proarrhythmia in compensated ventricular hypertrophy: the dog model with chronic 
complete atrioventricular block
A dog model of volume overload caused by complete atrioventricular block (AVB) has been exten-
sively studied. Important electrical, contractile, and structural alterations of the myocardium are 
found in this model [18,29]. Myocardial adaptation is associated with an enhanced susceptibility 
to torsades de pointes [18,29] and SCD. Most dogs exhibit compensated contractile function in the 
chronic stage of AVB (CAVB). Figure 2 illustrates the key features of this model as currently known. 
In vivo electrophysiologic recordings reveal significant QT prolongation with broad-based T waves 
in CAVB. Monophasic action potential recordings from the endocardium indicate that repolariza-
tion prolongation is more prominent in the LV than the right ventricle (RV), leading to exaggerated 
interventricular dispersion of repolarization. Torsades de pointes occur often spontaneously or can 
be readily induced by programmed electrical stimulation, repolarization-prolonging drugs, or both, 
which makes this animal model suitable for chronic studies of proarrhythmia.
At the cellular level, significant down-regulation of the K+ currents IKs and IKr [24], in combination 
with enhanced Na+-Ca2+ exchange [31], contribute to the alteration of spatial and temporal action 
potential heterogeneities. In addition, enhanced sarcoplasmic reticulum Ca2+ release [31] and an 
increased Na+ concentration [32], together with enhanced Na+-Ca2+ exchange, can cause Ca2+-
dependent abnormal impulse formation [33].
Regarding the K+ channel down-regulation, important information comes from a recent study of 
KCNQ1 and KCNE1, the genes encoding for the α and β subunit of the IKs channel [27]. Results 
are shown in Figure 3. In CAVB, KCNQ1 complementary DNA (cDNA; reverse-transcribed from 
messenger RNA) decreases by 80% and 90% in the LV and RV, respectively. KCNE1 cDNA diminishes 
by 70% and 75%. KCNQ1 protein expression in CAVB is decreased by 60% and 45% in the LV and 
RV, whereas the expression of KCNE1 decreases by 60% and 70%, respectively. The earlier finding 
of a 50% (LV) and 55% (RV) reduction in IKs density [24] is in good agreement with this molecular 
data. Taken together, these findings (and additional results not described here [27]) indicate that 
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Figure 2  Dog model with chronic atrioventricular block (CAVB). Top left, Acquired QT prolongation. ECG leads II and aVF and simultaneous 
monophasic action potential recordings from the endocardium of the left (LV MAP) and right ventricle (RV MAP). Bottom left, Spontaneous 
torsades de pointes (TdP) deteriorating into ventricular fibrillation (VF) with hemodynamic collapse. ECG lead II and LV pressure (LVP) 
recordings during anesthesia. After successful defibrillation, electrical and hemodynamic stability was regained within minutes. Right, 
Cellular basis of proarrhythmia in dilative ventricular hypertrophy after CAVB. Transmembrane action potential prolongation and enhanced 
Ca2+ release from the sarcoplasmic reticulum (second and third row from the top, respectively) are typical features. Enhanced Na+-Ca2+-
exchange activity and down-regulation of the delayed-rectifier K+ current I
Ks
 (bottom traces) contribute to action potential prolongation. SR, 
sinus rhythm; AAVB, Acute atrioventricular block. (Top left, Reproduced from Volders PGA, Sipido KR, Vos MA, et al: Downregulation of 
delayed rectifier K+ currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100:2455–
2461, 1999, by permission of the American Heart Association; bottom left, acknowledgment to Jet D. M. Beekman, Department of Medical 
Physiology, University Medical Center Utrecht, Netherlands.).
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Figure 3  Reduction of I
Ks
 in chronic atrioventricular block (CAVB) is caused by down-regulation of KCNQ1 and KCNE1 mRNA and protein 
expression. Top, Competitive multiplex reverse transcription polymerase chain reaction (PCR) showed CAVB-induced reduction of KCNQ1 
and KCNE1 complementary DNA (messenger RNA). Middle left, Western blot of myocardial proteins from left ventricle (LV) and right 
ventricle (RV) of a sinus rhythm (SR) and CAVB dog. Probing with KCNQ1 polyclonal antibody identified two bands with molecular weights 
(MW) of ~72 and ~120 kDa at SR. Bottom left, Experiments repeated on total proteins (Total) and membrane proteins (Mem.) isolated from 
LV cardiac myocytes at SR. Both 72- and 120-kDa bands were recognized in the total protein preparation, but only the 120-kDa band was 
predominant in proteins isolated from the membrane fraction. At the right, to verify that both bands were linked to KCNQ1, immunoblots 
were performed using preabsorbed (Pre-ab.) KCNQ1 antibodies. Middle right, Western blot of proteins extracted from the LV and RV of 
SR and CAVB dogs (Dogs 1 to 3) and probed with KCNE1 polyclonal antibody. The KCNE1 antibody recognized a band ~35 kDa and a 
faint band ~20 kDa in SR. In both blots (left and right), densitometric analysis revealed significant down-regulation of KCNQ1 and KCNE1 
proteins during CAVB in both ventricles. Bottom right, Control Western blots using proteins probed with anti-KCNE1 antibodies (Ctrl.) or 
with antibodies preabsorbed against the KCNE1 antigen (Pre-ab.), showing that the 35-kDa antigen contained the KCNE1-specific epitope. 
*P<0.05; **P<0.01 (SR vs. CAVB); †P<0.05 (RV vs. LV). (Modified from Ramakers C, Vos MA, Doevendans PA, et al: Coordinated down-
regulation of KCNQ1 and KCNE1 expression contributes to reduction of I
Ks
 in canine hypertrophied hearts. Cardiovasc Res 57:486–496, 
2003, with permission).
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the decrease of IKs involves the regulation of KCNQ1 and KCNE1 gene expression at the transcrip-
tional and translational levels.
mISSINg l INkS BETwEEN CHRoNIC mECHANICAl oVERloAD AND 
ElECTRICAl REmoDElINg
In the previous section, we described the molecular down-regulation of KCNQ1 and KCNE1 proteins 
that coassemble to form the IKs channel. For all acquired channelopathies currently known to us, 
the primary stimuli for down-regulation are unknown. However, mechanical stimuli are obvious 
candidates.
Recently, we have quantified mechanical overload in the dog model with AVB and found that 
diastolic stress, diastolic strain (i.e., stretch), systolic strain, and stroke work are all significantly 
increased at the myocardial level [34]. The imposition of bradycardia-induced volume overload is 
followed by the development of ventricular hypertrophy and QT prolongation. Whether and how any 
(or all) of the mechanical changes could influence IKs channel expression through transcriptional or 
translational regulation, or both (or other molecular mechanisms), is an intriguing question.
In contemporary working models of mechanosensing and -transduction by the cardiac myocyte, a 
major role is attributed to a protein complex of integrin ß1D/talin/melusin at the sarcolemma/Z-disc, 
whose importance in pressure overload has been demonstrated [35]. In addition, some cardiac 
mechanical stretch sensor machinery incorporates a protein complex of titin, muscle LIM protein 
(MLP), and telethonin (T-cap) interacting at the Z-disc (Figure 4A) [36]. Defects in the MLP/T-cap 
complex lead to dilative cardiomyopathy in MLP-/- transgenic mice and a subset of human dilative 
cardiomyopathy [36]. Furukawa and colleagues [37] have described that the extreme C-terminal 
region of T-cap binds to the cytoplasmic domain of KCNE1 (=minK; see Figure 4B). It is attractive 
to speculate that this molecular chain of titin/MLP/T-cap/KCNE1 serves as conduit for mechano-
electric remodeling. Whether and how the findings of gene-transcriptional and translational altera-
tions [27] fit into this hypothetical scheme remains to be determined.
Mechanical influences could also alter transcriptional activity through the intermediate filament 
protein desmin. Bloom and colleagues [38] have shown that changes in the spatial arrangement 
of both the desmin–lamin intermediate filament network and the nuclear envelope–associated 
chromatin can be induced by mechanical stretch. We have recently found that desmin expression 
decreases early after the induction of AVB in dogs [39], parallel to IKs down-regulation, which could 
also indicate a mechano-electric link.
More research is needed to answer these important questions of mechano-electric coupling during 
chronic overload.
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Figure 4  A Proposed working model of the cardiac stretch sensor machinery. Top, Normal conditions. Titin, anchored between Z-disc 
and M-line, exhibits elastic “molecular springs” (I band). Titin is able to store force generated by systolic compression (systole), and it 
largely determines passive myocardial stiffness (diastole). With increasing diastolic wall stress, the titin/MLP/telethonin (T-cap) complex 
is stretched and mechanical load is sensed. Bottom, Loss of the MLP/T-cap complex in knockout mice (MLPKO) causes a defective 
stretch-sensor function, ultimately leading to dilative cardiomyopathy (DCM), which, in turn, enhances wall stress and mechanical stretch 
stimuli. B, Model for the titin/T-cap/minK complex in cardiac myocytes. Top, Detection of T-cap by immunoelectron microscopy in skeletal 
muscle. T-cap is clustered where membrane structures corresponding to T-tubules and terminal cisternae contact the Z-line periphery 
(arrows). Bottom, Summary of known interactions of titin, T-cap, and minK (=KCNE1). T-cap connects the myofibrillar apparatus to the 
sarcolemma at the Z-line periphery. Phosphorylation of the C-terminal tail of the T-cap by yet unidentified kinases may regulate the stability 
of the complex. (A, Reproduced from Knöll R, Hoshijima M, Hoffman HM, et al: The cardiac mechanical stretch sensor machinery involves 
a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111:943–955, 2002, with permission; B, reproduced 
from Furukawa T, Ono Y, Tsuchiya H, et al: Specific interaction of the potassium channel β-subunit minK with the sarcomeric protein T-cap 
suggests a T-tubule-myofibril linking system. J Mol Biol 313:775–784, 2001, with permission.).
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Reversibility of electrical remodeling by mechanical unloading?
New insights in the role of mechanical overload derive from studies of cardiac unloading. Different 
strategies have been successfully proven to decrease LV hypertrophy and improve cardiac contrac-
tility after relief from chronically increased mechanical load [40]. Thus, contractile remodeling 
is potentially reversible, which could also apply to electrical remodeling. Patients treated for 
hypertension with enalapril [41] and losartan [42] exhibited decreased rate-corrected QT intervals. 
Several experimental studies showed related findings [43,44]. It is conceivable that the treatment 
with drugs affects signaling cascades independent of a reduction of mechanical load. However, 
pure mechanical unloading can also lead to a normalization of altered electrical properties [45,46]. 
This underscores the importance of mechano-transduction for the reversal of electrical remodeling 
during unloading, even after months and years of overload.
In contrast, other studies have reported that reverse electrical remodeling is absent during drug 
treatment [47], surgical intervention [48], or ventricular pacing (in CAVB) [49]. These issues clearly 
are not settled (see Chapters 34 to 37)2. Further investigations are warranted.
electro-mechanical remodeling
It can be concluded from the previous sections that chronic mechanical overload might well insti-
gate and modulate electrical remodeling, and vice versa, that altered electrical properties of hyper-
trophied cardiac myocytes can also influence contraction, and thereby myocardial mechanics.
In rodents, action potential prolongation may set the stage for increased Ca2+ transients [50]. 
thus enhancing contraction and systolic mechanical load. Sah and colleagues [51] have shown 
that membrane repolarization by the transient outward current, Ito, modulates the recruitment and 
synchronization of sarcoplasmic reticulum Ca2+ release through the L-type Ca2+ current. Interest-
ingly, the same group demonstrated in quiescent neonatal rat ventricular myocytes that a reduc-
tion of Kv4.2/3 (responsible for Ito) is followed by hypertrophy, with a proposed causal role for 
Ca2+-dependent activation of calcineurin [52]. Although the causality has been questioned [53], 
these data suggest that the relation between altered electrical properties and cellular hypertrophy 
may not always incorporate mechanical stimuli.
Based on studies with the Ca2+ indicators aequorin [54] and Indo-1 [55], Ca2+-dependent diastolic 
dysfunction may also directly influence diastolic mechanics.
In the canine model with CAVB, yet another mechanism of electro-mechanical remodeling applies. 
Action potential prolongation and altered cellular Ca2+ and Na+ handling contribute to enhanced 
contractile performance, but also to proarrhythmia [31]. Systolic strain, representing myofiber 
deformation during contraction, was significantly increased in AVB, in addition to a greater diastolic 
mechanical load [34]. This can be interpreted as a direct mechanical consequence of the described 
electrical alterations.
2 Cardiac Mechano-Electric Feedback and Arrhythmias: From Pipette to Patient. 2005
Boek_Donker_v5.indb   47 21-7-2008   10:21:25
48
Taken together, the available data suggest that chronic mechano-electric feedback forms a closed-
loop system with electro-mechanical remodeling, which was presented in detail in the introductory 
chapters of this book (see Preface)3.
NEED FoR SERIAl IN V IVo ASSESSmENT oF myoCARDIAl 
mECHANICS DuRINg CHRoNIC oVERloAD
Quantification of the mechanical load imposed on the myocardium during chronic overload could 
offer mechanistic insights and improve clinical decision making. Recent techniques of tagged 
magnetic resonance imaging [56] and ultrasound strain-rate imaging [57] may provide this informa-
tion. We have developed an alternative method to quantify myocardial mechanics, combining trans 
thoracic echocardiography, invasive LV pressure recordings, and mathematical modeling (Figure 
5) [34, 58]. This method is feasible in anesthetized experimental animals and also in patients. 
Myofiber stress (sf; kPa) is defined as mechanical force per myofiber cross-sectional area and is 
calculated as:
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with VLV and VW representing LV cavity and wall volume. Natural myofiber strain (ef; dimensionless), 
representing deformation, is defined as the natural logarithm of myofiber length (l) relative to its 
reference length (lref) at beginning of ejection during sinus rhythm:
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 Eq 2.
Myofiber stroke work (wf; kJ/m
3/beat) is computed as the area of the sf-ef loop, a local analog of 
the LV pressure–volume loop:
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3 Cardiac Mechano-Electric Feedback and Arrhythmias: From Pipette to Patient. 2005
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Figure 5  Serial quantification of myofiber mechanics throughout the cardiac cycle during chronic ventricular overload. Anesthetized dogs, 
before (sinus rhythm [SR]) and in chronic atrioventricular block (CAVB; 6 weeks). Top to bottom, Echographic M-mode (left ventricular [LV] 
mid-papillary plane). Endocardial and epicardial borders were delineated to calculate LV cavity and wall volume, incorporating longitudinal 
axes. LV dimensions during the cardiac cycle were electrocardiogram (ECG)-synchronized with LV pressure (LVP). Note time marker on ECG 
tracing in SR. A validated mathematical model [58] was used to calculate myofiber stress (s
f
), natural myofiber strain (e
f
; dimensionless), 
and myofiber stroke work (w
f
) represented by the area of the s
f
-e
f
 loop. Note that a negative e
f
 during systole indicates myofiber shortening. 
A positive e
f
 during diastole designates outward deformation; both occur during CAVB.
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Our approach allows serial mechanical phenotyping during long-term cardiac overload to: (1) char-
acterize the nature and timing of mechanical stimuli throughout the cardiac cycle (see Figure 5); (2) 
discern the effects of mechanical versus other stimuli of remodeling; (3) define the transition from 
a functionally compensated to a decompensated state; and (4) evaluate the effects of medical and 
surgical interventions influencing cardiac overload.
Widespread experimental and clinical application of the aforementioned techniques is awaited and 
may help to characterize serial mechanical phenotypes in chronic heart disease and their link to 
electrical and structural remodeling.
CoNCluSIoNS
Mechanical load is chronically increased in common cardiac diseases such as hypertension, valvular 
heart disease, and myocardial infarction. Ventricular hypertrophy often ensues as an adaptational 
response, but it is associated with significant morbidity and mortality. Electrical remodeling, notably 
impaired ventricular repolarization, can pose significant problems. It can manifest as prolongation 
of the ventricular action potential, but it may also be hidden under a “normal” action potential 
morphology and duration. The underlying alterations of K+ current expression and Ca2+ handling 
often are based on changes of genetic transcription or post-transcriptional modification.
Currently, the role of pathologic mechanical load to the molecular mechanisms initiating and main-
taining electrical remodeling is not understood. Recent findings indicate that myofiber stress or 
strain, or both, are primary mechanical stimuli sensed by the myocytes through protein complexes 
of integrin ß1D/talin/melusin at the sarcolemma/Z-disc and/or titin/MLP/T-cap at the Z-disc. A 
physical connection between the titin/T-cap complex and the ß subunit of the IKs channel, KCNE1, 
has been demonstrated and might be involved in the transduction of mechanical overload to K+ 
channel down-regulation. The translation of these elementary findings to mechano-transduction 
in the intact heart of humans and animal models requires detailed knowledge of the characteristics 
of myocardial mechanics during chronic overload. In the dog model with CAVB, increased diastolic 
stress, diastolic strain, systolic strain, and stroke work are associated with transcriptional changes 
of the IKs channel subunits KCNQ1 and KCNE1. A causal role for the mechanical stimuli is speculative 
and should be investigated at the molecular-genetic level.
The available data on cardiac electrophysiology and mechanics in chronic overload convince us 
that, as in acute studies, electro-mechanical signaling forms a closed-loop system with mechano-
electric feedback. Our new approach of calculating mechanics in the intact beating heart may 
prove useful for understanding how mechano-transduction may lead to remodeling.
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End-diastolic myofiber stress and 
ejection strain increase with 
ventricular volume overload 
Serial in-vivo analyses in dogs with 
complete atrioventricular block
Chapter 3
Myofiber mechanics in ventricular volume overload
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ABSTRACT
Background Myocardial stress and strain are considered primary mechanical stimuli for hypertro-
phic remodeling. Their values and significance in the intact beating heart during chronic overload 
remain poorly characterized. 
methods and Results Left-ventricular (LV) dimensions (echocardiography) and pressure (invasive) 
were simultaneously recorded in anesthetized dogs at sinus rhythm (SR), acute and 1, 2, 6, 12 
weeks of atrioventricular block (AVB), leading to structural, electrical and contractile remodeling. 
Mechanical load of the myocardium was quantified as myofiber stress (sf), being force along 
myofiber orientation per cross-sectional area, and natural myofiber strain (ef), being change in 
natural logarithm of myofiber length (l) divided by its reference length: ef = ln(l/lref). Time courses of 
sf and ef were calculated from LV pressure and dimensions, using a validated mathematical model 
of cardiac mechanics. End-diastolic sf increased from 2.0±0.1 kPa at SR to 3.4±0.3 kPa at acute 
AVB, remaining elevated for > 6 weeks. Systolic sf was not affected by AVB. Ejection strain rose 
instantly upon AVB, reaching a maximum at 2 weeks: 0.24±0.02 vs. 0.10±0.01 at SR. The increase 
of myofiber stroke work (sf-ef loop area) from 3.1±0.3 at SR to 6.0±0.5 kJ/m3/beat at 1 week AVB 
was attributed mainly to an increase of strain during ejection. Stroke work and ejection strain 
remained elevated up to 12 weeks. The rate of LV-mass increase was maximal (2.2±0.4 g/day) at 
1 week AVB.
Conclusions Serial mechanical phenotyping is feasible in the intact anesthetized dog with chronic 
ventricular overload. Our new approach yields values of mechanical load that are comparable to 
those found in isolated myocardium by others. In chronic AVB, both end-diastolic myofiber stress 
and ejection strain are increased. Early increases of both parameters coincide with peak hypertro-
phic growth, suggesting their important role for mechanotransduction. Peak systolic sf is likely not 
important for hypertrophy in this model, since it does not change throughout the experiment. 
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INTRoDuCTIoN 
It has long been recognized that cardiac hypertrophy is the adaptive response to altered hemody-
namic loading and that it is load-specific (e.g., pressure versus volume overload) [9,17]. In most, 
if not all, experimental models of overload, stress and strain are primary mechanical stimuli for 
hypertrophic remodeling [11,21,24]. Myofiber stress is defined as mechanical force along the 
myofiber direction per cross-sectional area and natural myofiber strain as the change in the loga-
rithm of myofiber length divided by its reference length. In cultured neonatal myocytes, stress and 
strain trigger mitogen-activated protein- and other kinase cascades, protooncogene expression 
and increased protein turnover [15,27,38]. Based on these elementary studies, the nature, degree, 
direction and timing of mechanical load during the cardiac cycle all appear crucial input factors for 
the activation of biochemical signals [15,21,27,38]. 
Despite the plethora of in vitro data on mechanotransduction over the last 15 years, exact quanti-
fication of mechanical stimuli at the tissue level and their significance for remodeling in the intact 
beating heart remain poorly identified, mainly due to methodological constraints. Calculation of 
wall stress finds widespread use, but is often based on isotropic tissue behavior or is limited to the 
analysis of meridional or circumferential components of stress. Thereby, the assessment of myocar-
dial mechanics strongly depends on ventricular geometry and the site of measurement. Invasive 
analysis of stress and strain with intramyocardially applied probes is cumbersome and limited to 
acute experiments or ex vivo studies only, which makes them unsuitable for serial analyses in the 
same patient or experimental animal. 
In recent years, we and others have extensively studied a canine model of volume overload due to 
complete atrioventricular block (AVB). Important electrical, contractile and structural alterations 
of the myocardium are found in this model [28,34,35,37]. Myocardial adaptation is associated with 
an enhanced susceptibility to torsades-de-pointes ventricular arrhythmias [25,34,35] and sudden 
cardiac death [32]. Most dogs exhibit compensated contractile function in the chronic stage of AVB 
[37]. The impetus to the present study was the lack of quantitative information on the mechanical 
stimuli, imposed on the myocardium in AVB, which potentially trigger structural and functional 
adaptations. Therefore, we sought to circumvent the constraints of intramyocardial measurements 
in vivo by factoring ventricular dimensions and pressure into a validated mathematical model of 
myocardial mechanics [1]. By doing so, we were able to estimate stress and strain in the myofibers 
of the tissue in a serial manner before and after induction of AVB. Thus, cardiac mechanical pheno-
typing was made possible in the intact anesthetized dog with chronic ventricular overload. 
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mETHoDS 
Experiments were conducted in accordance with the Dutch Law on Animal Experimentation and 
the European Directive for the Protection of Vertebrate Animals Used for Experimental and Other 
Scientific Purposes (86/609/EU). The Committee for Experiments on Animals of Maastricht Univer-
sity approved the experiments. 
Experimental model 
Adult mongrel dogs of either gender (27±1 kg) were used. After overnight fasting, premedica-
tion (0.15 mg/kg acepromazine, 0.4 mg/kg methadon, 0.06 mg/kg atropine i.m.) was administered. 
Animals were anesthetized with pentobarbital (20 mg/kg i.v.) and mechanically ventilated with 
a mixture of oxygen (40%), nitrous oxide (60%) and halothane (0.5–1% vapor concentration). 
A complete description of the perioperative care has been given before [35]. In 8 dogs AVB was 
induced by radio-frequency catheter ablation of the His bundle. All animals were studied serially 
at sinus rhythm (SR; control), acute AVB and 1, 2, 6 and 12 weeks thereafter. A standard 6-lead 
ECG was registered to synchronize left-ventricular (LV) echocardiographic and pressure recordings. 
At the end of the experiments the animals were sacrificed, their hearts excised and weighed. LV 
myocytes were enzymatically isolated to determine cell length and width in 50 randomly selected 
cells per animal. In addition, 7 dogs were sacrificed at SR for control purposes to compare cellular 
dimensions and heart weights at autopsy. 
LV pressure 
A 7F catheter (Sentron, Roden, Netherlands) was introduced into the LV cavity via the femoral artery 
to monitor pressure (pLV). End-diastolic (pLV,ed), peak-systolic pressure (pLV,syst), and the maximum 
rate of pressure rise (dpLV/dtmax) were determined off-line using custom-made software (IDEEQ, 
Maastricht University). 
LV dimensions 
Transthoracic echocardiography was performed (3.5 MHz transducer, Megas Ultrasound System, 
Esaote, Genoa, Italy). LV long axis inner diameter was measured from left parasternal long-axis 
views as the minimum (systole) and maximum (diastole) distance between the inner wall of the apex 
and the mitral-valve plane. LV M-mode recordings were derived from right parasternal short-axis 
views in the mid-papillary plane. Video frames were digitized and processed using custom-made 
software (IDEEQ, Maastricht University), allowing for the determination of endo- and epicardial 
borders, and short-axis diameters and wall thickness. Mean wall thickness was the average of 
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posterior and septal wall thickness. LV mass was estimated according to Reichek et al. [23]. The 
estimation of apical wall thickness and the calculation of LV cavity (VLV) and wall volume (VW) are 
described in the Appendix. 
Myofiber mechanics 
Conventionally, mechanical load of the cardiac wall is quantified by hoop stress, i.e.,the stress in 
circumferential direction, using models of wall mechanics [6,16], based on Laplace’s law. Hoop 
stress provides an underestimate of myofiber stress by about 40% [1]. Myofiber stress is defined 
as the force of the myofibers in the wall, as normalized per cross-sectional area. For most clinical 
applications that underestimation is not a problem, because the related correction factor is about 
fixed for a given heart. Changes in hoop stress follow changes in myofiber stress. In the present 
study, myofiber stress is quantified because this stress compares directly to the stress measured in 
experiments on isolated cardiac muscle [3], thus indicating its physiological importance. Myofiber 
stress is considered to be related to physiological processes in the neighborhood of the cells in the 
tissue, such as adaptation and remodeling. Complicated finite element models may provide the best 
estimates of myofiber stress [14,30], but they are difficult to handle. As a compromise between 
accuracy and simplicity a model [1] has been used to calculate average myofiber stress (sf) from LV 
pressure (pLV) and the ratio of cavity volume (VLV) to wall volume (VW) as illustrated in Figure 1: 
Myofiber stress: 
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 Eq. 1 
In a theoretical evaluation [1], the accuracy of the myofiber stress thus calculated was approxi-
mately 5%, showing that the major geometric determinant was the ratio VLV/VW, whereas all other 
geometric properties appeared of secondary importance. In the present study, the term “myofiber” 
designates a tissue bundle of interconnected cardiomyocytes embedded in an extracellular matrix. 
During systole, cardiomyocytes account for the active stress development, and during diastole, 
the passive stress development is partitioned between the extracellular matrix (collagen) and the 
cytoskeletal components contributing to the intrinsic passive properties of the cardiomyocyte 
(titin) [8]. The loa  bearing myofibers that contribute to cavity pressure are assumed to be mainly 
parallel to the curved wall surface. Average natural strain of the myofibers (ef) has been defined as 
the natural logarithm of myofiber length (l), relative to its reference length (lref). Using the physical 
principle of conservation of energy, it is derived from Eq. 1 that [1]: 
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Myofiber strain: 
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 Eq. 2 
This equation for myofiber strain has been validated in the open-chest canine heart [4], where fiber 
strain was measured directly on the epicardial surface by video. 
For dynamic strain changes during the cardiac cycle (ef,dyn), we used end-diastole as the reference 
state. Ejection strain (∆ef,ej), representing myofiber shortening during systole, was defined as the 
decrease of ef,dyn during ejection: 
Figure 1  Model of myofiber mechanics. Left side, myofibers (dark gray) are embedded in a truncated ellipsoid representing the LV. 
Dynamic changes of myofiber strain (e
f
) defined as the ratio of instantaneous myofiber length (l) (e.g., systole) compared to diastolic length 
(l
ref
) are largely determined by myofiber stress (s
f
). Echocardiographic LV dimensions are assessed in the mid-papillary plane (short-axis 
scan). Right side, from top to bottom, echocardiographic M-mode serves to determine LV septal (h
W,s
), posterior wall thickness (h
W,p
) and 
inner diameter (d
i
) in order to calculate LV-cavity (V
LV
) and wall volume (V
W
), incorporating long axes (not depicted). LV dimensions are ECG 
synchronized with LV-cavity pressure (p
LV
). Mathematical modeling of these global LV quantities provides values of s
f
 and e
f
 throughout 
the cardiac cycle. 
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 Eq. 3 
Ejection strain:      
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The subscripts ‘e ’ and ‘es’ refer to end diastole and end systole, respectively. To compare the end-
diastolic states of cardiac cycles between different experimental time points, myofiber strain of the 
end-diastolic midwall circumference is compared to its length at SR (ef,ed). It is used: 
End-diastolic strain:
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 Eq. 4 
During the cardiac cycle (Eq. 3), wall volume remains constant. Note that, as compared to LV-cavity 
volume (VLV,ed,SR) and LV-wall volume (VW,SR) at end-diastole during SR (Eq. 4), both LV-cavity volume 
at end-diastole (VLV,ed) and VW may change due to structural remodeling after AVB. 
During diastole, the short-axis cross-section of the LV deforms to non-circularity due to gravity. 
Thus, M-mode-derived diastolic cavity diameter is not appropriate for determination of cavity 
cross-sectional area. During isovolumic contraction, cavity volume, cavity area and cavity circum-
ference all remain practically constant, whereas the cross-section becomes practically circular. 
Thus, M-mode-determined diameter during the isovolumic contraction phase is used to estimate 
end-diastolic volume. In this analysis, the latter diameter is determined at the moment pLV reaches 
half of its systolic peak value. 
Total LV stroke work, represented by the area of the pLV-VLV loop, equals wall volume times myofiber 
stroke work. Myofiber stroke work wf is computed as: 
Myofiber stroke work:
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 Eq. 5
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Statistical analysis 
Data are presented as mean±SEM. Differences by repeated measures ANOVA or unpaired Student’s 
t-test (post-mortem heart weights and micromorphometry) are considered significant when 
P<0.05. 
RESulTS 
Hemodynamics 
Induction of AVB reduced the heart rate from 111±5 at SR to 56±3 beats/min at idioventricular 
rhythm (P<0.05; Table 1). Acute bradycardia decreased cardiac output from 2.8±0.4 to 1.6±0.2 
L/min (P<0.05) and was accompanied by an elevation of pLV,ed (0.7±0.0 to 1.1±0.1 kPa; P<0.05) 
[35]. Systolic pLV remained unaltered (Figure 2). Total LV stroke work (pLV-VLV-loop area in Figure 2) 
showed an increase that became significant from acute AVB onwards (from 0.30±0.04 J/beat at SR 
to 0.56±0.06 J/beat at 1 week; P<0.05). 
LV contractile performance was enhanced during AVB, as evident from the instantaneous increase 
of fractional shortening and the more delayed, but significant rise of dpLV/dtmax (Table 1). Both 
SR AAVB 1 week 2 weeks 6 weeks 12 weeks
LV pressure
  Peaksystole, kPa 12.8 ± 0.4 12.8 ± 0.7 13.0 ± 0.4 13.4 ± 0.3 14.0 ± 0.2 11.9 ± 0.2 
  Enddiastole, kPa 0.7 ± 0.0 1.1 ± 0.1* 1.1 ± 0.1* 1.0 ± 0.1* 1.1 ± 0.1* 0.8 ± 0.1 
  Maximum rise, kPa/s 243 ± 28 239 ± 30 371 ± 37* 364 ± 26*  321 ± 19* 230 ± 6 
Cardiac output, L/min 2.8 ± 0.4 1.6 ± 0.2* 1.5 ± 0.3* 2.2 ± 0.2 2.7 ± 0.2 2.5 ± 0.4 
Fractional shortening, % 20.4 ± 1.8 26.9 ± 2.1* 37.2 ± 3.9*  37.7 ± 4.3* 35.7 ± 3.6*  32.0 ± 3.3* 
Total LV stroke work, J/beat 0.30 ± 0.04 0.43 ± 0.09* 0.56 ± 0.06* 0.61 ± 0.05* 0.78 ± 0.07* 0.72 ± 0.13* 
Heart rate, beats/min 111 ± 5 56 ± 3* 42 ± 4* 42 ± 3* 43 ± 2* 39 ± 2* 
PP interval, ms 549 ± 26 416 ± 30* 577 ± 23  600 ± 29 620 ± 46 586 ± 29 
SR sinus rhythm; AAVB acute complete atrioventricular block; LV left ventricle; *P<0.05 vs. SR
Table 1  Hemodynamic and electrocardiographic measurements 
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parameters reached their maximal values at 1–2 weeks AVB. This contractile enhancement could 
be due to an elevated preload and neurohumoral activation [35]. The latter is reflected in the 
decreased PP interval during acute AVB (416±30 vs. 549±26 ms at SR; P<0.05; Table 1; Figure 2). 
The early decline of cardiac output, expressing incomplete circulatory compensation, was largely 
overcome by 2 weeks AVB. Hemodynamic status stabilized in the chronic phase thereafter despite 
a further slowing of heart rate (Table 1; Figure 2). 
LV dimensions and hypertrophy 
Serial echocardiography revealed that diastolic LV-cavity dimensions and wall thickness remained 
unchanged in the acute phase after induction of AVB (Figure 2). During chronic AVB, diastolic 
dimensions increased mainly along the longitudinal axis, whereas wall thickness did not signifi-
cantly alter (Table 2). Echocardiographic LV mass had already increased after 1 week. LV-mass 
increment per day was most prominent in the first week after AVB. Thereafter, it still increased, but 
far more gradual (Figure 3). 
Figure 2  Upper panels, M-mode echocardiograms of the LV septal and posterior wall synchronized with p
LV
 in a representative anesthe-
tized dog. Upon the creation of AVB, a narrow QRS-complex idioventricular rhythm ensued. Bradycardia was most pronounced at ≥1 week 
AVB. Note that the PP interval was shortened in the acute phase (AAVB). Lower panels, p
LV
-V
LV
 loops at the same time points. The area 
bounded by the p
LV
-V
LV
-loop trajectory represents total LV stroke work.
Boek_Donker_v5.indb   67 21-7-2008   10:21:28
68
Figure 3  Time course of hypertrophy after AVB. Note that the LV-mass increase per day 
(lower trace) was most pronounced in the first week. Photomicrographs illustrate predominant 
lengthening of LV cardiomyocytes during chronic AVB. Note that the scale bar applies to both 
photomicrographs. *P<0.05 vs. SR
SR AAVB 1 week 2 weeks 6 weeks 12 weeks
Short axis inner diameter
  Diastole, mm 39.8 ± 1.4 40.9 ± 1.6 41.6 ± 1.5 42.4 ± 1.4 44.4 ± 1.7 45.9 ± 2.0 * 
  Systole, mm 31.7 ± 1.3 29.8 ± 0.9 26.1 ± 1.9 *  26.5 ± 1.8 * 28.5 ± 1.8 * 31.1 ± 1.7 
Long axis inner diameter
  Diastole, mm 70.3 ± 2.5 68.4 ± 2.7 75.2 ± 1.9 * 75.7 ± 1.6 * 86.7 ± 1.8 * 90.3 ± 1.4 * 
  Systole, mm 63.9 ± 2.4 55.7 ± 2.1 * 54.8 ± 4.4 * 52.5 ± 3.7 * 64.2 ± 2.1 69.3 ± 2.9 * 
Mean wall thickness
  Diastole, mm 9.6 ± 0.5 9.3 ± 0.7 9.5 ± 0.4  9.4 ± 0.4 9.3 ± 0.3 9.2 ± 0.4 
  Systole, mm 13.1 ± 0.8 13.9 ± 1.0 15.2 ± 1.2 14.9 ± 1.1 14.3 ± 1.1 13.8 ± 0.6 
SR indicates sinus rhythm; AAVB acute complete atrioventricular block. *P<0.05 vs. SR
Table 2  Left-ventricular dimensions
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At sacrifice after 12 weeks AVB, total heart weights (323±13 g) and heart-weight-to-body-weight 
ratios (12.0±0.3 g/kg) were significantly larger than those of the control population of dogs with 
normal SR (216±8 g and 8.1±0.3 g/kg, respectively; both P<0.05). 
Micromorphometry showed predominant cardiomyocyte lengthening: 161±4 µm at 12 weeks AVB 
vs. 139±5 µm at SR; +16%; P<0.05). Cellular width changed to a lesser degree (+11%; 25.8±0.7 vs. 
23.3±0.3 µm, respectively; P<0.05; Figure 3). 
Myofiber mechanics 
Stable ECG-synchronized tracings of sf and ef throughout the cardiac cycle were reproducibly 
obtained in all animals at control, acute and chronic AVB. Examples for a representative dog are 
shown in Figure 4. 
Peak-systolic sf was not significantly affected by the presence of AVB. In contrast, end-diastolic sf 
increased instantaneously from 2.0±0.1 kPa at SR to 3.4±0.3 kPa at acute AVB, remained as high 
Figure 4  Representative examples of myofiber mechanics throughout the cardiac cycle in an individual dog before and after AVB. s
f
 and 
e
f
 are time-linked to ECG and p
LV
.
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until 6 weeks, with little change thereafter (3.7±0.4 to 2.9±0.4 kPa; 6 to 12 weeks, respectively; 
P=ns; Figure 5). Upon AVB, ∆ef,ej rose rapidly, reaching a maximum at 2 weeks: 0.24±0.02 vs. 
0.10±0.01 at SR (P<0.05; Figure 5), and was persistently high throughout the chronic phase. 
Myofiber stroke work, represented by the area bounded by the sf-ef loop, also increased rapidly 
after AVB: 4.3±0.7 vs. 3.1±0.3 kJ/m3/beat at SR (P<0.05). This parameter attained its maximum at 1 
week AVB (6.0±0.5 kJ/m3/beat) and remained elevated up to 12 weeks after AVB (Figure 5). 
Figure 5   Time course of myofiber mechanics before and after AVB. Upper panel, average values (n
dogs
 = 8) for s
f
 at peak systole and end 
diastole, and ejection strain. Lower panel, representative time-dependent changes of s
f
-e
f
 loops in an individual dog. The area bounded by 
the s
f
-e
f
 loop trajectory represents myofiber stroke work per beat, standardized per unit myocardial volume. *P<0.05 vs. SR.
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We also examined end-diastolic strain, which represents the resultant of end-diastolic stretch plus 
hypertrophic myofiber growth over time. In the acute phase of AVB, so when only stretch (and 
no hypertrophy) was present, end-diastolic strain measured 0.01±0.01. At 1 week, it had already 
increased to 0.04±0.02. Thereafter, it increased steadily to 0.15±0.03 at 12 weeks AVB in major 
part by the influence of hypertrophy. 
DISCuSSIoN 
In the present study we serially quantified the mechanical stimuli stress and strain in intact anes-
thetized dogs with chronic volume overload and hypertrophy. Synchronized measurements of LV 
dimensions and pressure were factored into a mathematical model of myocardial mechanics [1]. 
This approach allows serial intra-individual quantification of tissue mechanics in vivo. The values 
we obtained are comparable to values derived from preparations of isolated myocardium [3]. 
After the induction of AVB, increases of end-diastolic stress, end-diastolic strain and ejection strain 
were found to be the main mechanical changes, whereas peak systolic stress remained unaltered. 
Early increases of the former quantities coincided with peak hypertrophic growth in the first week 
after AVB. 
Mechanical changes and ventricular remodeling in dogs with AVB 
The acute decrease of heart rate imposed by AVB elevated end-diastolic pressure by the prolonged 
diastolic filling phase. As an immediate consequence, end-diastolic sf almost doubled. Also directly 
after AVB, a subtle, but significant increase of the end-diastolic strain was observed by 0.01 at 
acute AVB and by 0.04 at 1 week, respectively. At this latter time-point, the contribution of stretch 
could not be quantitatively distinguished from myofiber deformation by growth, which is inherent 
to the serial assessment of diastolic strain during hypertrophic growth. However, these data suggest 
that end-diastolic stretch of the LV myocardium after AVB can increase to somewhere between 
0.01 and 0.04 above control levels. 
Stretch applied to cardiomyocyte preparations, ranging between 0.005 and 0.10, has been reported 
to induce significant hypertrophic responses [27,38]. Others have described the transmural distribu-
tion of end-diastolic growth strains ranging between 0.10 (circumferential) and 0.15 (longitudinal) 
in dogs after 3.6 weeks of aortocaval fistula, which is similar to our data on end-diastolic strain 
at 6 weeks AVB (0.12) [22]. In that study [22], the composite nature (i.e., stretch and growth) of 
diastolic strain during developing hypertrophy has been circumvented by matching preload either 
by volume suppletion or bleeding, thereby setting the stretch component to a fixed value. In our 
study, stretch likely follows a similar temporal pattern as end-diastolic sf in the chronic phase of 
AVB. This assumption is supported by the finding that diastolic stiffness, calculated from the slope 
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of the sf–ef loop at end diastole, remained unaltered after AVB (16±2 kPa at 12 weeks AVB vs. 
24±7 kPa at SR; P=ns). This is in line with previous work in dogs with AVB [20] and suggests that 
stress can directly be transduced into strain, not hampered by increased myocardial stiffness. In 
dogs with aortocaval fistula, this concept does not hold, since increased myocardial stiffness and 
diastolic dysfunction influence diastolic stress-strain relations [2]. 
The increased preload during AVB did not only alter diastolic mechanics, but also influenced 
the systolic phase. In acute AVB, increased preload enhanced contractility by the Frank-Starling 
mechanism. Contractility was further stimulated by elevated serum levels of norepinephrine [35]. 
Independent from preload and neurohumoral stimulation, increased Ca2+ release from the sarco-
plasmic reticulum adds to the contractile performance in chronic AVB, especially during brady-
cardia [28]. As a mechanical corollary of enhanced contractility, ejection strain rose rapidly after 
AVB. At 1–2 weeks, it had more than doubled to approximately 27% myofiber shortening during 
ejection (compared to 11% at SR), despite an unchanged afterload. At 12 weeks, ejection strain was 
still elevated (approximately 21%) and likely influenced by the apposition of new sarcomeres. For 
comparison, in dogs with compensated hypertrophy due to aortocaval fistula, systolic strains only 
tend to increase above normal values [22]. Although volume overload has traditionally been associ-
ated with alterations of diastolic mechanics [9], it has been recognized that the myocardium may 
be ‘sensing’ the stimulus to hypertrophic growth throughout the cardiac cycle, including systole 
[11,21,36]. 
Further experiments are needed to compare the time course of myofiber mechanics to changes 
of load-dependent biomarkers. On theoretical grounds, ejection strain (which incorporates both 
short- and long-axis dimensions) has advantages over commonly used one-dimensional parameters 
like fractional shortening. It is a better representative of myocardial load during systole and relates 
more closely to load-dependent myocardial alterations. 
Based on the temporal relationship between increasing myofiber mechanics and LV mass, end-
diastolic sf and strain, and ejection strain are candidate mechanical stimuli for ventricular hyper-
trophy after AVB, as suggested for other models of volume overload [7,11,22]. To date a cellular 
sensor of sf is not known to exist, and it could well be that any cellular transducer is in fact an ef 
transducer. 
It is clear that the primary stimuli for hypertrophy may also be non-mechanical. Whereas neurohu-
moral stimuli and cardiac growth factors are obvious candidates, it remains to be determined 
whether they act independently from mechanical load in the beating heart. Studies in humans [26] 
and pigs [18] have confirmed the intricate relationships between ventricular mechanical stress, 
growth-factor formation and hypertrophy, showing that the contributive roles of angiotensin II, 
endothelin-1 and insulin-like growth factor 1 are selectively linked to both the type of hemody-
namic overload and to ventricular function. Future studies should elucidate the differential role of 
diastolic and systolic sf and ef for hypertrophy programs during chronic cardiac overload in vivo. 
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Based on the present finding of a persistent doubling of myofiber stroke work in AVB, which is 
related to local oxygen demand [5], we propose that a change in energetics could be yet another 
mechanism that dictates distinct gene-expression programs in chronic overload. 
Mechanical phenotyping: perspectives and clinical implications 
Patients with hypertrophy are well known to be at increased risk for fatal arrhythmias and prone to 
develop overt heart failure. The basic causes for electrical dysfunction and contractile deterioration 
in hypertrophy are still unclear and at the molecular-functional level they vary with the type of 
overload and the genetic coping mechanisms of the affected individual [13]. Mechanistic under-
standing could be significantly improved by mechanical phenotyping of the chronically overloaded 
heart, as we have done in this study, to 1) determine the precise nature and cyclic occurrence of 
mechanical stimuli, 2) distinguish between the contribution of mechanical and other stimuli of 
remodeling, 3) monitor the transition from compensated to decompensated circulatory function, or 
4) evaluate the effects of interventions. Our approach combines transthoracic echocardiography, 
invasive LV-pressure recordings and mathematical modeling, which is feasible in anesthetized 
experimental animals and potentially also in conscious patients. In the analysis of myocardial 
mechanics, we consider the LV to be thick-walled with anisotropic material containing myofibers. 
As a unique consequence, our levels of stress and strain are comparable to direct measurements in 
isolated cardiac muscle [3]. 
The incremental values of the present approach are 1) its minimally invasive character allowing 
serial intraindividual mechanical phenotyping at the tissue level, 2) the precise physical quantifica-
tion of tissue mechanics, acting as an in vivo stress/strain ‘measuring’ setup that avoids myocardial 
damage, and 3) the simplicity of the model requiring just a few global LV quantities. 
Others have applied three-dimensional motion reconstructions using tagged magnetic resonance 
imaging (MRI) to estimate stress and strain in vivo [12], or used ultrasound strain-rate imaging 
as a validated alternative for MRI-based methods in order to quantify myocardial deformation 
throughout the cardiac cycle [10]. These valuable techniques have so far only been used in a limited 
number of patients to serially estimate myocardial mechanics in chronic cardiac pathology [19,31] 
and, like our approach, await application in larger populations. 
Limitations 
All experiments were conducted under general anesthesia to allow for stable, reproducible condi-
tions. Anesthetic regimens included pentobarbital, halothane and nitrous oxide, which have been 
reported to depress contractile performance [29,33]. While this could have influenced our results 
to some extent, the serial analyses in individual dogs before and after AVB would still permit an 
accurate assessment of relative mechanical changes. 
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We demonstrated that myofiber mechanics and LV mass underwent considerable changes already 
within the first 2 weeks of AVB. Preferably, future studies should include more time-points of 
analysis during this early phase, but the number of experiments (requiring anesthesia) within such 
a short period is limited for ethical reasons. 
Conclusions 
Serial mechanical phenotyping at the tissue level is practicable in the intact heart of anesthetized 
dogs to monitor the time-course of chronic overload. In dogs with AVB, increased end-diastolic 
myofiber stress (sf), and ejection strain (∆ef,ej) during systole are the most prominent mechanical 
changes, resulting in the elevation of myofiber stroke work. Early changes of these local mechanics 
coincide with peak hypertrophic growth, suggesting their important role for mechanotransduction. 
Our new approach, which combines transthoracic echocardiography, invasive LV-pressure record-
ings and mathematical modeling of myofiber mechanics allows a direct comparison of values for 
sf and ef with those obtained in experiments on isolated cardiac muscle. This proper quantification 
may prove useful to further enhance understanding of mechanotransduction in the beating heart, 
and has potential clinical implications as an individualized approach to diagnosis and tailoring of 
therapy. 
Boek_Donker_v5.indb   74 21-7-2008   10:21:31
75
Chapter 3    MyoFIBER MECHANICS IN VENtRICUlAR VolUME oVERloAD
APPENDIX 
LV cavity and wall volume 
For the calculation of cavity and wall volume, the LV is assumed to be a truncated ellipsoid. LV long 
axis inner diameter (lba) is herein a 75% truncation of the longitudinal length of the ellipsoid. Outer 
LV short-axis diameter (do) was calculated as the sum of the inner diameter (di), posterior and septal 
wall thickness. Inner and outer volumes (Vi, Vo) depend on inner and outer short-axis diameters (di, 
do) and length lba by: 
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 Eq. 1 
The variable haW represents wall thickness at the apex. Using that for the reference state (subscript 
‘ref’), local wall thickness is proportional to wall tension (T) [1]. Apical wall thickness haW,ref is 
estimated as a fraction of equatorial wall thickness, depending on ellipsoid eccentricity E. (See also 
below: ‘Estimation of apical wall thickness’.) 
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 Eq. 2 
Reference di meters (do,ref, di,ref) are obtained by averaging diameters (do, di) over all systolic values. 
Per measuring moment the ratio lba/(di,ref+do,ref) is averaged over the group of measurements. Length 
lba for a given measurement is obtained by multiplication of this averaged ratio with (di,ref+do,ref) of 
the particular experiment. Substituting the result of Eq. 2 in Eq. 1, wall volume VW is (by subtraction 
of inner from outer volume in the reference state):
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 Eq. 3 
For calculation of the dynamically varying LV volume VLV, dynamically varying haW is corrected for 
wall thinning with diameter increase:
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Thus, VLV is expressed as a function of haW, do and di, while using Eqs. 1,3: 
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The use of VLV is preferred over Vi because of efficient noise reduction by appropriate averaging. 
Estimation of apical wall thickness 
Wall thickness is considered to be proportional with total wall tension T, being the sum of two 
perpendicular components. Assuming a thin-walled ellipsoid with long to short-axis ratio E, the 
radius of curvature at equator (ρez) and apex (ρa) depends on short-axis length 2r and E by:
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 Eq. 6 
Using Laplace’s law on membrane tension, for equator and apex it holds that 
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Subscripts ‘a’, ‘ec’, and ‘ez’ refer to apical, equatorial-circumferential, and equatorial-axial, respec-
tively. For axial tension at the equator (Tez) it holds, like in a pressurized cylinder:
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Solving Eqs. 6–8 by expressing tensions as a function of ρLV, r and E, for the ratio of wall thickness 
at apex to that of base, it is found: 
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 Eq. 9
Eq. 9 has been applied to obtain Eq. 2. 
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biopsy sampling using a 
minimally invasive trans-thoracic 
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ABSTRACT
Myocardial biopsies are an increasingly important tool to unravel the molecular mechanisms of 
cardiac disease. We evaluate a novel minimally invasive transthoracic approach for left-ventricular 
(LV) intra-mural biopsies, which enables repetitive individual sampling in adult dogs. Forty three 
generally anaesthesised dogs were studied during sinus rhythm (SR, control) and multiple times 
after the induction of volume overload hypertrophy (complete atrioventricular block [AVB]). 
Through a small cutaneous incision, an automatic biopsy needle was advanced into the apicolateral 
LV, guided by fluoroscopy. Electrocardiography (ECG), LV pressure and echocardiography served 
to monitor the procedure. One hundred eighty-eight intra-mural LV biopsies were obtained in 82 
serial experiments (usually SR, 1, 2 and 6 weeks AVB) with a maximum of 8 repeated biopsies. All 
biopsies (~10 mm3) were suitable for simultaneous application of different cell-biological (light and 
electron microscopy, immunohistochemistry) and molecular techniques (PCR, Western blotting). 
In chronic experiments, repeated biopsy sampling did not influence hemodynamics, mechanics, 
electrocardiographic parameters or myocardial remodelling during SR or AVB. The rate of signifi-
cant complications was as low as 4% of experiments. Minimally invasive sampling of LV needle 
biopsies enables serial assessment of myocardial remodelling using different molecular techniques 
in individual animals. The technique is safe and has no long-term effects on cardiac function or 
structure.
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INTRoDuCTIoN
Myocardial biopsy sampling offers indispensable diagnostic options to unravel the mechanisms of 
myocardial disease in different conditions [3,18]. Currently, cardiac biopsies are mostly obtained 
using a trans-venous catheter-based bioptome enabling to sample sub-endomyocardial tissue 
from the right ventricle (RV), as introduced in 1962 [13]. This trans-vascular approach is also used 
trans-arterially to sample from the left ventricle (LV) [9]. In experienced hands, the catheter-based 
technique is relatively safe with complication rates of 1–4% [10] and is routinely applied in clinical 
referral centers [9]. It is important to note that the limited invasiveness of the technique makes 
it possible to sample cardiac biopsies in a serial manner to monitor specific disease processes in 
individual patients over time. Yet, (sub)endomyocardial tissue samples have significant drawbacks 
relating to (1) sampling errors [15] and lack of representativity, which requires to take at least 5 
biopsies per session and even more for focal processes [19]; (2) small sample size (usually <1 mm3) 
[15] and (3) poor tissue quality due to squeezing and cutting artefacts in a relatively small tissue 
sample [11], which often render the biopsies unsuitable for histology, immunohistochemistry and 
electron microscopy [15].
An alternative way to sample ventricular myocardial tissue is by the use of a biopsy needle, which 
enables to obtain larger, intra-mural samples of superior quality compared to endomyocardial 
biopsies. This technique was first described using limited thoracotomy [7], but needle biopsies have 
generally been confined to the use in patients and animals undergoing standard thoracotomy for 
direct vision of the puncture site and potential bleeding [17]. Today, needle biopsies can be safely 
and quickly obtained during open-heart surgery using automatic biopsy devices [14,20].
In the study reported here, we developed a novel transthoracic approach to sample LV needle 
biopsies from individual anaesthetised dogs in a serial manner and evaluated its application in 
chronic experiments after the induction of cardiac hypertrophy.
mATERIAlS AND mETHoDS
Experiments were conducted in accordance with the ‘European Directive for the Protection of 
Vertebrate Animals Used for Experimental and Other Scientific Purposes (86/609/ EU)’. The 
Committee for Experiments on Animals of Maastricht University approved the experiments.
Serial trans-thoracic sampling of LV intra-mural biopsies
We studied a total number of 43 adult mongrel dogs of either gender weighing 28±1 kg at baseline 
during normal sinus rhythm (SR, control). All experiments were performed under general anaes-
thesia. After overnight fasting, pre-medication (0.15 mg/kg acepromazine, 0.4 mg/kg methadone, 
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0.06 mg/kg atropine i.m.) was administered. Complete anaesthesia was induced by thiopental (20 
mg/kg i.v.) and maintained with halothane (0.5–1%) and O2:N2O (1:2).
The dogs were positioned in a right-sided supine position, the left anterolateral thorax was shaved, 
disinfected with iodine and draped with sterile towels. The apex was palpated on the left-sided 
chest. The X-ray tube was set to a vertical position (0°) to identify the apicolateral LV in the 
sagittal plane (Figure 1a), and visualised in an oblique left-lateral fluoroscopic view (Figure 1b). 
In the sagittal plane, the biopsy needle forms an angle of ~60° with the longitudinal axis of the 
sternum. In the transverse plane (Figure 1c), the apicolateral LV was approached by holding the 
biopsy needle in an angle of ~60° to an imaginary horizontal line, in parallel to the table (Figure 
1c). Mechanical ventilation was briefly stopped during sampling to minimise the risk of pulmonary 
injury. A 14G automatic biopsy needle (Acecut, TSK Laboratory, Japan) was opened and slowly 
advanced trans-thoracically through a small (~5 mm) cutaneous incision in the inter-costal space 
overlying the LV apex (Figure 1d). This was done under continuous fluoroscopic guidance whilst 
approaching the apicolateral LV wall (Figure 1b). Contact with the epicardial surface was recogn-
ised by sensing a mild resistance and cardiac pulsations as pulse-synchronous motion of the needle 
shaft, often accompanied by ventricular extra-systoles on the electrocardiogram (ECG) (Figure 2a). 
Subsequently, the needle was quickly advanced into the epicardial layers at an angle of ~60° to 
the surface. Then, it was forwarded by ~10 mm as controlled by centimetre markers on the shaft 
to assure deep intra-mural sampling. The oblique angle to the epicardial surface was applied to 
minimise the risk of hemopericardium due to trans-mural puncture. After puncture, the automatic 
cutting mechanism of the biopsy needle was immediately released and the device was retracted. 
We aimed at completing the intra-myocardial insertion of the needle, the actual sampling and the 
retraction of the device within 2–3 heartbeats to avoid unnecessary movements of the device, 
potentially causing additional damage or bleeding of the myocardium or arrhythmias. At least two 
cylindrical transmural samples were taken per experiment. For further processing, biopsies were 
either immediately frozen in isopentane, pre-cooled with liquid nitrogen and stored at -80°C or 
fixed in 3% glutaraldehyde and stored at 4°C. Light and electron microscopy, PCR and Western 
blotting were performed according to standard protocols [4,16].
Throughout the procedure, a standard 6-lead ECG was registered and the LV intra-cavitary blood 
pressure was monitored in a sub-set of experiments (Figure 2a and Figure 2b). After sampling, 
all animals were followed-up echocardiographically (Figure 2c) for at least 60 min to monitor 
LV contractility and potential occurrence of pericardial effusion. Echocardiograms were usually 
performed every 5 min during the first 20 min after sampling. If pericardial effusion was absent 
or had not increased to a maximum of more than ~5 mm, anaesthesia was terminated. After 
detubation, additional echocardiograms were performed before and after transportation to the 
cage, usually at 30, 45 and 60 min after sampling. When pericardial effusion increased to more 
than ~10 mm in the first hour after sampling, we decided to intervene surgically by left-lateral 
thoracotomy, pericardiotomy, evacuation of blood from the pericardial space and local hemostasis 
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Figure 1  Serial percutaneous sampling of LV intra-mural biopsies. a Schematic illustration of optimal biopsy needle positioning in the 
sagittal plane in relation to the intra-thoracic location of the heart in the adult dog. b Under fluoroscopic guidance, the needle is advanced 
into the apicolateral LV wall. c Schematic illustration of optimal biopsy needle positioning in the transverse plane (caudal view) in relation to 
the intra-thoracic location of the heart. d A small incision facilitates percutaneous introduction of the biopsy needle into the left anterolateral 
inter-costal space overlying the LV apex. See text for detailed description. For full colour illustration, see page 222.
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of the bleeding site. LV hemodynamics, mechanics and echocardiographic estimates of LV mass 
were assessed as described before [4,5]. The complete procedure is described as a practical step-
by-step approach in Flowchart 1.
All dogs were studied serially during SR and after the induction of complete atrioventricular block 
(AVB). AVB was induced by radiofrequency (RF) catheter ablation of the His bundle. Sampling was 
performed under baseline conditions at sinus rhythm (SR; control) and, in the same animals, at 
different time points after AVB ranging from 2 days up to 6 weeks. The dogs were sacrificed several 
weeks later and the hearts were excised and inspected macroscopically.
STAT IST ICS
Data are presented as the mean±standard error of the mean (SEM). Data were compared using 
Student’s t-test for unpaired data. Differences were considered statistically significant if P<0.05.
Figure 2  Procedural monitoring during biopsy sampling. a Electrocardiographic and hemodynamic monitoring shows ventricular extrasys-
toles (arrowhead) during intra-myocardial insertion of the biopsy needle. SR, sinus rhythm, pLV, intra-cavitary LV pressure. Ten minutes 
after sampling, the ECG and LV pressure tracings are similar to the baseline (SR). b Monitoring of heart rate and LV systolic and diastolic 
pressure trends reveals stable tracings after sequential sampling of four biopsies accompanied by multiple ventricular extra-systoles 
(arrowheads). c Trans-thoracic echocardiographic approach in the adult dog. The right parasternal transducer positions allows long axis 
(1) and, after rotation, short axis views (2), whereas left parasternal apical scanning provides four-chamber views (3). Note that besides 
B-mode also M-mode and Doppler-flow measurements (not shown) can be easily performed. Ao, ascending aorta; LA, left atrium; RA, right 
atrium. For full colour illustration, see page 223.
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RESulTS
The biopsies measured ~1×1×10 mm and weighed ~15 mg (Figure 3a). The tissue was of good 
quality and suitable for subsequent analysis in all biopsies. To assess the intra-mural extension of 
the biopsies, we performed light-microscopic analyses of complete specimens (Figure 3b) and (sub)
endocardial pieces (Figure 3c), demonstrating that (sub)epicardial and (sub)endocardial myocar-
dium is present in, at least, a subset of the biopsies. Macroscopic inspection of the sampling sites 
revealed proper sampling from the apicolateral LV wall and only minimal local fibrosis with a 
diameter of ~1–2 mm limited to the puncture site (Figure 3d).
Light and electron microscopy revealed a normal homogeneous myocardial texture in the absence 
of contraction bands allowing detailed analyses of the cardiomyocyte (ultra) structure and of 
cell–cell contacts (Figure 4a and Figure 4b). Representative immunohistochemical double label-
ling allows to study intra-myocardial protein localisation and their spatial distribution pattern in 
cardiomyocytes, noncardiomyocytes and extra-cellular matrix (Figure 4c).
Serial LV function and structure in bioptized vs non-bioptized dogs
Serial analysis of LV systolic and diastolic hemodynamics, mechanics and LV mass increase in chronic 
experiments revealed no significant differences between repeatedly bioptized and non-bioptized 
individual dogs after induction of bradycardia-induced volume overload due to AVB (Figure 5). Also, 
electrocardiographic parameters were comparable in both groups over time (Figure 6).
To control for influences of repeated biopsy sampling itself on protein expression, we studied 
cardiomyocytespecific proteins known to change after AVB, such as the K+channel sub-unit KCNQ1 
and the ß-1 adrenergic receptor [16]. The expression level of both proteins remained unaltered in 
repeated biopsies of three control dogs (Figure 7).
Procedural experiences and complications
Generally, the animals recovered from the procedure within a few hours and post-operative wound 
infection was not observed. In the first 34 experiments, we observed cardiac tamponade in 5 (15%) 
experiments. Four dogs died (12%) and 1 underwent successful left-lateral thoracotomy, pericar-
diotomy and operative evacuation of the hemopericardium. It is important to note that all these 
dogs were heparinized (1,000 IU i.v.) around biopsy sampling, as routinely applied in our operation 
room to avoid catheter-induced thromboembolism and only 3 dogs had been hemodynamically 
monitored during the experiment.
To reduce the initial complication rate, we adapted the procedure: heparin was omitted without 
negative sequelae, and echocardiography was introduced to monitor the procedure, especially the 
occurrence of hemopericardium. The latter occurred in only 2 (4%) of 48 experiments and could be 
immediately diagnosed and treated surgically in 1 dog having tamponade, whereas the other dog 
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Figure 3  Processing of LV myocardial needle biopsies. a Biopsies can be easily lifted from the needle 
with tweezers. The specimen can be processed as a complete intra-mural cylinder or can be dissected 
into smaller pieces. After freezing, cryosections can be prepared, allowing simultaneous application 
of different analytical methods as e.g., Histo histology, IHC immunohistochemistry, EM electron micro-
scopy, PCR polymerase chain reaction and WB Western blotting. Scale bar indicates 1 cm. b The LM 
photomicrograph illustrates the good quality of the myocardial samples using Masson’s Trichrome stai-
ning (cardiomyocytes [red]/fibrous tissue [blue]). This example of an intra-mural biopsy extends from 
the epicardium (top inset) to the endocardium (bottom inset). Scale bars indicate 1 mm. c Intra-mural 
extension of the biopsy sample can also be confirmed by visualisation of the (sub)endocardial layers 
as illustrated in the light-microscopic photograph using toluidine blue counterstained with periodic 
acid-Schiff; endocardium (pale blue), working myocardium (blue) and glycogen (magenta)containing 
Purkinje fibres. Scale bars indicate 100 µm. d At autopsy, only limited scar formation occurred at 
the sampling sites (arrowheads) after repeated biopsies. Scale bar indicates 2 mm. For full colour 
illustration, see page 224.
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Figure 4  Cell-biological myocardial analysis in LV needle biopsies. a Representative light-microscopic (toluidine blue counterstained with 
periodic acid Schiff) and electron-microscopic photographs showing longitudinally sectioned cardiomyocytes within a normal myocardial 
texture from a dog bioptized during SR, demonstrating the excellent tissue quality. Scale bars indicate 20 µm. b Light-microscopic and 
electron-microscopic photographs corresponding to a showing cross-sectioned cardiomyocytes. Scale bars indicate 20 µm. c Immuno-
fluorescent histochemistry in LV myocardium double-labelling the cardiomyocyte intermediate filament desmin (green), the fibroblast 
intermediate filament vimentin (red; left and middle) and alpha smooth muscle actin present in the vessel wall (red, right), in longitudinally 
(left, right) and transversally sectioned myocardium (middle). Scale bars indicate 20 µm. For full colour illustration, see page 225.
Boek_Donker_v5.indb   89 21-7-2008   10:21:43
90
Figure 5  Serial analysis of LV hemodynamics, mechanics and hypertrophy in bioptized vs non-bioptized animals. Group mean values 
of 4 dogs bioptized at SR, 1, 2 and 6 weeks AVB compared to 4 non-bioptized dogs at identical experimental timepoints. P=ns for any 
parameter between the two groups.
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Figure 6  Serial analysis of electrocardiographic parameters in bioptized vs non-bioptized animals. Group mean values of 4 dogs bioptized 
at SR, 1, 2 and 6 weeks AVB compared to 4 non-bioptized dogs at similar experimental timepoints. P=ns for any parameter between the 
two groups.
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Figure 7  Serial analysis of myocardial protein expression before and after biopsy sampling. a Western blot analysis shows that the 
K+-channel subunit KCNQ1 and b the ß-1 adrenergic receptor remained unaltered in repeated biopsies of control dogs in SR.
Parameter Technique Recommendation Complications / Comments
Identification of
sampling site
Palpation/
fluoroscopy
Sample in apicolateral LV, avoid thin-walled 
apex and coronaries in the lateral LV
Cardiac tamponade, coronary perforation
Intramyocardial
sampling
Operator Feel mild resistance and cardiac pulsations 
on needle shaft before intra-myocardial 
insertion
Extra-myocardial biopsy, no biopsy
ECG Monitor the occurrence of ventricular extra-
systoles originating from the biopsy site*
Extra-myocardial biopsy, no biopsy
Microscopy Use standard histological staining to ensure 
tissue quality and intra-myocardial extent, 
e.g., hematoxylin/eosin, toluidin blue, 
Masson’s trichrome
Light microscopy allows to visualize 
endocardium/epicardium and myocardium in 
the same section
Cardiac function ECG Monitor standard leads throughout the 
experiment
Sinus tachycardia and signs of ischemia can 
aid to diagnose a cardiac tamponade in time
Echocardiography Assess cardiac contractility and pericardial 
effusion directly after sampling and repeat 
frequently in the first hour
Cardiac tamponade can be diagnosed in time
LV intra-cavitary
pressure catheter
(optional)
Monitor LV systolic blood pressure 
throughout the experiment (optional)
Progressive decrease of systolic LV
blood pressure can aid to diagnose a cardiac 
tamponade in time
* Arrhythmic ventricular responses may incidentally be absent. LV: left ventricle
Table 1  Practical considerations
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was found dead in the cage >12 h after the experiment. Autopsy revealed a hemopericardium due 
to puncture of a small coronary side-branch. We summarized our experiences in Table 1.
DISCuSSIoN
In the present study, we demonstrate how LV needle biopsies can be repeatedly obtained in dogs 
undergoing chronic experiments. A trans-thoracic approach together with optimal safety moni-
toring ensures a low complication rate, quick post-operative recovery and optimal tissue quality.
Serial myocardial sampling using needle biopsies in a chronic experimental setting is generally 
limited by the invasiveness of a thoracotomy, which results in only few sampling points, e.g., at 
the control stage and before sacrifice of the dogs [17]. We circumvented this by choosing a trans-
thoracic, percutaneous approach, thus avoiding the thoracotomy. Historically, different closed-
chest approaches have been reported in canine and human hearts to sample ventricular needle 
biopsies from the LV anterior wall, apical area [2] and the inter-ventricular septum [1] under local 
or general anaesthesia. After the 1970s, percutaneous needle biopsy techniques have not been 
widely applied in patients or experimental animals, and no further technical developments have 
been reported. This might be largely due to the advent of catheter-based techniques, which are less 
invasive, relatively easy to use and safe, and, moreover, suitable for repeated biopsies.
The novel trans-thoracic approach we described in this study shares many advantages with the 
trans-vascular technique: (1) it is minimally invasive; (2) it has a low rate of potentially life-threat-
ening complications (~4%) despite the limited number of experiments we performed, which is 
comparable to the clinically accepted trans-vascular techniques [10]; (3) it is suitable for repeated 
biopsies and thereby allows individual follow-up studies; (4) it can be performed within a few 
minutes; (5) it can be easily performed in a standard experimental animal laboratory (see Flow-
chart 1) with experienced bio-technicians reaching a sufficient level of competence after having 
performed ~25 biopsies. Moreover, the approach can likely be applied in other large animal species. 
This assumption is based on comparative anatomical considerations and reports of experiments 
with minimally invasive thoracoscopic cardiac access in sheep [6], pigs [21] and goats.
Multiple serial intra-mural biopsies from the same LV area did not influence functional and 
structural remodelling processes that occur after AVB. All analysed mechanical parameters were 
compatible with our earlier work [4,5]. Also, under control conditions, repeated biopsy sampling from 
the apicolateral LV wall did not significantly influence the expression of cardiomyocyte-specific 
proteins that have been shown to be altered in remodelling processes early after the induction of 
AVB [16]. These findings support the minimally invasive character of the technique and are in line 
with the macroscopic finding of only slight local fibrosis at barely visible puncture sites. Thus, it can 
be concluded that myocardial damage is confined to the puncture site. However, the total number 
of biopsies taken in individual animals might be relevant in this regard. We obtained a maximum 
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of eight serial needle biopsies in up to four consecutive closed-chest experiments per dog. Higher 
numbers of serial ventricular needle biopsies in chronic experiments have only been reported in 
studies using cardiac allograft biopsies in dogs undergoing orthotopic [12] or heterotopic [8] heart 
transplantation. In these studies, post-operative fibrosis and adhesions after open-heart surgery 
likely play a role in reducing the risk of hemopericardium and tamponade, but may also increase the 
probability of biopsy-induced functional and structural myocardial changes.
Needle biopsies offer ample opportunities for a detailed myocardial analysis (Figure 3, Figure 4 and 
Figure 7). The tissue specimens are relatively large, cutting artefacts are limited to the border zones 
and they represent a cross-section through the ventricular wall potentially extending into the (sub)
endocardium (Figure 3). Our serial approach allows to discern even mildly fluctuating expression 
patterns in long-term studies because individual dogs serve as their own controls [4,16]. These 
subtle changes are likely missed in group comparisons due to inherent inter-individual differences. 
These aspects meet contemporary issues in cardiac research, aimed at a comprehensive multi-level 
molecular analysis in individual subjects.
CoNCluSIoNS
A novel minimally invasive trans-thoracic approach for serial LV intra-mural needle biopsies has 
been successfully developed in adult dogs. The procedure is safe and allows repeated sampling in 
individual animals without influencing cardiac function or structure in long-term experiments. 
Different cell-biological and molecular techniques can be simultaneously applied in these biopsy 
specimens. The approach is potentially applicable to other animal models of cardiac disease and 
offers the opportunity to study molecular mechanisms relevant for myocardial remodelling in 
chronic experiments relating to various pathological conditions.
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APPENDIX
Induce general anesthesia, intubate and start mechanical ventilation
Assure stable right-sided supine position of the animal *
Shave and disinfect left-lateral thorax and assure sterile conditions
Set X-ray tube to vertical position (0°)
Identify left-lateral thoracic area overlying apex
- Palpate apex pulsations (mark area)
- Adjust fluoroscopy to visualize apex (Figure 1 a, b)
Make small (~5 mm) cutaneous incision above apex
Find optimal spatial orientation of biopsy needle before insertion
- Sagittal plane: adjust needle at ~60° to sternum (Figure 1 a, b)
- Transverse plane: adjust needle at ~60° to table (Figure 1 c, d)
Interrupt briefly mechanical ventilation
Perform step-by-step myocardial biopsy sampling
- Advance biopsy needle towards apicolateral LV (continuous fluoroscopy)
- Feel mild resistance, cardiac pulsations on needle shaft and 
  ventricular extrasystoles on ECG monitor, advance 10 mm into LV wall,  
  release automatic cutting mechanism, quickly retract biopsy needle
Restart mechanical ventilation and close cutaneous incision
Perform post-procedural echocardiographic monitoring
* Perform baseline echocardiograms for comparison to post-procedural echocardiograms
Flowchart 1  Procedure—minimally invasive biopsy technique
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ABSTRACT
objectives Electrical remodeling in cardiac hypertrophy often involves the downregulation of 
K+ currents, including ß-adrenergic (ß-A) sensitive IKs. Temporal patterns of ion-channel down-
regulation are poorly resolved. In dogs with complete atrioventricular block (AVB), we examined 
(1) the time course of molecular alterations underlying IKs downregulation from acute to chronic 
hypertrophy; and (2) concomitant changing responses of repolarization to ß-adrenergic receptor 
(ß-AR) stimulation. 
methods and Results Serial left-ventricular (LV) biopsies were collected from anesthetized dogs 
during sinus rhythm (SR; control) and at 3, 7 and 30 days of AVB. KCNQ1 mRNA and protein 
decreased within 3 days (protein expression 58±10% of control), remaining low thereafter. ß1-AR 
mRNA and protein decreased more gradually to 53±8% at 7 days. In chronic-AVB LV myocytes, 
IKs-tail density was reduced: 1.4±0.3 pA/pF versus 2.6±0.4 pA/pF in controls. ß-A enhancement of 
IKs was reduced. Isoproterenol shortened action-potential duration in control cells, while causing 
heterogeneous repolarization responses in chronic AVB. ß-A early afterdepolarizations were 
induced in 4 of 13 chronic-AVB cells, but not in controls. In intact conscious dogs, isoproterenol 
shortened QTc at SR (by -8±3% from 295 ms), left it unaltered at 3 days AVB (+1±3% from 325 ms) 
and prolonged QTc at 30 days (+6±3% from 365 ms). 
Conclusions Profound decrease of KCNQ1 occurs within days after AVB induction and is followed 
by a more gradual decrease of ß1AR expression. Downregulation and blunted ß-A activation of 
IKs contribute to the loss of ß-A-induced shortening of ventricular repolarization, favoring proar-
rhythmia. Provocation testing with isoproterenol identifies repolarization instability based on 
acquired channelopathy.
Boek_Donker_v5.indb   102 21-7-2008   10:21:45
103
Chapter 5    tEMPoRAl PAttERNS oF ElECtRICAl REMoDElING IN VENtRICUlAR HyPERtRoPHy
INTRoDuCTIoN
Electrical remodeling in cardiac hypertrophy often comprises the downregulation of sarcolemmal K+ 
currents, including the delayed-rectifier K+ current IKs [1,2]. K
+-current downregulation may act to 
prolong the action-potential duration and enhance excitation–contraction coupling during chronic 
overload. However, it can confer exaggerated spatial and temporal heterogeneities of ventricular 
repolarization, rendering the heart more susceptible to deleterious tachyarrhythmia [3]. Temporal 
patterns of ion-channel downregulation during chronic overload are still poorly resolved.
In the canine model of chronic complete atrioventricular block (AVB) and ventricular hypertrophy, 
increased spatial [1,4] and temporal dispersion of repolarization [5] predispose to acquired torsades 
de pointes and sudden cardiac death [6]. At the cellular level, K+ currents IKs and IKr are reduced 
[1], whereas sarcoplasmic reticulum Ca2+ release and INaCaX are enhanced, especially at slow heart 
rates [7]. An increase in subsarcolemmal Na+ concentration underlies the altered Ca2+ handling [8]. 
Previous work has shown that the reduction of IKs in chronic AVB can be due to a down-regulation 
of KCNQ1-and KCNE1-gene transcription in the basal and midlateral parts of the left-(LV) and 
right-ventricular wall [9]. In the interventricular septum only KCNQ1 mRNA is decreased [10]. These 
findings indicate regional heterogeneity of ion-channel remodeling in the overloaded myocardium. 
Until now the time courses of electromolecular changes have remained unclear, especially in the 
early phase of overload.
Modern insights support the contention that an intact basal IKs expression plus ß-adrenergic 
receptor (ß-AR) stimulation are both essential for IKs to figure in repolarization, which has been 
demonstrated in the rabbit [11], dog [12,13] and human heart [14]. This suggests that the separate 
or combined loss of IKs-channel subunits and IKs-relevant ß-adrenergic (ß-A) signaling molecules 
in acquired cardiac pathology carries a risk of repolarization instability and arrhythmia. In relation 
to this, failure of appropriate action-potential shortening to ß-AR stimulation, and torsades-like 
arrhythmias have previously been reported in LV wedge preparations under pharmacological IKs 
inhibition [15,16].
The present study was designed to examine the time course of molecular alterations underlying IKs 
downregulation in the canine LV after AVB induction. We quantified the mRNA and protein expres-
sion of KCNQ1 and KCNE1 subunits and ß-AR subtypes in serial myocardial biopsies, and measured 
catecholamine levels in blood plasma. Concomitant changes of cellular and in-vivo repolarization 
were closely examined. We hypothesized that the propensity of repolarization to shorten upon ß-AR 
stimulation would be undermined after AVB, favoring proarrhythmia during maintained overload.
Boek_Donker_v5.indb   103 21-7-2008   10:21:45
104
mETHoDS
Animal handling was in accordance with the ‘European Directive for the Protection of Vertebrate 
Animals Used for Experimental and Other Scientific Purposes (86/609/EU)’ .The experiments were 
approved by the Committee for Experiments on Animals of Maastricht University and conformed 
with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes 
of Health (NIH Publication No. 85-23, revised 1996). Adult mongrel dogs of either gender were used. 
Premedication consisted of 10 mg oxycodone HCl, 1 mg acepromazine maleate and 0.5 mg atropine 
sulphate i.m. Complete anesthesia was induced by thiopental (20 mg/kg i.v.) and maintained by 
inhalation of halothane (0.5–1.0%) and N2O and O2 (2:1). Ampicilline (1000 mg) was administered 
before and after the experiment. For additional analgesia, buprenorphine was given (0.015 mg/kg 
i.m.) after the operation.
In-vivo studies
AVB was induced by radiofrequency catheter ablation of the His bundle under anesthesia 
(ndogs=31). In-vivo experiments were performed serially at sinus rhythm (SR) and at 0, 3, 8 and 
30 days of AVB, using each dog as its own control. Venous blood samples were collected from 
these trained animals at conscious state (after minutes of quiescence) for determination of plasma 
catecholamines (see below). Premedication was subsequently administered to achieve conscious 
sedation, and a standard 6-lead ECG was registered along with a unipolar recording at the chest 
position corresponding to V4. Under these conditions, a short-lasting ß-A challenge with isoprot-
erenol (1 µg/kg, i.v.; provocation testing) was given to increase heart rate >25% during SR or idio-
ventricular rhythm, followed by relaxation (ndogs=6). The QT interval was measured and corrected 
for heart rate by Van-de-Water’s formula: QTc=QT - 0.087 (RR - 1000) [17]. Beat-to beat variability 
of QT interval was quantified as short-term variability of 30 consecutive beats: STV = Σ (QTn – QTn 
+ 1)/ 30× √2 [5].
In 12 animals, a minimally-invasive procedure was used for biopsy sampling under closed-chest 
conditions, allowing fast recovery of the dogs and permitting repetitive sampling at SR and 3, 7 
and 30 days of AVB. Intramural needle biopsies (1 × 1 × 10 mm) extending from the epicardium 
into the LV wall were obtained from the apicolateral region under fluoroscopic guidance with 
a commercially-available automated biopsy device (14-G, Acecut, TSK Laboratory, Japan). This 
device was percutaneously inserted into the thorax, i.e., through a small dermal incision near the 
processus xyphoideus. At least 2 biopsies were obtained per experiment. Tissue quality was excel-
lent in nearly all samples (>98%). Histology confirmed minimal injury to the myocardium at the 
sampling sites. Biopsies were frozen to -80°C in isopentane chilled with liquid nitrogen and then 
stored until molecular analysis. Dogs were monitored by echocardiography after this procedure to 
exclude cardiac tamponade, although in our experience this closed-chest approach is generally 
uncomplicated (>95%) and fatal outcome is rare (<3%). Such complications did not occur in this 
study.
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Analysis of plasma catecholamines
Blood samples (10 mL) were collected into tubes containing lithium heparin as the anticoagulant 
and transported to the laboratory on ice within 30 min. Samples were centrifuged at 3000 rpm for 
10 min at 4°C. 100 µL of glutathione (95 g/L) was added to 2 mL plasma before storage at -20°C. For 
analysis, plasma was mixed with an internal standard (3,4-dihydroxybenzylamine-hydrobromide) 
followed by liquid– liquid extraction with 99% n-heptane and 1-octanol/acetic acid. After evapo-
ration of the organic phase, 100 µL of the acetic acid layer was injected and analyzed by reversed 
phase-high performance liquid chromatography with electrochemical detection.
mRNA and protein expression studies
Total RNA was isolated from the biopsies using the RNEasy Mini kit (Qiagen/Westburg, Leusden, 
The Netherlands) according to the manufacturer’s protocol. DNAseI-digestion was performed after 
elution of the total RNA from the column. First-strand cDNA was synthesized using 1 µg total RNA 
in combination with an anchored oligo-dT14VN and reverse 18S rRNA primer [18]. Fluorescence-
based kinetic real-time PCR was performed using a LightCycler™ system (Roche Diagnostics Neder-
land, Almere, The Netherlands) in combination with the intercalating fluorescent dye SYBR Green 
I [10]. Amplicons (KCNQ1, KCNE1, and ß1-, ß2-and ß3-ARs) were quantified using the LinRegPCR 
method [19] and were expressed relative to the constitutively active 18S rRNA gene. For primers 
used see Table 1.
Protein expression was analyzed by Western blotting and densitometric quantification. Proteins 
were extracted from total homogenates derived from unfixed 5-µm-thick cryosections dissolved 
in equal amounts of lysis buffer containing 62 mmol/L Tris-HCl, 1.25 mmol/L EDTA, 2% NP40, 2.5 
Transcript Forward (F)/reverse (R) TAnneal  (°C) Amplicon length (bp) NCBI Accession number
KCNQ1 F: GTCGAGTTTGGCAGCTATGCA 60  274 Not available 
R: CGCAAAGAAGGAGATGGCAA 
KCNE1 F: ATGCTGAGTTACATCCGCTC 57  98 Not available 
R: TACGCCTTGTCCTTCTCCT 
β1-adrenergic receptor F: TACAACGACCCCAAGTGCT 55  100 U73207 
R: AGGTACACGAAGGCCATGA 
β2-adrenergic receptor F: AATCCCCTTATCTACTGCCG 55  93 U73206 
R: ATTCCCATAGGCCTTCAGG 
β3-adrenergic receptor F: TTCTGTCCCTGACTCCATCA 55  106 U92468 
R: AAGTCCTCCTGACACTGCTGT 
Table 1  Primers
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mmol/L PMSC, 12.5 µg/mL leupeptin, 12.5% glycerol, 100 µg/mL aprotinin, 2.3% SDS for 30 min 
on ice and sample buffer containing 62 mmol/L Tris-HCl, 2.3% SDS, 10% glycerol, 5% ß-mercap-
toethanol, 0.05% bromophenol blue for 4 min at 95°C. Equal amounts of total protein (30 µg/
lane), determined by protein assay, were loaded onto each lane of Tris-HCl precast polyacrylamide 
gradient gels (4–20%) (BioRad Laboratories, Hercules, CA, USA). After separation, proteins were 
transferred to PVDF membranes (BioRad Laboratories, Hercules, CA, USA). Transfer and loading was 
controlled by Ponceau S and Coomassie brilliant blue staining. Immunostaining was performed with 
primary antibodies directed against KCNQ1 (1:50, Santa Cruz Biotechnology, Santa Cruz, CA, USA), 
KCNE1 (1:100, Alomone Labs, Jerusalem, Israel), ß1-AR (1:250, Calbiochem, Merck Biosciences, 
Darmstadt, Germany), and ß2AR (1:500, Chemicon, Temecula, CA, USA). Membranes were blocked 
for at least 15 min in 2% nonfat dry milk (NFDM) in Tween-buffer (TWB), containing 0.13% Tween 
20 in phosphate-buffered saline (PBS). Incubation with the primary antibodies was done for 2 h 
in 1% NFDM or 5% BSA. After 3 × 5 min washing in TWB, blots were incubated for 1 h using the 
appropriate peroxidase-conjugated secondary antibodies: swine anti-rabbit (1:5000, Dako Cyto-
mation, Glostrup, Denmark), goat anti-chicken (1:10,000, Jackson Immuno Research, West Grove, 
PA, USA) and bovine anti-goat (1:250, Santa Cruz Biotechnology, Santa Cruz, CA, USA), washed in 
TWB (3 × 5 min) and visualized on X-ray films (Fujifilm, Rotterdam, The Netherlands) using ECL or 
ECLplus (Amersham Biosciences, Amersham, UK). Densitometric quantification was performed with 
Quantity One® software using a GS 800 scanner (BioRad Laboratories, Hercules, CA, USA).
Cellular experiments
Hearts were quickly excised from anesthetized SR (ndogs=20; controls) and AVB (ndogs=22) dogs. For 
the cell-isolation method see Ref. [1]. A collagenase-digested part of the apicolateral LV wall was 
dissected and myocytes were isolated from most of the transmural wall except for a rim (=1.5 mm) 
of epicardial and endocardial tissue. Only quiescent rod-shaped cells with clear cross-striations 
were used for the experiments.
Transmembrane potentials were recorded using high-resistance (30–60 MW) glass microelectrodes 
filled with 3 mol/L KCl. Whole-cell currents were measured using patch pipettes with resistances 
of 1.0–3.0 MW when filled with internal solution. Experiments were performed at 37±1°C. Cell 
capacitances were 186±6 pF (ncells=54) in control and 192±9 pF (ncells =36) in AVB cells.
The external solution contained (in mmol/L): NaCl 145, KCl 4.0, CaCl2 1.8, MgCl2 1.0, glucose 11, 
HEPES 10, pH 7.4 with NaOH at 37°C. In most patch-clamp experiments KCl was omitted from 
the external solution to increase IKs amplitude and suppress IK1 [1,20]. The patch–pipette solution 
contained (in mmol/L): potassium aspartate 125, KCl 20, MgCl2 1.0, MgATP 5, HEPES 5, EGTA 10, 
pH 7.2 with KOH. L-type Ca2+ current (ICaL) was blocked with nifedipine (5 µmol/L). Almokalant was 
dissolved in the superfusate (2 µmol/L) to block IKr. Isoproterenol was first dissolved in distilled water 
containing 30 µmol/L ascorbic acid, kept at 5 °C and in the dark until use. HMR1556 ((3R,4S)-(+)-N-
[3hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4yl]-N-methylmethanesulfonamide, 
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Aventis Pharma Deutschland GmbH, Sanofi–Aventis, Frankfurt am Main, Germany) was used to 
block IKs. This compound is highly selective for IKs: at a concentration of 500 nmol/L it blocks the 
current completely [13], whereas other currents are unaffected [21]. HMR1556 was dissolved in 
dimethyl sulfoxide as 100 mmol/L stock solution and diluted in the superfusate to achieve a final 
concentration immediately before experimental application. The final concentrations of dimethyl 
sulfoxide (maximally 0.1%) in the superfusate had no measurable effects on ion currents and action 
potentials.
Statistics
The data are expressed as mean±SEM. Data comparisons were made with the Student’s t-test for 
unpaired or paired data groups. Serial changes (mRNA, protein expressions; QT intervals) were 
tested using linear-regression analysis and repeated-measures ANOVA. Differences were consid-
ered statistically significant if P<0.05.
RESulTS
Temporal patterns of mRNA and protein expression of IKs subunits and ß-adrenergic 
receptors during emerging hypertrophy
The rate of hypertrophic growth was maximal within 1 week of AVB induction, when echographic 
LV mass increased by 2.2±0.4 g/day [22]. At chronic AVB, heart weights (upon sacrifice) were >30% 
heavier than SR controls (306±17 g versus 233±11 g, respectively; P<0.05). When corrected for 
body weight, this difference remained significant: 10.7±0.3 g/kg versus 8.7±0.5 g/kg, respectively 
(P<0.05), confirming the presence of hypertrophy.
KCNQ1 mRNA decreased to 58±13% of control (P<0.05) already after 3 days of AVB and further 
down to 42±9% at 30 days. KCNQ1 protein paralleled this decline: 58±10% of control after 3 days, 
53±10% at 30 days (P<0.05; Figure 1). Expression levels of KCNQ1 at chronic AVB match with 
previous findings [10]. KCNE1 mRNA and protein did not change significantly after AVB at any of 
the time points (Figure 1).
ß1-AR mRNA decreased more gradually to 73±5% of control (P<0.05) at 7 days and 63±8% at 30 
days. ß1-AR protein showed a similar significant decline, as illustrated in Figure 1. ß2-AR mRNA 
and protein remained unaltered (Figure 1). Levels of ß3-AR mRNA were too low to be detected and 
quantified reliably, and were not examined by Western blotting.
For control purposes, we collected serial biopsies (7, 14 and 49 days apart) in 3 dogs with sinus 
rhythm. Western-blot analysis revealed no significant differences in protein expression of KCNQ1 
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Figure 1  Temporal patterns of mRNA and protein expression of IKs subunits and β-ARs after 
AVB. Left upper panels, KCNQ1. Right upper panels, KCNE1. Left lower panels, β1-AR. Right 
lower panels, β2-AR. Serial myocardial biopsies were obtained at SR and 3, 7 and 30 days of 
AVB in 12 dogs. *,P<0.05 versus SR.
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and ß1-AR, indicating that the observed changes after AVB (in the other dogs) were not contami-
nated by the biopsy sampling itself.
Biophysical properties of downregulated IKs
Biophysical properties of IKs in myocytes from dogs with chronic AVB (ncells=15; ndogs=7) were 
compared to controls (ncells=19; ndogs=12). Consistent with protein downregulation, IKs density was 
significantly smaller in chronic AVB: 1.4±0.3 pA/pF versus 2.6±0.4 pA/pF in controls (P<0.05; tail 
currents at -25 mV after 3-s steps to 50 mV; Figure 2A). The kinetics of both activation and deac-
tivation of IKs were not different between chronic-AVB and control myocytes (Figure 2B, Table 2). 
Voltage dependence of IKs activation was also similar in chronic-AVB and control cells (Figure 2C). 
The sensitivity of IKs to pharmacological block by HMR1556 remained unchanged in chronic-AVB 
myocytes (ncells=6) with an IC50 of 81 nmol/L versus 78 nmol/L in controls (ncells=6; Figure 2D).
IKs showed a decreased responsiveness to isoproterenol in chronic-AVB myocytes. SC50 values were 
63 nmol/L for AVB and 30 nmol/L for control cells. Maximal stimulation at 300 nmol/L isoproterenol 
enhanced IKs 4.0±0.7 fold in AVB versus 7.9±0.7 fold at control (P<0.05; Figure 3). The kinetics of 
IKs were affected similarly by ß-AR stimulation in AVB and control cells (Table 2). For voltage steps 
from -50 mV to 20 mV, halftimes for activation decreased by approximately 100 ms, whereas 
halftimes for deactivation increased by about 50 ms.
Activation, depolarizing step from −50 mV to +20 mV. Deactivation, repolarization to −25 mV. 
Numbers: ncells=10, ndogs=8 for chronic AVB; ncells=10, ndogs=6 for control. Iso, isoproterenol. *P<0.05 
versus baseline.
Consequences of IKs downregulation for repolarization response to isoproterenol
Isoproterenol (100 nmol/L) shortened action-potential duration (APD95) significantly in control 
cells (ncells=6; ndogs=3; Figure 4A). This was mainly due to the stimulation of IKs, because block of 
IKs by HMR1556 (500 nmol/L) in the presence of isoproterenol reversed it [13]. Heterogeneous 
responses of repolarization were found in chronic AVB: APD95 remained unchanged in 7, decreased 
in 4 and increased in 2 myocytes (ndogs=10; Figure 4B). Despite the limited ability of chronic-AVB 
cells to shorten APD in response to isoproterenol (100 nmol/L), IKs still contributed to some degree 
under these conditions, as evident from the (extra) APD prolongation observed after application 
of HMR1566 (Figure 4A and B). In the absence of isoproterenol, HMR1556 did not change APD 
(ncells=5), in line with recent findings in normal dog [13] and human [14].
Early afterdepolarizations (EADs) were induced in 4 of the 13 chronic-AVB cells with isoproterenol 
(100 nmol/L) alone, and in 6 of 13 myocytes during isoproterenol plus HMR1556 (Figure 5). EADs 
developed at short (500 ms) and long (1000 and 2000 ms) pacing cycle lengths. They were not 
observed at baseline. In control myocytes, no EADs were observed under any of these conditions 
(Figure 5).
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Figure 2  Downregulation of I
Ks
 in chronic AVB cells. A Chronic AVB (CAVB) led to a decrease of I
Ks
 density. B Kinetics of both activation 
and deactivation of I
Ks
 were not different between AVB and control myocytes. Upper panels, arrows indicate I
Ks
 traces at depolarizations 
to 40 mV (SR versus CAVB), which were used for comparison of kinetics after artificial equalization of amplitude (in left panel below; see 
also Table 2). Vertical bar, 500 pA. Horizontal bar, 1 s. Inset, voltage-clamp protocol. C Voltage dependence of I
Ks
 activation was similar 
in CAVB (filled circles) and control cells (open squares). D Sensitivity of I
Ks
 to pharmacological block by HMR1556 remained unchanged in 
CAVB cells (filled circles). *, P<0.05.
Control, halftimes (ms) Chronic AVB, halftimes (ms) 
Activation Deactivation Activation Deactivation 
Baseline 511±63 128±13 509±36 121±9 
Iso (100 nmol/L) 412±53* 185±15* 429±36* 171±20* 
Activation, depolarizing step from −50 mV to +20 mV. Deactivation, repolarization to −25 mV. Numbers: ncells=10, ndogs=8 for chronic 
AVB; ncells=10, ndogs=6 for control. Iso, isoproterenol. *P<0.05 versus baseline. 
Table 2  Kinetics of I
Ks
 activation and deactivation
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A cAMP-activated Cl- current (ICl) could also contribute to the action-potential shortening in 
response to ß-A stimulation. In dog ventricle however, such a current is reportedly absent [23], 
whereas it was also shown that anthracene increased the incidence of EADs by isoproterenol 
suggesting the presence of cAMP-activated ICl [24]. We performed additional experiments and 
measured currents during wash-in of 3 µmol/L isoproterenol in conditions that should reveal this ICl 
(K+-and Na+-free solutions with symmetrical [Cl-]; current measured at -80 mV). Current density at 
baseline was -0.32±0.06 pA/pF in control (ncells=7) and -0.30±0.05 pA/pF in chronic-AVB myocytes 
(ncells=7, P=NS). In the presence of isoproterenol (3 µmol/L) the current was -0.36±0.06 pA/pF and 
-0.35±0.04 pA/pF, respectively (P=NS). In 4 cells, this current was not sensitive to the Cl- channel 
blocker niflumic acid (100 µmol/L). These data suggest that if present, the cAMP-dependent ICl is 
very small and does not contribute to differences in repolarization between control and chronic 
AVB.
Figure 3  Decreased responsiveness of I
Ks
 to ß-A 
stimulation in chronic-AVB (CAVB) cells. Upper panel, 
representative examples of I
Ks
 at baseline and when 
increased by ß-A stimulation (isoproterenol, 100 
nmol/L) in a control (SR) and a CAVB cell. Relative 
data shown are based on I
Ks
-tail amplitudes. Vertical 
bar, 5 pA/pF. Horizontal bar, 2 s. Lower panel, dose 
dependence of I
Ks
 stimulation by isoproterenol at 
control and CAVB. Inset, voltage-clamp protocol. 
*, P<0.05.
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QT responses to isoproterenol in conscious AVB dogs
To investigate whether repolarization responses to ß-AR stimulation were also altered in vivo, we 
subjected 6 dogs to short-lasting challenges with isoproterenol (1 µg/kg i.v.; >25% increase of 
heart rate) at SR control and during idioventricular rhythm at 3, 8 and 30 days of AVB.
The heart rate dropped from 128±12 bpm at SR to 41±4 bpm at 3 days AVB, remaining low there-
after (Figure 6). At baseline during conscious sedation, QT time (chest lead V4) measured 253±10 
ms at SR. It increased thereafter from 371±12 ms at 3 days to 414±7 ms at 30 days AVB (P<0.05 
versus 3 days), indicating electrical remodeling [1].
Next we investigated the actions of isoproterenol (1 µg/kg i.v.). Both in SR and idioventricular 
rhythm a strong chronotropic effect was noted, as expected: heart rates increased from 128±12 
bpm to 201±9 bpm (SR) and from 41±4 bpm to 58±5 bpm (3 days AVB), respectively. These 
chronotropic responses remained proportionally similar at the later stages of AVB (Figure 6B). 
QT-interval measurements were performed at 2 time points during each experiment: (1) when heart 
rate increased 25% above the baseline value (for comparability between experiments; hatched 
bars Figure 6 B and C); and (2) during peak chronotropic response (black bars Figure 6B and C). 
Figure 4  Effects of ß-A stimula-
tion on the action potential. Action 
potentials/APD95 at baseline (bas), 
in the presence of isoproterenol 
(iso; 100 nmol/L) and after addi-
tion of HMR1556 (500 nmol/L) 
in control A and chronic-AVB B 
myocytes. Pacing cycle length, 
1000 ms. Upper panels, repre-
sentative examples. Lower panels, 
APD95 values (mean±SEM) for the 
different conditions. Vertical bar 
denotes 50 mV. Horizontal bar, 100 
ms. *, P<0.05 versus baseline. #, 
P<0.05 versus iso 100.
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A profound shortening of repolarization accompanied the peak heart-rate increase at SR: QT 
decreased from 253±10 to 211±5 ms (QT -17%; P<0.05). At 3 days AVB, QT shortened from 371±12 
ms to 347±6 ms (heart rate +25%; QT -6%; P<0.05) to 324±4 ms (peak response; QT -13%; P<0.05). 
At 30 days AVB, however, QT changes during isoproterenol became much less pronounced despite 
similar increases in heart rate: QT altered from 414±7 ms to 409±11 ms (heart rate +25%; QT 
-1%; P=NS) to 392±10 ms (peak response; QT -5%; P<0.05). Individual QT times were often longer 
than their baseline values and they varied considerably on a beat-to-beat basis, indicating in-vivo 
repolarization instability (Figure 6A and D). The latter was not observed at SR or acute AVB. When 
corrected for heart rate, QTc was shortened by isoproterenol during SR, unchanged at 3 and 8 days 
AVB, and overtly prolonged in chronic AVB (Figure 6C). Beat-to-beat variability of QT (quantified 
as STV) decreased from 2.5±0.4 ms to 1.6±0.3 ms (P<0.05) in response to isoproterenol during SR. 
At 3 days AVB QT STV remained unchanged (4.0±0.4 ms to 4.8±0.7 ms; P=ns), whereas at 30 days 
it actually increased from 5.4±0.6 ms to 7.4±0.7 ms (P<0.05) during ß-A stimulation (Figure 6D). 
Ventricular tachycardia was not observed, supposedly because local myocardial ß-A stimulation 
was not intense enough.
Plasma levels of catecholamines
To assess the influence of natural catecholamines on repolarization, plasma levels of dopamine, 
epinephrine and norepinephrine were measured in venous blood samples at all time points, including 
Figure 5  EADs in the presence of ß-A stimulation in chronic-AVB (CAVB) cells. Incidence of EADs at baseline, in the presence of 
isoproterenol (iso; 100 nmol/L) and after addition of HMR1556 (500 nmol/L) in control (SR) and CAVB cells. Right panels, representative 
action potentials with EADs in the presence of isoproterenol at pacing cycle lengths (CL) of 2000 ms and 500 ms.
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Figure 6  QT responses to isoproterenol in conscious AVB dogs. A Heart rates (HR; filled squares) and corresponding QT times (open 
circles) during infusion of isoproterenol (1 µg/kg, i.v.) in a representative dog during SR (upper panel), and at 3 days (middle panel) and 
30 days of AVB (lower panel). The grey zone indicates the period of isoproterenol infusion. Vertical lines indicate the time points of 25% 
heart-rate increase (inserted for comparability). B Heart-rate responses to isoproterenol. White bars indicate baseline conditions during 
SR and after 3, 8, 30 days of AVB. Hatched bars, 25% heart-rate increase above baseline. Black bars, peak responses. C QT
c
 responses 
to isoproterenol at baseline (white bars) and during isoproterenol infusion (hatched bars, at 25% heart-rate increase above baseline; black 
bars, during peak responses of heart rate). D Beat-to-beat variability of QT (quantified as short-term variability; STV) at baseline (open 
squares) and during isoproterenol (filled circles) in individual dogs (connected by lines) during SR and after 3 and 30 days of AVB. Same 
symbols at the side indicate mean±SEM. *, P<0.05 for isoproterenol versus baseline.
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the recovery phase after induction of AVB (0 days). Measured levels of dopamine ranged from ‘not 
detectable’ to 0.32 nmol/L under control conditions (median
0.12 nmol/L) and did not alter during AVB. Likewise, epinephrine concentrations did not change 
significantly (Figure 7; open squares). Norepinephrine, however, (control concentration 0.87±0.23 
nmol/L) increased significantly upon induction of AVB (0 days) and peaked at 2.50±0.56 nmol/L 
around 8 days AVB. In the chronic phase of AVB thereafter (>8 days), norepinephrine returned to 
control levels (Figure 7; filled diamonds). We speculate that the early rise of this catecholamine is 
a response mechanism to overcome incomplete circulatory compensation in the first 2 weeks of 
AVB [22].
DISCuSSIoN
The present study demonstrates that a profound decrease of KCNQ1 mRNA and protein occurs 
within days after induction of AVB in the apicolateral region of the canine LV. It is followed by a 
more gradual decrease of ß1-ARs. The kinetics of downregulated IKs and its responsiveness to the 
selective blocker HMR1556 remain unaltered in AVB myocytes. However, ß-AR stimulation of IKs 
is decreased. At the level of the cellular action potential these molecular and biophysical charac-
teristics translate to the loss of ß-A-induced shortening of repolarization, favoring the occurrence 
Figure 7  Plasma levels of natural catecholamines during AVB. Concentrations of epinephrine and norepi-
nephrine in venous blood plasma at SR and 0, 3, 8 and 30 days of AVB. *, P<0.05 versus SR.
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of EADs. In conscious dogs, QT and QTc responses to ß-A challenges confirm the IKs-related loss 
of ventricular repolarization shortening in chronic AVB, when beat-to-beat QT instability is also 
eminent.
Downregulation of IKs and ß-adrenergic regulation
Downregulation of IKs at the chronic stage of AVB has been reported previously in the dog [1,9] and 
rabbit [25]. Decreases in IKs were also found in other animal models of cardiac hypertrophy and/or 
failure [2,26,27], and in humans [28]. In the present study we closely analyzed the biophysical prop-
erties of downregulated IKs in chronic-AVB myocytes. The unaltered kinetics and responsiveness 
to HMR1556 indicated that reductions in channel numbers, rather than conformational changes, 
underlie the diminution of this current. Another aspect of IKs downregulation was the finding, that, 
in contrast to the reduction of KCNQ1, KCNE1 did not change. We observed a similar differential 
response in the canine interventricular septum after chronic AVB [10]. However, reductions of both 
KCNQ1 and KCNE1 mRNA and protein were found in the basal and midlateral parts of the LV and right 
ventricle [9]. In the latter study, mRNA expression was quantified using a combination of Northern 
blot and multiplex competitive real-time PCR, whereas in the recent septum study [10] and the 
present one fluorescence-based kinetic real-time PCR was employed. The latter is a more accurate 
method. To exclude a methodological reason for the apparent discrepancies in KCNE1 results, we 
redetermined KCNE1 mRNA in tissue from the basal and midlateral LV of normal and chronic-AVB 
dogs (as in Ref. [9]) using the fluorescence-based kinetic real-time PCR (as in the present study), 
and found a similar decrease of expression as described previously [9]. Based on these data, we 
consider regional heterogeneity of IKs-subunit remodeling in the LV, even among α-and β-channel 
subunits, the most likely explanation for the different results in the three studies.
The question arises why the decrease of KCNQ1 did not change the kinetics of IKs. Wang et al. 
[29] examined the influence of various ratios of KCNQ1 : KCNE1 on the current kinetics of the 
assembled IKs channel. Ratios of 2:1 and 1:1 resulted in similar current characteristics, and both 
closely resembled the activation kinetics and voltage dependence of native IKs [29]. Thus, a unilat-
eral decrease of KCNQ1 of ~50% (as in AVB) would not be expected to affect the kinetics of native 
IKs significantly, in line with the present findings.
Stimulation of IKs by ß1-ARs depends predominantly (if not exclusively) on protein-kinase-A stimula-
tion of KCNQ1 subunits [30]. Modulation via ß2-ARs has also been suggested, mainly by the finding 
that cardiac IKs density is increased in transgenic mice expressing fusion proteins of IKs subunits and 
human ß2-ARs [31]. ß2-A signaling could modulate the function of these IKs channels even in the 
absence of exogenous ß-A agonists [31]. ß3-A regulation of IKs has also been reported, although 
with different results in different models: ß3-AR stimulation enhanced IKs in Xenopus oocytes 
expressing human KvLQT1/MinK channels [32], but inhibited the current in guinea-pig ventricular 
myocytes [33]. From the three receptor subtypes (ß1, ß2 and ß3) examined in the present study, 
only ß1 expression showed a clear and sustained decrease compatible with the decreased ß-A 
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responsiveness of IKs in AVB cells. We cannot exclude that, apart from the decreases of KCNQ1 and 
ß1-AR, other elements of the IKs-macromolecular signaling complex [34] or ß-A cascade are also 
involved in the downregulation of IKs.
The effect of ß-AR downregulation is probably not the same for all ion channels. We found that 
the maximal response of ICaL during depolarizing steps to 0 mV was the same in control and chronic 
AVB (manuscript under revision). Differences in ß-A responsiveness between ICaL and IKs could be 
explained by different coupling of these channels to their receptors and/or signaling cascades. 
Isoproterenol stimulation of L-type Ca2+ channels results mainly from a local activation of the 
signaling cascade [35]. At the present time there is no such data available for IKs channels.
Temporal patterns of remodeling at the molecular and in-vivo level: do they match?
Using a minimally-invasive procedure under closed-chest conditions, we obtained LV myocardial 
biopsies in a serial manner. Thus, follow-up of the transcriptional expression of IKs-channel subunits 
and other IKs-relevant proteins (including ß-AR subtypes) was possible using each dog as its own 
control, thereby minimizing problems of biological variability. Such problems are often encountered 
in group comparisons when different animals are used. To the best of our knowledge, this is the first 
study to describe serial molecular-expression patterns in LV myocardial tissue from individual dogs. 
We believe that this approach holds great promise for future studies of myocardial remodeling in 
chronic pathological conditions.
When we align the patterns of KCNQ1 and ß1-A downregulation with the altering QT responses in 
vivo and the changes of plasma norepinephrine, an interesting picture emerges. Considering that IKs 
downregulation is a major determinant of the AVB-induced repolarization prolongation [1], the fast 
decrease of KCNQ1 (at 3 days; Figure 1) apparently contrasts with the much slower response of QT 
and QTc prolongation by remodeling (after >8 days of AVB; Figure 6). However, the contribution of 
IKs to repolarization depends critically on ß-AR stimulation [13] and therefore this system must be 
taken into account when explaining the temporal differences. We find it likely that the early rise of 
norepinephrine (Figure 7) ‘neutralizes’ the loss of KCNQ1, effectively maintaining a pseudonormal 
IKs in the first week of AVB. In the period thereafter, the waning of norepinephrine levels and the 
additional downregulation of ß1-ARs (Figure 1) gradually uncovers the QT prolongation. In a similar 
time-dependent manner, the loss of ß-A-induced shortening of ventricular repolarization could be 
explained.
The lack of an effect of isoproterenol on the QTc interval at 3 and 7 days AVB (Figure 6C) could arise 
from the influence of high levels of endogenous norepinephrine in the ventricles at this stage. This 
could have obscured the effect of the exogenous ß-A agonist.
Different mechanisms control the chronotropic responses to isoproterenol during SR and AVB, i.e., 
via stimulation of the sinus node and via stimulation of distal His-bundle cells, Purkinje cells or 
even ventricular working myocardium, respectively. The sensitivity of these pacemaking tissues to 
isoproterenol may not be the same in the two conditions.
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Consequences of IKs downregulation
In control myocytes, ß-A activation shortened the APD consistently, which indicated that the 
stimulation of outward currents (mainly IKs) prevailed over the stimulation of inward currents 
(mainly ICaL). In chronic-AVB cells, heterogeneous APD responses were observed, likely as the result 
of IKs downregulation in the presence of an unchanged ICaL and enhanced INaCaX [7]. The reduced 
IKs still contributed to repolarization during ß-AR stimulation, as evident from the (extra) APD 
prolongation after administration of HMR1566 (Figure 4). Under these conditions (isoproterenol 
plus HMR1566) the frequent generation of EADs in chronic-AVB cells, and their absence in control 
myocytes (Figure 5), strongly suggested that other ionic changes (e.g., enhanced Na+–Ca2+ exchange 
[7]) also contributed to the proarrhythmia. Taken together our results indicate that the already 
labile ventricular repolarization in chronic AVB is adversely challenged during episodes of intense 
ß-A activation. The generation of ß-A EADs would exaggerate this repolarization lability and also 
trigger abnormal impulses.
Approximately 10% of the dogs with chronic AVB die suddenly. In some of these, sudden death 
occurred during excitement, as witnessed by animal technicians. In other animals, ambulatory elec-
trocardiographic recordings revealed polymorphic ventricular tachycardia as the mode of death [6]. 
Tachycardia was immediately preceded by an accelerated idioventricular rhythm and short-coupled 
ventricular beats from different foci [6]. The data suggest a significant contribution of the sympa-
thetic nervous system to the initiation of these arrhythmic events. Given the findings of KCNQ1 
downregulation and ß-A proarrhythmia in this dog model, there is an interesting similarity with 
the human congenital long-QT 1 syndrome. Sympathetic triggers of torsades de pointes, as during 
exercise and emotion, have long been recognized in long-QT-1 patients [36]. In latent carriers of 
KCNQ1 mutations, intravenous epinephrine can unmask the abnormal repolarization [37], much like 
our findings with isoproterenol in dogs with AVB. To our knowledge, the present study is the first to 
describe provocation testing using isoproterenol in acquired cardiac channelopathy.
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ABSTRACT
It is poorly understood how mechanical stimuli influence in vivo myocardial remodeling during 
chronic hemodynamic overload. Combined quantitation of ventricular mechanics and expression 
of key proteins involved in mechanotransduction can improve fundamental understanding. Adult 
anesthetized dogs (n=20) were studied at sinus rhythm (SR) and 0, 3, 10, and 35 days of complete 
atrioventricular block (AVB). Serial left ventricular (LV) myofiber mechanics were measured. 
Repeated LV biopsies were analyzed for mRNA and/or protein expression of ß1D-integrin, melusin, 
Akt, GSK3ß, muscle LIM protein (MLP), four-and-a-half LIM protein (fhl2), desmin, and calpain. 
Upon AVB, increased ejection strain (0.29±0.01 vs. 0.13±0.02, SR) and end-diastolic stress (4.8±1.1 
vs. 2.7±0.4 kPa) dominated mechanical changes. Brain natriuretic peptide plasma levels were 
correspondingly high (33±4 vs. 19±1 pg/ml, SR). ß1D-Integrin protein expression increased chroni-
cally after AVB. Melusin was temporarily overexpressed (+33±9%, 3 days AVB vs. SR), followed by 
elevated ratios of phosphorylated (P)-Akt to Akt and P-GSK3ß to GSK3ß (+26±6% and +30±8% at 
10 days AVB vs. SR). These changes corresponded to peak hypertrophic growth at 3 to 10 days. MLP 
increased gradually to maxima at chronic AVB (+36±7%). In contrast, fhl2 (-22±3%, 3 days) and 
desmin (-30±9%, 10 days AVB) transiently declined but recovered at chronic AVB. Calpain protein 
expression remained unaltered.
In conclusion, volume overload after AVB causes a transient compromise of cytoskeletal integrity 
based, at least partly, on transcriptional downregulation. Subsequent cytoskeletal reorganization 
coincides with the upregulation of melusin, P-Akt, P-GSK3ß and MLP, indicating strong drive to 
compensated hypertrophy.
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INTRoDuCTIoN
It is still poorly understood how mechanical signals are sensed by the myocardium and transduced 
into cellular-biological responses. Mechanical load imposed on the myocardium can be dissected 
into stress, which is the force per cross-sectional area of tissue, and strain, the resultant cellular 
deformation. Stress and strain exhibit cyclic beat-to-beat variations in the normal heart, and they 
are both stimuli for and responders to remodeling induced by pathological overload.
Recently, we described the time course of left ventricular (LV) myocardial mechanics in dogs with 
bradycardia-induced volume overload due to complete atrioventricular block (AVB) [11]. Early after 
AVB, increased end-diastolic myofiber stress and ejection strain are imposed on the myocardium, 
and they coincide with peak hypertrophic growth, suggesting their role as primary stimuli for 
mechanotransduction.
Besides ventricular hypertrophy, the AVB model is characterized by important electrical, contractile, 
and structural remodeling, yet an exact relation with mechanical overload is currently unknown.
In the present study, we examined the time-dependent effects of increased load on myocardial 
remodeling during AVB, focusing specifically on the expression of key proteins involved in mecha-
notransduction and cytoskeletal integrity, i.e., laminin, ß1D-integrin, ß1D-integrin-interacting protein 
melusin, Akt (protein kinase B), GSK3ß, muscle LIM protein (MLP), four-and-a-half LIM protein 2 
(fhl2), and desmin. Serial analysis of myofiber mechanics was combined with the determination of 
plasma levels of brain natriuretic peptide (BNP), a biochemical marker of load. Repetitive sampling 
of intramural LV biopsies was applied to analyze protein expressions in individual dogs over time.
mETHoDS
Experiments were conducted in accordance with the ‘European Directive for the Protection of Verte-
brate Animals Used for Experimental and Other Scientific Purposes (86/609/EU)’. The Committee 
for Experiments on Animals of Maastricht University approved the experiments.
Model of complete atrioventricular block
Twenty adult mongrel dogs of either sex weighing 25±1 kg were used. After dogs were fasted 
overnight, premedication (1 ml/10 kg i.m. Acetadon containing 1.5 mg/ml acepromazine, 4 mg/ml 
methadone, and 0.6 mg/ml atropine) was administered. Complete anesthesia was induced by thio-
pental sodium (20 mg/kg iv) and maintained with halothane (0.5–1%) and O2-N2O (1:2). AVB was 
induced by radio-frequency catheter ablation of the His bundle. Animals were studied serially at 
sinus rhythm (SR; control) and at 0, 3, 10, and 35 days AVB. A standard six-lead ECG was registered. 
After the animals were killed (35 days AVB), the hearts were excised and weighed.
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LV mechanics
LV mechanics were quantified as myofiber stress and strain by applying serial transthoracic echo-
cardiography synchronized with recordings of LV cavity pressure using a validated mathematical 
model [2], as we have recently described in detail [11]. Plasma levels of BNP were determined in 
peripheral venous blood, collected in chilled EDTA tubes, centrifuged (1,600 g, 10 min, 4°C), and 
stored at -80°C until measured in duplicate by a radioimmunoassay specific for canine BNP-32 
(Phoenix Pharmaceuticals, Mountain View, CA).
Serial percutaneous sampling of LV intramural biopsies
Intramural LV needle biopsies were taken serially in dogs at SR and after 3, 10, and 35 days AVB. 
A 16-gauge biopsy needle (Acecut, TSK Laboratory) was percutaneously inserted into the apico-
lateral LV wall, under fluoroscopic guidance. At least two samples (~10 mm3) were obtained per 
experiment. Tissue quality was optimal in most biopsies (>98%). All animals were followed by 
transthoracic echocardiography after biopsy sampling to exclude cardiac tamponade, although in 
our experience the closed-chest approach is generally uncomplicated (>95%) and fatal outcome is 
rare (<3%). Such complications did not occur in this study.
Light and electron microscopy
For light (LM) and electron microscopy (EM), biopsies were processed and analyzed as described 
before [4]. Briefly, tissue was fixed in 3% glutaraldehyde and embedded in epoxy resin. LM analysis 
was performed on periodic acid-Schiff (PAS)-/Toluidine blue-stained sections to depict cardio-
myocyte glycogen content, sarcomeres, mitochondria, and nuclei. PAS positivity and absence of 
contractile filaments in >10% of the cell surface area of transversely sectioned cardiomyocytes 
were considered abnormal.
Immunohistochemistry
Indirect immunohistochemistry was performed on briefly fixed tissue (3% glutaraldehyde or 3.7% 
formaldehyde) using primary antibodies directed against desmin (DE-R-11, 1:10) (Dako Cytomation, 
Glostrup, Denmark), MLP (1:80) [1], vimentin (K36, 1:10) (Frans C. Ramaekers, Maastricht University), 
and laminin (L9393, 1:150) (Sigma, St. Louis, MO). Specific labeling was visualized using appropriate 
secondary antibodies applying immunoperoxidase or immunofluorescence techniques. Nuclei were 
stained using Mayers hemalum or propidium iodide. For negative control, the primary antibodies 
were omitted. Immunofluorescent labeling was analyzed using confocal laser scanning microscopy 
(Bio-Rad MRC600, Bio-Rad, Hercules, CA).
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Real-time PCR
Total RNA was isolated from the biopsies with the use of the RNEasy Mini kit (Qiagen/West-
burg, Leusden, The Netherlands). Fluorescence-based kinetic real-time PCR was performed with a 
LightCycler system (Roche Diagnostics, Almere, The Netherlands), and amplicons were quantified 
relative to the constitutively active 18S rRNA by using the LinRegPCR method [31].
Western blotting
Total homogenates were derived from unfixed cryosections (5 µm) dissolved for 30 min on ice in 
lysis buffer (62 mmol/l Tris, 1.25 mmol/l EDTA, 2% Nonidet P-40, 2.5 mmol/l phenylmethylsulfonyl 
chloride, 12.5 mg/ml leupeptin, 12.5% glycerol, 100 mg/ml aprotinin, 0.5 mM sodium orthovana-
date, and 2.3% SDS) and sample buffer for 4 min at 95°C (62 mmol/l Tris, 2.3% SDS, 10% glycerol, 
5% ß-mercaptoethanol, and 0.05% bromophenol blue). Equal amounts of total protein (7.5–30 
µg/lane), determined by protein assay (Bio-Rad), were loaded on 10% SDS-PAGE gels, transferred 
to nitrocellulose membranes, and controlled by Coomassie brilliant blue, Ponceau S staining, and 
GAPDH immunoblotting. Membranes were blocked in BSA (3%, 1 h) in Tween buffer (TWB), contai-
ning PBS and Tween 20 (0.05%), and incubated with the primary antibody in BSA (0.5%, 1 h) against 
desmin (DE-R-11, 1:5,000), ß1D-integrin (2B1, 1:100) (Mubio, Maastricht, The Netherlands), melusin 
(1:500) [7], MLP (1:500) [1], fhl2 (1:500) [24], Akt (9272, 1:1000), phosphorylated (P)-Akt (Ser473, 
1:1000), GSK3β. (9315, 1:1000), P-GSK3β. (Ser9, 1:1000) (Cell Signaling Technology, Danvers, 
MA), and the regulatory subunit of calpain I and II (P1, 1:1100) (Chemicon, Temecula, CA). After 
blots were washed in TWB, they were incubated (1 h) using the appropriate secondary antibodies, 
washed again, and visualized on X-ray films (Fujifilm, Rotterdam, The Netherlands) with enhanced 
chemiluminescence (Amersham Biosciences, Amersham, UK). Densitometric quantification was 
performed with Quantity One software using a GS-800 scanner (Bio-Rad). All immunoblots were 
performed in duplicate.
Statistical analysis
Data are presented as means±SE. Data were compared by using Student’s t-test for unpaired or 
paired data. Serial data were tested by repeated-measures ANOVA using Bonferroni’s post test 
comparison. Differences were considered statistically significant if P<0.05.
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RESulTS
Temporal aspects of mechanical overload and BNP expression
For information regarding hemodynamic changes after AVB in this study, we refer to Table 1. 
Consistent with our previous study [11], LV mechanical load was characterized by early increases of 
end-diastolic myofiber stress (4.8±1.1 vs. 2.7±0.4 kPa at SR, P<0.01) and ejection strain (0.29±0.01 
vs. 0.13±0.02 [no units] at SR, P<0.01). End-diastolic stress normalized after 35 days AVB (Figure 
1, A and B). Systolic myofiber stress did not change during AVB (37.3±3.6 vs. 38.0±4.3 kPa at SR, 
P=not significant (ns)).
The impact of increased stress and strain on the myocardium was reflected by maximally elevated 
plasma levels of BNP as early as 3 days after AVB (32.9±3.5 vs. 19.1±1.0 pg/ml at SR; P<0.01). BNP 
remained high throughout the experimental period (Figure 1C). Temporal changes of plasma BNP 
correlated well with ejection strain (r2=0.75), whereas only a weak correlation with end-diastolic 
stress was found (r2=0.004) (Figure 2D).
Dynamic cardiomyocyte remodeling after AVB
The presence of cardiac hypertrophy was confirmed at autopsy after 35 days. Total heart weight 
(270±12 g) and heart weight-to-body weight ratio (10.7±0.6 g/kg) were larger than in a matching 
control population of dogs with SR (202±12 g and 8.0±0.4 g/kg, respectively; both P<0.05).
key proteins involved in mechanotransduction. 
Western blot analysis revealed a significant increase of ß1D-integrin expression after AVB when 
compared with SR (Figure 2A), whereas its extracellular ligand laminin did not alter (Figure 3A). 
Time-dependent expression of melusin, a protein directly interacting with the cytoplasmic domain 
of ß1D-integrin at the Z disk, was characterized by an early peak at 3 days AVB (+33±9% vs. SR, 
P<0.05), which gradually declined thereafter (Figure 2B).
The P-Akt-to-Akt (P-Akt/Akt) ratio increased at 10 days AVB (+26±6% vs. SR, P<0.05) (Figure 
4A). The Akt substrate GSK3β was phosphorylated along with Akt, reaching peak values of the 
P-GSK3β-to-GSK3β (P-GSK3β/GSK3β) ratio at 10 days (+30±8% vs. SR, P<0.05) (Figure 4B). 
This higher degree of Akt and GSK3β phosphorylation was transient, because the P-Akt/Akt and 
P-GSK3ß/GSK3ß ratios at 35 days AVB were not different from control.
The cardiac LIM domain proteins MLP and fhl2, which both act at the Z disk downstream from 
ß1D-integrin-melusin, showed divergent expression patterns during AVB. MLP gradually increased 
to maxima at chronic AVB (+36±7% at 35 days vs. SR, P<0.01; Figure 2C), whereas fhl2 exhi-
bited an early decline (-22±3% vs. SR, P<0.01) (Figure 2D). Immunohistochemical studies revealed 
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SR AAVB 3 days 10 days 35 days
LV pressure 
  Peak systole, kPa 12.5 ± 1.1 10.0 ± 0.7 12.4±2.0 12.1 ± 0.6 12.3 ± 0.8 
  End diastole, kPa 0.8 ± 0.1 1.5 ± 0.3* 1.3 ± 0.2 1.1 ± 0.2 0.8 ± 0.1 
  Maximum rise, kPa/s 142 ± 9 141 ± 20 244 ± 44* 238 ± 21* 236 ± 41* 
Heart rate, beats/min 107 ± 5 44 ± 9* 45 ± 4* 46 ± 4* 48 ± 4* 
Cardiac output, l/min 3.1 ± 0.4 1.4 ± 0.4* 1.8 ± 0.3 2.0 ± 0.3 2.2 ± 0.1 
Ejection fraction, % 48 ±  4 62 ± 5 70 ± 2* 77 ± 3* 75 ± 3* 
Values are means ± SE. SR, sinus rhythm (control); AAVB, acute atrioventricular block; LV, left ventricular. *P< 0.05 vs. SR.
Figure 1  Time course of mechanical 
overload before and after atrioven-
tricular block (AVB). Average curves 
(n=5 dogs) of end-diastolic stress (s
f
) 
A, ejection strain (∆e
f,ej
) B, and plasma 
levels of brain natriuretic peptide (BNP) 
C are shown. Changes of ejection strain 
D (right), and not of end-diastolic stress 
D (left), correlate well with altering 
BNP plasma levels. *P<0.05 vs. sinus 
rhythm (SR); †P<0.05 vs. 3 days AVB.
Table 1  Hemodynamic and electrocardiographic measurements
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that, during AVB, MLP expression increased throughout the cytoplasm and was also prominently 
expressed in the nucleus (Figure 5). The temporal expression of MLP correlated highly with incre-
asing echographic LV mass (in grams) over the weeks after AVB (Figure 6). In addition, we found 
a good correlation between the expression of melusin, the ratiometric expression of P-Akt/Akt 
and P-GSK3ß/GSK3ß, and the degree of hypertrophic growth (LV mass increase per time in g/day; 
Figure 6).
Time course of cytoskeletal and sarcomeric changes. 
(Immuno)histological analysis revealed a normal compact myocardial texture and no alteration of 
the extracellular space during AVB (Figure 3) in line with earlier work [37]. The extracellular space 
was characterized by unaltered expressions of the ß1D-integrin-interacting extracellular protein 
laminin (Figure 3A) and the fibroblast intermediate filament vimentin (Figure 3B). Micromorpho-
Figure 2  Time course of Z-disk protein expression before and after AVB. Serial Western blot analysis of ß
1D
-integrin A, melusin B, muscle 
LIM protein (MLP) C, and four-and-a-half LIM protein 2 (fhl2) D is shown. Average values (n=7 dogs) are standardized to SR; rel, relative. 
*P<0.05 vs. SR; †P<0.05 vs. 3 days (3d) AVB.
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Figure 3  Time course of structural remodeling before and after AVB. Immunofluorescent double staining for desmin (green) and laminin 
(red) A and desmin (green) and vimentin (red) B showing no differences between SR and AVB. C light microscopy (LM) photomicrographs 
of periodic acid-Schiff-/Toluidine blue-stained left ventricular (LV) myocardium from serial biopsies of one individual dog showing increased 
cytoplasmic glycogen content during AVB (asterisks), which was absent at SR. D electron microscopy photomicrographs illustrating 
ultrastructural details, as glycogen accumulation in areas with depletion of sarcomeres and remnants of myofibrils (asterisks) altered 
mitochondrial shape and size as compared with SR (arrowheads). E relative number of cardiomyocytes showing depletion of sarcomeres. 
Scale bars in A–C indicate 10 µm. *P<0.05 vs. SR; †P<0.05 vs. 10 days AVB. For full colour illustration, see page 226.
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Figure 4  Time course of Akt and GSK3ß protein expression and phosphorylation before and after AVB. Serial 
Western blot analysis and normalized ratio of phosphorylated (P) to total protein expression of Akt A and GSK3ß 
B are shown. Average values (n=5 dogs) are standardized to SR. *P<0.05 vs. SR.
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Figure 5  Cardiomyocyte expression pattern of MLP before and after AVB. LM photomicrographs show immunohistochemical expression 
of MLP in LV myocardium at low A and high B and C magnification, in transversely A and B and longitudinally C sectioned cardiomyocytes. 
At control (SR), a mild MLP expression was observed within the cytoplasm and the nucleus B and C; solid arrowheads. Note that noncar-
diomyocyte nuclei B and C, open arrowhead stain blue, whereas cardiomyocyte nuclei show MLP labeling B and C, solid arrowhead. In 
negative control (MLP.), both cardiomyocyte nuclei B and C, solid arrowhead and noncardiomyocyte nuclei B and C, open arrowheads stain 
blue, indicating the absence of MLP labeling. During AVB, both cardiomyocyte cytoplasmic and nuclear expression of MLP are increased 
B and C. Scale bars indicate 10 µm. For full colour illustration, see page 227.
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metry of cardiomyocyte cross sections showed comparable diameters between SR (23±1 µm), 
10 days (24±1 µm, P=ns), and 35 days AVB (25±1 µm, P=ns), supporting previous data showing 
predominant cellular lengthening after AVB [11,37].
Cytoskeletal integrity was further explored by analysis of the intermediate filament desmin (Figure 
7). During SR, quantitative analysis of mRNA and protein expression showed a downregulation at 3 
and 10 days AVB and subsequent normalization (Figure 7, A and B). Desmin immunolabeling was in 
agreement with the mRNA and protein data and exhibited a normal cross-striated pattern at the 
Z line and prominent expression at the intercalated disk. At 3 and 10 days AVB, desmin labeling at 
the intercalated disk clearly decreased compared with the Z-line labeling. After 35 days, desmin 
expression was restored, particularly at the intercalated disks (Figure 7, C and D).
To determine whether the early decrease of desmin was also reflected by derangements of sarco-
meric structures, we analyzed the cardiomyocyte ultrastructure by EM (Figure 3D). We found 
cytoplasmic areas largely devoid of sarcomeric structures, notably at 10 days AVB. These areas 
exhibited remnants of myofibrils and were filled with glycogen and with healthy-appearing, abnor-
mally large-and small-sized mitochondria. We did not observe mitochondrial swelling, loss of intra-
Figure 6  Temporal expression of melusin, P-Akt/Akt, P-GSK3β/GSK3β, and MLP related to LV hypertrophy. The time course of melusin, 
P-Akt/Akt, and P-GSK3β/GSK3β expression A–C, shaded lines correlated (insets) highly with the echocardiographically determined 
increase of LV mass per time, a measure of hypertrophic growth A–C, solid lines, whereas the time course of MLP expression D, shaded 
line correlated (inset) highly with the time course of the echographic LV mass after AVB D, solid line (n=5 dogs). Shaded bars A–C indicate 
time interval of peak hypertrophic growth. *P<0.05 vs. SR; †P<0.05 vs. 3 days AVB.
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Figure 7  Time course of desmin 
expression before and after AVB.
Serial real-time PCR a and Western 
blot analysis b show average 
values standardized to SR (n=9 
dogs). Immunofluorescent labeling 
of desmin (green) and nuclei (red) c 
and LM photomicrographs d show 
immunohistochemical expression 
of desmin in serial biopsies. Scale 
bars indicate 25mm. *P<0.05 vs. 
SR; †P<0.05 vs. 3 days AVB. For 
full colour illustration, see page 
228.
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matricial granules, disrupted mitochondrial cristae, mega-mitochondria with lipid-like inclusion, 
cytoplasmic vacuolization or edema, tortuous nuclei, intramatricial glycogen clumps, membrane 
disruption, or whorl-like myelin structures indicating the absence of ischemia or degeneration 
during AVB [4] (Figure 3D).
To quantify these abnormalities by LM, we performed PAS staining to depict the glycogen accu-
mulation observed during EM analysis. The number of abnormal glycogen-stuffed cardiomyocytes 
per microscopic section area was increased at 10 days AVB (5±2% vs. 2±1% at SR, P<0.05) and had 
normalized again at 35 days AVB (Figure 3E).
Finally, to examine whether the Ca2+-dependent protease calpain could be involved in the loss of 
cytoskeletal and contractile elements, serial Western blot analyses of the regulatory subunits of 
calpain I and II were performed, which showed an unaltered protein expression throughout the 
experimental period.
DISCuSSIoN
Time course of myofiber mechanics and plasma BNP
In the present study we have confirmed previous results [11] that both end-diastolic stress and 
ejection strain are driven to maximal amplitudes within the first week of AVB. As a first new finding, 
this acute and enduring volume overload is reflected by a parallel release of the load biomarker 
BNP. Absolute plasma levels of BNP after AVB were comparable to those in dogs with compensated 
overload of different cause, varying roughly between 25 [16] and 40 pg/ml [3]. Correlation analysis 
suggests that BNP release after AVB is mainly driven by systolic ejection strain. In vitro studies 
support that mechanical stimuli applied during systole can be even more capable of increasing BNP 
transcription than diastolic stimuli [40]. Nevertheless, diastolic load may well contribute to the 
BNP release after AVB, despite a weak temporal correlation. Diastolic mechanical stimuli have been 
shown to trigger BNP release in other animal models [15] and in humans with overload [25].
Dynamic expression of key mechanotransduction proteins after AVB
Key proteins located at the Z-disk level have been proposed to sense and transduce mechanical 
stimuli [13,22,30]. Among those, integrins are obvious candidates that span the sarcolemma [32]. 
In cardiomyocytes, ß1D-integrin is dominantly expressed [36] and has been shown to be relevant for 
mechanotransduction under basal (i.e., normal load) conditions and pathological overload [33]. Its 
increased expression has been observed during hypertrophy after adrenergic stimulation in vitro 
[28, 32] and during chronic aortic constriction in mice [5]. During AVB, ß1D-integrin expression 
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was increased from 3 days onward. This early and sustained upregulation is in line with findings in 
other models of hypertrophy [5,28,32]. Interestingly, the immunoexpression of laminin, the primary 
extracellular ß1D-integrin ligand [32], and vimentin, a fibroblast marker, were found unaltered (Figure 
3B). These findings suggest that the cardiomyocyte protein ß1D-integrin, and not components of the 
extracellular matrix, is among the first upstream elements (“initiators”) activated by mechanical 
stimuli in this model.
At its cytoplasmic domain, ß1D-integrin binds to melusin, a striated muscle-specific protein involved 
in mechanical signaling, promoting cardiac compensation and preventing failure [6,10]. The latter 
was concluded from experiments in mice after aortic constriction. Melusin-null animals exhibited 
less hypertrophy and more rapid LV dilation and failure [6], whereas transgenic mice overexpres-
sing melusin showed a prolonged phase of compensated hypertrophy in the absence of fibrosis 
as compared with wild-type animals [10]. In wild-type mice, aortic constriction led to an over-
expression of melusin after 1 wk during compensated hypertrophy, whereas melusin returned to 
baseline, when LV dilation and impaired contractility ensued after 12 wk [10]. Interestingly, we 
found a similar temporal expression pattern of melusin after AVB, with an upregulation at 3 days 
AVB and a gradual decline thereafter. It is tempting to speculate that, early after AVB, increased 
melusin expression promotes compensated hypertrophy through mechanisms that remain to be 
elucidated. This pro-compensatory effect of melusin appeared closely related to the stimulation of 
hypertrophic growth [6], which could also hold for the AVB model, where melusin overexpression 
coincides with measures of peak hypertrophic growth (Figure 6A).
In downstream hypertrophic signaling, melusin is involved in the phosphorylation of Akt and GSK3ß 
in response to mechanical load [6,10]. We found that the overexpression of melusin coincided with 
the ratiometric increase of P-Akt/Akt and P-GSK3ß/GSK3ß during a phase of maximal mechanical 
load (Figure 1, A and B) and hypertrophic growth (Figure 6).
Phosphorylation inhibits the constitutively active antihypertrophic effect of GSK3β and, thereby, 
likely stimulates different transcriptional events [14].
MLP is another key Z-disk protein involved in mechanotransduction and -sensing. It interacts with 
ß1D-integrin via ß-actinin, is associated with the actin cytoskeleton, and was recently identified as 
a crucial element of the “cardiac mechanical stretch sensor machinery” consisting of a MLP-titin-
telethonin protein chain [22]. It has been postulated that a defective chain, as in MLP-null mice and 
a subset of patients with reduced MLP levels and heart failure [41], leads to dilated cardiomyopathy 
due to malfunctioning mechanosensing [22]. In dogs with AVB, MLP expression gradually increased 
to significant levels at chronic AVB, which suggests that the MLP-titin-telethonin chain is likely not 
defective in this model. This is further supported by the finding of BNP release after AVB, which 
requires, according to a recent study [22], an intact MLP-titin-telethonin chain as prerequisite for 
BNP increase during mechanical overload. It has recently been shown that MLP plays an important 
role in the stimulation of cardiomyocyte hypertrophy via activation of the calcineurin-nuclear 
factor of activated T-cell pathway [17,18]. MLP may act as a scaffold protein to facilitate sarcomere 
assembly [17] and stimulate further downstream signaling [22]. These findings of a procompensa-
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tory role of MLP in other models of hypertrophy [17,18,22] are in agreement with the high corre-
lation of the temporal expression patterns of MLP and increased LV mass after AVB (Figure 6). We 
found that, after AVB, MLP expression increased in both the cardiomyocyte cytoplasm and nucleus 
(Figure 5). These subcellular localizations have been described for MLP and other LIM proteins [21]. 
Nuclear relocation in conjunction with MLP downregulation has been linked to a “phenoconver-
sion” toward heart failure [12]. However, in our model with compensated hypertrophy, the nuclear 
translocation is associated with increased MLP levels, suggesting increased transcriptional activity, 
as also postulated for other LIM proteins [21].
The other Z-disk LIM domain protein that we studied, fhl2, also colocalizes with ß1D-integrin, 
ß-actinin, and the actin cytoskeleton and is relevant for cardiomyocyte differentiation and myofi-
brillogenesis [20], as described for MLP. In contrast, fhl2 expression during AVB is transiently 
reduced around 10 days of AVB. This implicates a different role for fhl2 in the AVB model, which 
should be analyzed in more detail in future experiments. Importantly, fhl2 and MLP have a divergent 
protein structure, which is compatible with a different functional role [21]. In contrast with MLP, 
fhl2 is regarded as a repressor of hypertrophy [29]. It interacts with ERK2, an element of the MAP 
kinase signaling pathway. Hypertrophic responses induced by adrenergic stimulation, and mediated 
via ERK2, are partially antagonized by fhl2, which attenuates transcription [29]. In line with this 
finding, fhl2-null mice, which exhibit a normal cardiac phenotype, show increased hypertrophic 
growth after catecholamine infusion, supporting repressor-like activity of fhl2 in the overloaded 
myocardium [23]. ERK2 interacts with fhl2, but it does not interact with MLP, which underscores 
the protein-specific action of LIM proteins [29]. The early transient downregulation of fhl2 after 
AVB coincides with an enhanced adrenergic tone [34] and maximal hypertrophic growth in the 
first 10 days after atrioventricular block. It could well be that hypertrophy is partly caused by 
enhanced adrenergic stimulation and mediated via MAP kinase/ERK2. The latter pathway could be 
incompletely repressed by the fhl2 reduction at this stage, promoting hypertrophy.
Transitory changes of cytoskeletal elements after AVB
The depletion of sarcomeres and glycogen accumulation at 10 days AVB was similar but less exten-
sive than reported in chronic hibernating myocardium (~30%) [4]. These morphological changes 
have been interpreted as signs of myocardial dedifferentiation [4]. Interestingly, glycogen accumu-
lation after AVB coincided with the ratiometric increase of P-GSK3β/ GSK3β, which interacts with 
glycogen synthase, promoting glycogen synthesis and accumulation [14]. Whether this observation 
is a purely metabolic phenomenon or a sign of beneficial cardiomyocyte remodeling remains to be 
elucidated.
The critical changes of the early phase after AVB are further characterized by the transient down-
regulation of desmin, which is the most important intermediate filament in cardiomyocytes and 
essential for their structural integrity and function, as recently reviewed [9]. It forms a scaffold 
that interconnects adjacent myofibrils at the Z disks, serving as a physical link between the sarco-
lemma, cytoskeleton, and the nuclear envelope [9,22,30]. A transient downregulation of desmin 
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early during acquired mechanical overload has not been reported in the literature, but it could be 
a consequence of the abrupt mechanical impact of AVB exhibiting aspects of mild heart failure. In 
ventricular hypertrophy, desmin expression has been reported to be either unaltered [35] or incre-
ased [19, 38], but from studies in desmin knockout mice it has become clear that the absence of 
desmin is associated with cardiac hypertrophy and failure [9,26]. Our data suggest that the reduced 
desmin expression is regulated at the transcriptional level. We could not find a dominant role for 
calpain as a posttranslational modifier, which has been suggested with respect to the depletion of 
sarcomeres [8] and desmin disintegration [27], although we have only analyzed protein levels of the 
regulatory subunit of calpain I and II and not its protease activity, nor other proteases.
Importantly, during chronic AVB the degree of sarcomere depletion, glycogen accumulation, and 
total desmin content had normalized and desmin was even upregulated in a subset of dogs, espe-
cially at the intercalated disk. Since contractile activity has been reported to increase desmin 
expression by increased gene transcription [39], it could well be that the persistently high levels of 
ejection strain contribute to the normalization of desmin expression in the chronic phase of AVB.
CoNCluSIoNS
The mechanical load acutely imposed on the ventricular myocardium after AVB causes a transient 
compromise of cytoskeletal integrity. This is based, at least partly, on transcriptional downregula-
tion. By yet unknown molecular mechanisms, the dog with AVB is able to prevent serious disruption 
of sarcomeric elements and further downregulation of the important intermediate filament protein 
desmin. Toward chronic AVB a gradual structural reorganization and a strong drive to functionally 
compensated hypertrophy are attended by the early upregulation of melusin and MLP, known as 
procompensatory proteins in other models of ventricular hypertrophy and failure.
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of complete left-ventricular 
pressure-volume and stress-strain 
loops in the human heart
Application of the CircAdapt model
cHAPTER 7
Non-Invasive Assessment of Hemodynamics & Mechanics in the Human Left Ventricle
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ABSTRACT
Quantification of left-ventricular (LV hemodynamics and mechanics in the human heart has 
important clinical potential, because it can be used to estimate the severity of acute and chronic 
cardiac decompensation, as well as the primary factors influencing myocardial remodeling. Pres-
sure-volume and stress-strain relations of the LV allow comprehensive assessment of systolic and 
diastolic LV function and myocardial loading conditions. Non-invasive assessment of LV function is 
currently based on, but limited to, Doppler echocardiography or magnetic resonance imaging (MRI). 
LV-pressure recordings are generally lacking because they require invasive diagnostic techniques. 
We developed a novel approach to simulate LV intracardiac hemodynamics and myofiber mechanics 
based on the CircAdapt model (Am J Physiol, 2005) applied in humans with different types of 
cardiac overload.
In 12 patients, 3 with hypertension, 3 with hypertension and mitral/ aortic regurgitation, 2 with 
mitral regurgitation, and 4 without ventricular overload, we made patient-specific fits of whole 
circulation hemodynamics using CircAdapt modeling. To this aim, we identified a novel combination 
of measured 2-dimensional- and Doppler echocardiographic parameters, and arm cuff-measured 
blood pressure, which served as input into the model.
Peak systolic (range 118-162 mmHg) and end-diastolic LV pressures (range 5-18 mmHg) agreed 
within ±10% and ±16% (SD), respectively, with the invasively measured pressures during cardiac 
catheterization in the same patients, showing the reliability of the CircAdapt simulation. With Circ-
Adapt, systolic and diastolic stress and strain imposed on the myocardium could also be obtained. In 
validation experiments on 7 adult anesthetized dogs, pressure-volume loops generated by invasive 
and noninvasive methods for the same heart beats were similar. 
In conclusion: non-invasive determination of LV hemodynamics and mechanics can be achieved by 
CircAdapt simulation in patients with different forms of cardiac mechanical overload.
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Chapter 7    NoN-INVASIVE ASSESSMENt oF HEMoDyNAMICS & MECHANICS IN tHE HUMAN lEFt VENtRIClE
INTRoDuCTIoN
Enduring hemodynamic overload is an important trigger for myocardial remodeling in common 
cardiovascular diseases like hypertension, valvular heart disease and after myocardial infarction, 
ultimately leading to heart failure. Many therapeutic regimens are aimed at lowering the mechanical 
burden on the heart during overload, as it beneficially influences adverse myocardial remodeling. 
Yet, clinical monitoring of mechanical overload is ill-practiced, and often lacks accuracy and 
specificity. It usually relies on indirect measures such as serological biomarkers, arm-cuff blood 
pressure, Doppler echocardiography and in selected cases invasive catheter-based techniques for 
hemodynamic tailoring of therapy, i.e., Swan-Ganz monitoring.
A thorough assessment of left-ventricular (LV) mechanics requires simultaneous measurement of 
cavity pressure and volume during the cardiac cycle, which can currently only be obtained by 
conductance catheters [4,21]. Due to the invasiveness of these measurements this is not routinely 
applied in clinical practice.
Experimental data provide ample evidence that mechanical stimuli act as principal driving forces 
for myocardial hypertrophy and failure. These insights have stimulated a growing clinical interest 
to evaluate LV hemodynamics and mechanics as a basis for novel diagnostic and therapeutic 
strategies and as prognostic indicators [6]. Especially diastolic mechanics are considered relevant 
for hypertrophic myocardial remodeling [16,17,25] and elevated LV-filling pressures are a unifying 
diagnostic and prognostic feature of the failing heart [34].
Generally, calculation of myocardial stress and strain in the LV requires data on LV geometry and 
forces, i.e., intracavitary pressure imposed on the tissue. Since LV pressure cannot be measured 
non-invasively, a number of Doppler echocardiographic approaches has been proposed, by which 
LV-filling pressures can be estimated [5,9,19,23,26,28,31,34,35,39]. All these studies use empirical 
relations of indirect hemodynamic and functional parameters to estimate diastolic cardiac func-
tion and filling pressures. Yet, non-invasive methods to determine LV pressure dynamically from 
beginning to end of diastole are currently not available. Moreover, no straightforward, easy-to-use 
clinical diagnostic modality exists to perform LV pressure-volume and stress-strain assessment at 
the bedside.
Therefore, we adjusted the CircAdapt computer model of whole circulation dynamics [3] to fit 
patient-specific non-invasive measurements using 2-dimensional (2D) and Doppler echocardiog-
raphy combined with arm-cuff blood pressure. This approach allows completely non-invasive 
estimation of LV pressure-volume and myofiber stress-strain relations throughout the cardiac 
cycle. CircAdapt simulated LV hemodynamics were compared to invasive assessment during cardiac 
catheterization in humans and experimental animals.
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CircAdapt model - principle
The CircAdapt model of the whole circulation is composed of various modules, representing 
contractile chambers, compliant large blood vessels, valves and peripheral resistances (Figure 1) 
[3]. The core of the model is a system of differential equations in state variables, i.e., volumes of 
chambers and blood vessels, transvalvular flows and sarcomere variables. The most relevant equa-
tions are summarized in the Appendix. A major built-in feature is its self-structuring capability, 
i.e., the model itself generates chronic adaptation of the constituent tissues to mechanical and 
hemodynamic load, e.g., hypertension or mitral regurgitation (Figure 1). Thus, for a given systemic 
flow and systemic arterial blood pressure, the sizes of all cavities, walls and blood vessels are the 
result of a time-dependent redistribution of load-simulating chronic adaptation (Figure 1).
The CircAdapt simulation starts by modeling a standard human circulation using the existing model 
[3]. Next, patient-specific quantitative information on the individual circulation as obtained by 2D- 
and Doppler echocardiography and arm-cuff blood-pressure measurements is incorporated into the 
model using a fitting procedure designed to match the CircAdapt simulation to the measurements. 
The outcome of this simulation renders the complete cardiac hemodynamics and mechanics, the 
time courses of LV pressure and volume, and myofiber stress and strain of a specific patient.
Figure 1  Left panel, schematic representation of the CircAdapt model. Contractile chambers, large blood vessels, valves and peripheral 
resistances (System, Pulm) are indicated by circles, rounded boxes, diodes and rectangles, respectively. Symbols LV, RV, LA, and RA represent 
left and right ventricles and atria, respectively. Symbols Ao, PulmArt, PulmVen and VenCav represent aorta, pulmonary arteries, pulmonary 
veins and caval vein, respectively. (See Appendix for equations and principles). Mid panel, schematic representation of a CircAdapt-simulated 
adaptation of the systemic circulation to hypertension. Increasing the peripheral resistance (System) results in concentric hypertrophy of 
the LV, and increased wall thickness of the Ao. Right panel, schematic representation of a CircAdapt-simulated adaptation of the systemic 
circulation to mitral regurgitation. Inducing mitral regurgitation results in eccentric hypertrophy of the LV and dilatation of the LA.
Boek_Donker_v5.indb   150 21-7-2008   10:22:02
151
Chapter 7    NoN-INVASIVE ASSESSMENt oF HEMoDyNAMICS & MECHANICS IN tHE HUMAN lEFt VENtRIClE
CircAdapt-simulated LV pressure compared to catheterization in humans
The Medical Ethics Committee of the Academic Hospital Maastricht approved the experiments. All 
patients gave informed consent to the study.
In 12 patients, 3 with hypertension, 3 with hypertension and mitral/ aortic regurgitation, 2 with 
mitral regurgitation, and 4 without ventricular overload, cardiac catheterization was performed for 
clinical diagnostic purposes, i.e., analysis of chest pain or dyspnea, or preoperative work-up prior 
to valvular surgery. Selection was based on the presence of normally-conducted sinus rhythm, 
undisturbed regional LV wall motion and the absence of significant coronary artery disease. During 
catheterization, LV intracavitary- and aortic pressure were measured using standard fluid-filled 
pig-tail catheters (Biosense Webster). Simultaneously, a standard 12-lead ECG and arm-cuff blood 
pressure were recorded. Transthoracic echocardiography (Philips Sonos 4500) was performed 
within 30 minutes after the catheterization in the same supine position accompanied by arm-cuff 
blood pressure measurement. The relevant patient characteristics are summarized in Table 1.
Echocardiographic measurements and primary analysis
In every individual, the aortic and mitral pulsed-wave Doppler echocardiographic flow velocities 
were averaged over 3-5 heart beats by periodically shifting the digitized image along the time 
Patient ID Age Gender Type of Overload Cardiovascular Disease
1500 77 f - -
3094 53 f - -
5835 55 m - -
9323 59 m - -
5847 62 m PO Hypertension
6079 46 f PO Hypertension
7059 53 f PO Hypertension
0179 71 f PO, VO Hypertension, MR (mild)
4996 60 m PO, VO Hypertension, MR (mild)
5877 70 f PO, VO Hypertension, MR (mild), AR (mild)
5575 55 m VO MR (severe)
9388 58 m VO MR (severe)
Table 1  Patient characteristics. PO indicates pressure overload, VO indicates volume overload; MR (grade) indicates mitral regurgitation, 
AR (grade) indicates aortic regurgitation
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axis for the best correlation of the R-wave of the ECG (Figure 2). The time window of averaging, 
as used for further analysis, started before the R-wave at the beginning of the mitral flow, and 
extended over one cardiac cycle. The flow velocity and time were calibrated by vertical and hori-
zontal stretching of the image, respectively. Early (ve) and atrial (va) peak mitral velocities and peak 
aortic velocity (vao) were determined graphically. The shape, i.e., roundedness, of the aortic flow 
curve, which is related to kurtosis, was quantified by the ratio of median velocity (vmed) during 
ejection over peak velocity (vao). All times were measured relative to the peak of the R-wave. Timing 
of aortic flow was defined by valve opening (t2), peak flow (t3) and valve closure (t4). The moment 
of mitral valve opening (t5) was defined as the point where the tangent of the rising slope at half 
peak velocity crossed to zero-flow level. From the point where this tangent crossed the level of 
maximum velocity ve, a second line was drawn parallel to the downslope of the early peak at half 
peak velocity. The latter line crossed the zero velocity axis at time t6. The interval t5-t6 marks the 
duration of the early peak. Closure of the mitral valve occurred at moment t1.
From 2D echocardiographic parasternal views, short axis internal and external diameters were 
measured; long-axis length was determined as the distance between the atrial side of the mitral-
valve plane and midwall position of the apex at mid ejection. Considering the LV to be a truncated 
ellipsoid, cavity volume VLV, wall volume Vw and stroke volume Vstr were estimated from the latter 
dimensions. Systolic and diastolic LV dimensions were determined in the frames just before the 
beginning and just after the end of ejection, respectively, as described before (17].
CircAdapt simulation - initialization
Initially, the normal circulation was modeled by CircAdapt simulation as described before [3], using 
the parameter settings shown in Table 2. General hemodynamics at rest were normal and the diam-
eter of the large bloodvessels and left-sided valves were adjusted until mean flow velocity reached 
0.17 m/s [8]. Next, a state of exercise was simulated by a threefold systemic flow and a double heart 
rate. In this state, wall mass and cavity volume of the atria and ventricles were adjusted to satisfy 
the loading conditions of the sarcomere, i.e., range of myocardial strain, mid value of sarcomere 
length, and peak passive stress. The wall thickness of the blood vessels was adjusted to set peak 
wall stress at the level of adaptation. A stable configuration developed after repeated adaptation 
cycles with rest – exercise – rest – exercise – rest. In the resulting resting state, ∆ fiber strain and 
maximum passive stress of the sarcomere in the atria and ventricles were stored to define the likely 
loading levels at chronic normal operation.
CircAdapt simulation - patient-specific modeling
The present patient-specific simulations focus on the LV, with emphasis on the complete pressure-
volume loop including ejection and filling mechanics. All measured parameters (Figure 2) were 
averaged for the whole group. The resulting set of average values was considered representative 
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Figure 2  Analysis of pulsed-wave Doppler echocar-
diographic signals. Top panel: From top to bottom, 
ECG, mitral flow velocity and aortic flow velocity. 
Images of 3 beats have been overlain. Velocity read-
ings: v
e
= early mitral peak, v
a
= atrial mitral peak, 
v
med
= median ejection velocity, v
ao
= peak aortic 
velocity. Time readings: t
1
= mitral valve closure, t
2
= 
aortic valve opening, t
3
= peak ejection, t
4
= aortic 
valve closure, t
5
= mitral valve opening, t
6
= extrapo-
lated ending of early mitral flow peak. Cycle time has 
been averaged. Bottom graph: Resulting simulation 
of aortic and mitral flow velocity with CircAdapt in the 
same format as the top panel.
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for the reference heart beat. Heart rate, mean systemic flow, mean aortic pressure and LV wall 
volume were substituted in CircAdapt according to the measurements, implying switching off 
regular chronic LV adaptation to mechanical and hemodynamic load. After simulating a heart cycle, 
all measured values were determined from the simulation, following the experimental protocol 
as described in Figure 2. From the differences between simulated and experimentally measured 
variables, adjustments to the model were calculated (Figure 3). Aortic pulse pressure and stroke 
volume were used to adjust aortic stiffness. From aortic flow velocity and cardiac output followed 
the dimension of the aortic valve cross-section. From mean arterial pressure and cardiac output 
followed the systemic peripheral resistance. Timing of sarcomere contraction followed from timing 
of aortic-valve opening and closure. LV contractility followed from maintaining LV end-diastolic 
volume. Timing of events before, during and just after ejection (t1-t5) was used to adjust timing of 
ventricular contraction. The dimension of the mitral valve cross-section followed from transmitral 
flow velocity and cardiac output. The duration of the transmitral early filling wave, i.e., the E-wave, is 
considered to depend on the resonance frequency, as formed by mitral valve inertia and compliance 
of the left atrium and LV combined. The E-wave duration was used to adjust the summed stiffness 
of atrium and ventricle. The ratio of the early filling peak (ve) and atrial peak (va) of transmitral flow 
velocity (E/A ratio), determines the ratio of ventricular stiffness to atrial stiffness. With increasing 
Value Unit Remarks
HEMODYNAMICS
Mean systemic flow 85 ml/s = 5.1 l/min
Mean aortic pressure 12.2 kPa = 92 mmHg
Cycle time 850 ms HR = 71 beats/min
LARGE BLOOD VESSELS
Mean flow velocity 0.17 m/s [8]
Peak wall stress 500 kPa
SARCOMERE
∆ Fiber strain in cycle 0.23 [-]
Mean sarcomere length 1.97 µm
Maximum passive stress 2.6 kPa
STATE OF EXERCISE
Mean systemic flow 255 ml/s = 15.3 l/min
Cycle time 425 ms HR = 142 beats/min
Table 2   Values as substituted in the CircAdapt model of the normal human circulation
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LV stiffness relative to atrial stiffness, early filling is hindered, and atrial contraction is enhanced 
due to a more prominent volume load of the atrium. An overestimation of end-diastolic LV volume 
was adjusted by increase of LV contractility. Combination of known diastolic compliances of atrium 
and ventricle with known volume displacements renders LV diastolic pressure. LV end-diastolic 
pressure was measured as pressure increase from begin to end diastole.
The ratio of median velocity to peak aortic velocity expresses roundedness of the aortic flow peak, 
as described above. This parameter was used to adjust velocity of unloaded sarcomere shortening 
vsarc. Lowering vsarc lowers aortic flow rate at the beginning of ejection, but extends the duration of 
ejection, resulting in broadening of the flow peak. Except for the LV, all chambers and blood vessels 
Figure 3  Scheme of adjustment of model parameters in patient-specific modeling. Differences between 
measured and simulated values of pressures, timing, volume and velocities were used to adjust model 
parameters related to aorta, both ventricles, left atrium and left-sided valves. Time readings: t1= mitral 
valve closure, t2= aortic valve opening, t3= peak ejection, t4= aortic valve closure, t5= mitral valve 
opening, t6= extrapolated ending of early mitral flow peak.
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regularly adapted size and mass to the varying hemodynamic load, thus mimicking adaptation to 
the chronic condition.
In the simulation of the reference state, after each cardiac beat, above-described adjustments were 
carried out. After about 50-100 beats, a steady state was reached. Convergence was not fast and 
oscillations occurred due to cross-relationships between most variables. The resulting simulation 
shows blood pressures and flows, and myofiber stresses and strains in all cardiac chambers, blood 
vessels and over valves as a function of time within a heart beat.
A sensitivity analysis was carried out to investigate the sensitivity of resultant parameters like 
aortic stiffness, peak passive stress in atrium and ventricle, peak active ventricular stress, velocity 
of unloaded sarcomere shortening vsarc, end-diastolic LV pressure, and mean atrial pressure. For 
the latter analysis, measured times were varied by 10 ms, and the other measured variables were 
varied by 10%. For each variation, a simulation was performed with the above mentioned fitting 
procedure.
Finally, feasibility of the method to determine pressure-volume loops non-invasively was tested by 
carrying out patient-specific simulations, applied to all patients separately. LV intracavitary pres-
sure as measured invasively during catheterization was compared with the LV pressure predicted 
by the CircAdapt simulation for the same individual.
Experimental validation of CircAdapt-simulated LV pressure by comparison to simultaneous 
catheterization in adult dogs
Experiments were conducted in accordance with the ‘European Directive for the Protection of Verte-
brate Animals Used for Experimental and Other Scientific Purposes (86/609/EU)’. The Committee 
for Experiments on Animals of Maastricht University approved the experiments.
7 Adult mongrel dogs of either gender and weighing 24±1 kg were used. Peri-operative care and 
anesthesia were performed as described before [16]. All animals were studied under complete anes-
thesia during normally conducted sinus rhythm. Transthoracic echocardiography and LV intracavi-
tary and aortic pressure measurements were performed simultaneously as described before [17].
Statistical analysis
Data are presented as mean±standard deviation (SD). No statistical comparisons were performed 
due to the limited number of individuals analyzed in this pilot study.
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RESulTS
For the 12 patients, group mean values of the measured parameters related to timing of flow events 
and left-sided hemodynamics are shown in Table 3. All times are indicated relative to the peak of 
the R-wave in the ECG. The overall variability of the patient data was quite high because of the 
heterogeneous character of the group. Patient-specific fit of the pulsed-wave Doppler echocar-
diographic signals was possible in all patients. Its quality is indicated by the simulation results as 
shown in the bottom panel of Figure 2.
CircAdapt simulation mimics catheterization of the human heart
CircAdapt-simulated LV-intracavitary pressure curves, which are completely based on non-
invasively acquired parameters, yield a high degree of similarity to the invasively-measured data 
recorded during LV catheterization performed within 30 minutes before the CircAdapt simulation 
study in the same individual patients (Figure 4). This holds for all individual patients, independent 
of the presence and type of hemodynamic overload.
The 4 control individuals (Table 1) had LV peak-systolic pressures (LVPsyst) and LV end-diastolic pres-
sures (LVPend-diast) during catheterization of 132.0±5.6 and 7.7±2.4 mmHg, respectively, which were 
similar to the CircAdapt simulation yielding 125.8±10.1 and 8.8±1.9 mmHg. Patients with pressure 
overload (PO) or combined PO and volume overload (VO) had LVPsyst and LVPend-diast of 139.0±14.9 
and 9.9±2.7 mmHg during catheterization, and 142.3±16.7 and 9.6±4.2 mmHg based on CircAdapt, 
respectively. Patients with VO had invasively measured LVPsyst and LVPend-diast of 126.0±9.9 and 
11.7±0.8 mmHg, and simulated values of 130.0±7.1 and 14.5±5.0, respectively (Figure 5).    
LVPsyst (range 118-162 mmHg) and LVPend-diast (range 5-18 mmHg) generally agreed within ±10% and 
±16% with the invasively measured pressures during cardiac catheterization, as compared in the 
same individual patients, showing the reliability of CircAdapt in a general population of patients 
with cardiac overload due to cardiovascular disease and in controls (Figure 5). Moreover, besides 
LVPsyst and LVPend-diast, CircAdapt provides a simulation of the rate of rise and decay of the LV pres-
sure curves (LV dP/dt) (Figure 5).
Sensitivity analysis
Reference hemodynamics are shown (Figure 6), as obtained by patient-specific fit to the aver-
aged values (Table 3). For these averages no original ultrasound measurements were available of 
course.
Sensitivity of various parameters is shown for changes in the measured variables (Table 4). The 
following relationships appeared most prominent. Aortic stiffness (kao) increases more than linear 
(exponent ~1.4) with aortic pulse pressure. Peak atrial passive stress (SpasA) is more than propor-
tional (exponent ~1.7) with the E/A ratio. Peak passive ventricular stress (SpasV) increases with stroke 
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volume and mitral peak velocity. The decrease of the atrial and ventricular stress with increase of 
LV wall volume can be easily understood, because stress decreases with increasing wall thickness 
for a given pressure load. The shape of the aortic flow curve, as expressed by the ratio of median 
to peak aortic flow velocity, decreases with velocity of unloaded sarcomere shortening vsarc. Mean 
left atrial pressure increases with early peak velocity.
Considering the measurements of timing, the most prominent relations are the following: sarcomere 
velocity vsarc highly depends on shape, i.e., if the moment of mitral valve closure is late, aortic valve 
opening early, and its closure late, the start of the aortic flow curve is steep, and ejection time is 
long. The stress SpasV and diastolic pressures ped and pLA decrease with the duration of the E-wave 
(t6-t5), indicating decrease of stiffness of the compliance-inertia circuit around the mitral valve. 
Interestingly, this dependency has not been found previously for SpasA.
Mean ± SD Unit
TIMING (tRwave=0 ms)
Cycle time 945 ± 121 ms
Opening aortic valve (t2) 28 ± 22 ms
Peak aortic flow (t3) 110 ± 23 ms
Closure aortic valve (t4) 335 ± 26 ms
Opening mitral valve (t5) 407 ± 22 ms
End of E-peak (t6) 711 ± 58 ms
A peak mitral flow -75 ± 41 ms
Closure mitral valve  (t1) -9 ± 32 ms
VELOCITIES
Peak aortic velocity 1.37 ± 0.28 m/s
Median aortic velocity 0.98 ± 0.21 m/s
E-peak mitral velocity 0.74 ± 0.15 m/s
A-peak mitral velocity 0.73 ± 0.22 m/s
PRESSURES
Max. aortic pressure 130 ± 16 mmHg
Min. aortic pressure 75 ± 6 mmHg
VOLUMES
Stroke volume 68 ± 18 ml
End diastolic volume 106 ± 25 ml
LV wall volume 153 ± 45 ml
Table 3  Summary of measured parameters in 12 patients
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Figure 4  Comparison of simulated and invasively measured LV and aortic pressure curves for all individual patients. Individual patient 
characteristics are summarized in Table 1. Differences in timing between simulated and invasively measured pressures are a result of small 
differences in heart rate between time-delayed measurements.
Figure 5  Patient-specific CircAdapt simulated LV pressures compared to invasive measurements in all individual patients (black rect-
angles) and dogs (open rectangles, left panel, insert). LVP
end-diast
 indicates LV end-diastolic pressure defined as end-diastolic pressure 
minus minimum LV pressure, LVP
syst
 indicates peak-systolic pressure (left panel), LV dP/dt indicates maximum rate of rise or decay of the 
LV pressure curves (right panel), the line of unity is indicated by dashed lines.* Indicates mean slope of comparison.
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CircAdapt simulation directly compared to simultaneous catheterization in adult dogs
A direct comparison of invasively measured and CircAdapt-simulated LV pressure curves was 
performed in adult dogs. In this analysis invasive measurements and data acquisition for the Circ-
Adapt simulation were recorded simultaneously on a beat-to-beat basis and were not time-delayed 
as in the human study. This analysis revealed a reasonable overall accuracy of the CircAdapt 
simulation comparing complete curves covering the whole cardiac cycle. Group mean measured 
LVPend-diast was 3.8±1.0 mmHg, which is the most critical LV pressure parameter within the cardiac 
cycle, and was estimated by CircAdapt as being 5.9±1.6 mmHg (Figure 5).
Figure 6  Hemodynamics by patient-specific modeling to the 
average values, as presented in Table 3. From top to bottom: 
Aortic (AO) and LV pressure; (LV) and left atrial (LA) pres-
sure (5x); AO, mitral (MT) and pulmonary venous (PV) flow; 
LV and LA volume. Bottom left: Pressure – volume loops of 
LV. Bottom right: Fiber stress – fiber strain loops of LV.
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Parin ↓   Parout → kao SpasV SpasA SactV vsarc ped pLA
[-] kPa kPa kPa mm/s kPa kPa
Reference value 8.32 2.6 14.9 51.0 3.82 1.12 0.51
TIMING [s-1]
Cycle time -0.7 0.4 -0.1 0.3 -0.1 0.1 -0.1
Opening aortic valve (t2) -0.9 3.8 1.2 1.3 13.3 -2.1 -0.3
Peak aortic flow (t3) -0.2 -0.9 0.7 -2.1 1.9 -1.1 -0.6
Closure aortic valve (t4) 1.6 -3.2 -1.5 -2.1 -6.7 0.8 -0.7
Opening mitral valve (t5) 0.0 7.8 -0.1 1.6 -0.5 6.3 4.6
End of E-peak (t6) 0.2 -6.4 1.0 -0.3 0.5 -5.9 -3.5
Closure mitral valve (t1) 0.1 -1.4 -1.1 1.3 -8.3 1.8 0.5
VELOCITIES
Peak aortic velocity -0.1 0.1 0.0 -0.4 1.7 -0.2 0.2
Median aortic velocity 0.1 0.1 -0.3 0.7 -1.9 0.6 0.3
E-peak mitral velocity 0.0 0.5 1.7 0.0 0.0 0.2 1.2
A-peak mitral velocity 0.0 1.1 -1.7 0.0 -0.1 1.2 0.7
PRESSURES
Max. aortic pressure 1.4 -0.1 0.2 0.8 0.0 0.0 0.1
Min. aortic pressure -1.4 0.0 -0.3 0.1 -0.2 0.3 0.3
VOLUMES
Stroke volume 0.0 1.6 -0.9 0.3 0.3 1.4 0.7
End diastolic volume 0.0 0.3 0.8 0.6 0.4 -0.6 0.0
LV wall volume 0.0 -1.5 -0.2 -1.0 -0.9 -0.1 0.1
k
ao= aortic stiffness, SpasV= passive LV stress, SpasA= passive LA stress, SactV= active LV stress, vsarc= sarcomere velocity, ped= 
end-diastolic LV pressure, pLA= mean left atrial pressure.
Table 4  Sensitivity analysis, the numbers indicate relative sensitivity d ln(Par
out
)/dt in [s-1] for timing parameters, and d ln(Par
out
)/d ln(Par
in
) 
for the other parameters
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DISCuSSIoN
The CircAdapt model allows the simulation of LV hemodynamics and dimensions in individual 
patients in an entirely non-invasive way. On the basis of parameters derived from transthoracic 
echocardiography and arm-cuff-measured blood pressure we demonstrate reasonable agreement 
between simulated and invasively measured data in human patients with different forms of cardiac 
mechanical overload.
CircAdapt provides non-invasive patient-specific simulation of LV-pressure curves
As a unique result, the CircAdapt computer simulation generates LV intracavitary pressure curves 
during the whole cardiac cycle. These pressure curves can be simulated for individual patients by 
completely non-invasive means.
Only a few studies have reported comparable approaches of echocardiographic ‘pressure imaging’. It 
has been shown that LV intraventricular pressure gradients can be estimated non-invasively during 
diastole from digitized echocardiographic color M-mode maps of transmitral flow [10-12,23,24]. 
Yet, in these studies only a part of the cardiac cycle is addressed, whereas the CircAdapt simulation 
provides dynamic pressure data with a high temporal resolution throughout the cardiac cycle.
In addition, a number of echocardiographic approaches have been presented to estimate LV-filling 
pressures or related parameters, i.e., LV end-diastolic pressures [31] or mean capillary wedge pres-
sures [34]. These approaches are based on parameters derived from transmitral and pulmonary vein 
Doppler echocardiographic flow pattern, often combined with tissue Doppler echocardiographic 
measurements of mitral annular or myocardial tissue velocities [1,5,19,20,26,28,30-33,36,37,45]. 
In these studies, elevated LV filling pressures could be predicted with reasonable accuracy. Yet, 
absolute intracavitary pressure values, as in CircAdapt, could not directly be derived from the 
echocardiographic data.
CircAdapt provides non-invasive patient-specific assessment of LV pressure-volume and 
stress-strain loops
In addition to the information on LV intracavitary pressure, CircAdapt also provides data on 
complete pressure-volume relationships throughout the cardiac cycle, which have not been gener-
ated non-invasively before. Only a few studies have addressed this issue by invasive means using 
pressure or conductance catheters, echocardiography or ultrasonic crystal or using ex vivo tech-
niques, describing diastolic [27] or complete [43,44] pressure-volume relations.
The CircAdapt model does not only provide diastolic pressure-volume information but also data 
on the systolic phase covering the whole cardiac cycle. This allows e.g., the assessment of param-
eters as the slope of the end-systolic and end-diastolic pressure-volume relation, which have been 
considered as measures of contractility and diastolic function and properties by others before 
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[7,41,42]. In this way CircAdapt may help to improve the characterization of systolic and diastolic 
cardiac function.
Moreover, the CircAdapt model also provides a comprehensive quantification of LV myocardial 
tissue mechanics, as evident from the myofiber stress-strain loops in Figure 6. As an example of 
the usefulness of LV mechanical assessment in the clinical setting, we studied a patient presenting 
with congestive heart failure due to severe global ischemia as a consequence of multivessel coro-
nary artery disease before and after treatment (Figure 7). Comparable approaches, providing non-
invasive comprehensive assessment of patient-specific LV hemodynamics and mechanics in a serial 
manner, have to the best of our knowledge not been reported before.
A few echocardiographic and arm cuff blood pressure parameters are sufficient to simulate 
whole circulation dynamics
A novel combination of 2D and Doppler echocardiographic parameters of transmitral LV inflow, 
aortic LV outflow is sufficient to simulate whole circulation hemodynamics using the CircAdapt 
model.
Transmitral flow could be simulated by identifying just a few key parameters from the dynamic 
Doppler flow profiles. Mitral inflow velocities have been extensively described to reflect LV filling 
pressures. The early diastolic flow is largely determined by myocardial relaxation and left atrial 
pressure [34]. The mitral inflow velocity pattern changes characteristically with decreasing filling 
pressure, i.e., the early diastolic velocity (E) decreases and the deceleration time (DT) of E lengthens. 
As filling pressure increases, E and the E/A-ratio (>1) increase and the deceleration time shortens 
[34]. Moreover, it is well known that not only flow velocities but also timing and duration of 
flow provides valuable information in this regard [38,40]. The CircAdapt model accounts for the 
complexity of mutual dependencies of LV in- and outflow and dimensions by addressing a broad 
range of relevant parameters, allowing feed-back and cross-relation adjustments in a closed-loop 
model system. We made a step forward in accuracy by applying a new strategy of non-invasive 
patient-specific modeling. This improved accuracy compared to conventional estimates is largely 
achieved by the integration of patient-specific measurements in a simulated complete circulation, 
which has gone through a process of physiologic adaptation.
Limitations
The LV intracavitary and aortic pressures measured invasively during catheterization could not be 
recorded simultaneously with the echocardiogram. In order to assure comparability, all echocar-
diograms were performed within 30 minutes after the catheterization with the patient lying in an 
identical supine position. The additionally performed experimental study in adult dogs, allowing a 
simultaneous comparison of computer simulation and LV catheterization, supports the accuracy 
of the CircAdapt model found in the series of human patients by providing simulated complete LV 
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pressure curves and LV end-diastolic pressure values which are in reasonable agreement with the 
invasively measured values.
Arm-cuff blood pressure was not significantly different between the catheterization and the 
echocardiographic recordings. Yet, differences between invasively measured and simulated intra-
cavitary pressures might be explained by methodological differences of blood pressure measure-
ments between catheter-based invasive measurements, automatic cuff measurements and the 
conventional auscultatory method, as reported in the literature [18,22,29].
Figure 7  CircAdapt simulation of pressure-volume (top panel) and stress-strain 
(bottom panel) loops of an individual patient presenting with congestive heart failure 
due to global ischemia as a consequence of multivessel coronary artery disease 
before (solid line) and after initiation of medical treatment (dashed line).
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Patient selection was based on normally conducted sinus rhythm, undisturbed regional LV wall 
motion and the absence of significant coronary artery disease. For a broader clinical implementa-
tion, differences in regional wall motion should be incorporated as well as rhythm and conduction 
disturbances. These issues deserve further improvement of the CircAdapt model to allow a broad 
implementation in clinical practice.
CoNCluSIoNS
Non-invasive determination of LV hemodynamics and mechanics can be achieved by CircAdapt 
simulation in patients with different forms of cardiac mechanical overload. Based on a list of 
timings, standard echocardiographic measures, Doppler flow velocities and arm cuff blood pressure 
values, a stable, well-defined, and completely non-invasive patient-specific fit can be obtained at 
the bedside. In addition complete LV pressure tracings, pressure-volume and stress-strain loops can 
be generated, allowing comprehensive systolic and also diastolic assessment of cardiac function 
including quantification of end-diastolic pressure and function, considered as important triggers 
for cardiac remodeling.
Perspective
The CircAdapt simulation of cardiac hemodynamics and mechanics can be transferred into clinical 
practice with relative ease and offers the perspective of an easy-to-use bedside hemodynamic 
and mechanical assessment during various stages of heart disease. In conjunction with serum 
biomarkers of overload-induced remodeling, favorable and unfavorable patterns of cardiac 
mechanical overload can be identified in individual patients over time, as shown for other non-
invasive approaches [13-15]. This strategy might aid to improve clinical decision making, prognostic 
judgments, risk-stratification, tailoring of therapy and proper timing of interventions.
The CircAdapt model seems suitable for sequential patient-specific simulation of cardiac over-
load in an entirely non-invasive way. This will allow assessment of the individual load history over 
months and years in patients with cardiac disease inducing mechanical overload.
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APPENDIX
Principles of the CircAdapt model
The CircAdapt model of the whole circulation [3] is designed to simulate beat to beat hemody-
namics in the four-chamber heart containing valves and the large bloodvessels. Chambers, valves 
and vessels are represented by modules, based on temporal differential equations in state variables. 
By connecting the modules a network forms, representing the whole circulation. The core of the 
model is a system of differential equations, to be solved by numerical integration. Chambers and 
blood vessels are cavities with a compliant wall, which gets its stiffness from fibers in the consti-
tuting tissue. Using cavity volume Vcav as a state variable, fiber extension l/lref is calculated by the 
one-fiber model [2]:
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Using a model of fibe  mechanics, fiber stress (sf) is calculated as a function of fiber extension. 
For fiber stress in chamber walls a model of sarcomere dynamics with two state variables has been 
used. Fiber stress in the vessel wall is modeled by passive elastic behavior only. Using the one-fiber 
model, cavity pressure pcav is calculated from this stress. Thus, it is used:
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Cavities and vessels may be connected by valves or resistances. In a valve, flow q is a state variable. 
With positiv  pressure drop ∆p or forward flow, the valve opens. The time derivative of flow in an 
open valve is determined by pressure drop over the valve and pressure loss due to the Bernoulli 
effect:
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Parameter Aopen represents the cross-section of the open valve. A major feature of the CircAdapt 
model is that size of cavities and walls adapts so that mechanical load of the constituting tissues 
is normalized. For instance when mean systemic pressure is elevated, the LV will show concentric 
hypertrophy. This self-adapting property causes the model to simulate circulation hemodynamics 
very realistically. The model is programmed in MATLAB (www.mathworks.com). Simulation time 
for one cardiac beat is about 2 seconds on a regular PC.
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DISCuSSIoN
In this chapter, we summarize and discuss the results presented in this thesis, put them into clinical 
perspective and propose improved algorithms for clinical diagnostics and decision-making.
CARDIAC mECHANomyoPATHy – EXPERImENTAl INSIgHTS
Cardiac mechanomyopathy
We propose the term “cardiac mechanomyopathy” to indicate the multi-facetted remodeling 
processes in hemodynamically-overloaded hearts, their underlying mechanical stimuli, and the 
mutual relations between these stimuli and different functional and structural elements in the 
myocardium. A schematic illustration of the elements involved in the pathophysiological mecha-
nisms contributing to cardiac mechanomyopathy is depicted in Figure 1.
In the studies for this thesis we investigated the canine heart with chronic complete atrioventricular 
block (AVB) in order to unravel functional and structural aspects of this model of cardiac mechano-
myopathy. The AVB model has a longstanding research history in the field of ventricular hypertrophy 
and heart failure, which dates back more than 50 years [13,22,41,110,131,132,150,151,167,197-199]. 
Mechanical [43,44,110,112,198], hemodynamic [37,44,55,101,188], structural [1,42,43,140,141, 
155,178,185,188,197] and electrophysiological [140,141,145,146,152,155,175,185,186,188-190] 
properties have been extensively characterized. The dog with chronic AVB is also an established 
model of acquired ventricular proarrhythmia: both torsades de pointes (TdP) and delayed after-
depolarization-dependent monomorphic ventricular tachyarrhythmias are readily induced. In the 
chronic phase, the model exhibits compensated ventricular contractile function, which can be 
considered a beneficial adaptation to bradycardia-induced overload, whereas the proarrhythmia 
clearly is a pathological feature.
Apart from the canine model with AVB, other canine models of cardiac overload have been 
described: the aorto-caval fistula model [8,9,91,94,114,184,192], the aortic regurgitation model 
[49,51,56,93,170,195], the mitral regurgitation model [27,40,81,119,149,154,169,170,201], the 
aortic stenosis/banding model [26,27,54,67,71,85,153,158], the coronary microembolization/
occlusion model [87,136-138], ventricular pacing models [1,124,126], the left bundle branch 
block model [182], the experimental hypertension model [17,87], and the rapid ventricular pacing 
model [4,11,28,92,105,118,148,192]. In almost all of these models, cardiac mechanics have been 
addressed, e.g., for aorto-caval fistula see references [8,9,111], aortic regurgitation [51,56,170], 
mitral regurgitation [27,40,76,119,149,170,201), aortic stenosis/banding [27,54,67,71,85,158], 
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Figure 1  Cardiac mechanomyopathy. Schematic illustration of cardiac mechanomyopathy composed of interacting structural and func-
tional elements, from the (sub-)cellular to the organ level, all (in-)directly influenced by the primary stimuli, i.e., the mechanical forces 
imposed on the myocardium. Note that all elements of the scheme may have mutual interrelations. The relative importance of various 
elements depends on the individual constitution, the genotype, the mechanical stimuli imposed on the system, and their mutual inter-
relations may change dynamically over time.
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ventricular pacing [124-126,174], and left bundle branch block [182]. Yet, in these publications, 
mechanical stimuli are mostly related to LV geometry and the degree of hypertrophy. Studies that 
relate mechanical stimuli to more in-depth analyses of the myocardial structure or function are 
scarce [9,27,40,85,114,119,158].
This lack of literature regarding the integration of mechanical, structural and functional data 
also holds for human cardiac disease due to mechanical overload. The first descriptions of 
mechanical stimuli imposed on the human heart during various pathologies date back many 
decades [73,122,123,139] and are still pursued [82,107,125,171]. Yet, as holds for the experimental 
models mentioned above, integrative studies focusing on the link between mechanical stimuli and 
myocardial remodeling are scarce in the literature. However, such studies are necessary to enhance 
mechanistic understanding of overload-induced cardiac remodeling.
CARDIAC mECHANomyoPATHy IN THE CANINE moDEl wITH 
ATRIoVENTRICulAR BloCk
Assessment of cardiac mechanical overload
In the studies described in Chapter 3 and Chapter 6 we analyzed the mechanical stimuli acting 
on the myocardium in the canine AVB model by using a validated mathematical model of cardiac 
mechanics [5]. This partly invasive technique, incorporating LV intracavitary pressure measure-
ments, is further developed in Chapter 7 resulting in a completely non-invasive approach appli-
cable in humans [6].
For the canine AVB model, we found that diastolic myofiber stress and ejection strain, but not 
systolic stress, are importantly altered early after induction of bradycardia-induced overload and 
these changes coincide with peak hypertrophic growth. Other studies using MRI, echocardiography 
and conductance catheters [52,82,159,178,188] confirm these findings in experimental dogs and 
humans with AVB.
In general terms, stress and strain are the only mechanical factors known to exist in physics. They 
are known to be important stimuli for hypertrophic remodeling in the heart, as described in other 
animal models of volume overload [47,48,72,97,98,113,200]. In most studies only maximal and/or 
minimal values of stress and strain are addressed during the cardiac cycle. Yet, many other poten-
tially important parameters can be derived from continuous signals of stress and strain throughout 
the cardiac cycle [72,113]. E.g., it is possible to analyze the peak changes relative to mean changes, 
the relative changes, the rate of changes, the cumulative changes, i.e., the integrated sum of a 
parameter in a specific time interval. At this moment we do not know whether and to what extent 
these derived parameters influence myocardial remodeling. In the canine AVB model, the cardiac 
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cycle is characterized by bradycardia and an independent contraction of atria and ventricles. In this 
situation, continuous assessment of cardiac mechanics could be helpful to explore the potential 
role of mechanical stimuli during a prolonged diastolic phase and the role of asynchronous atrial 
contractions resulting in numerous independent ‘atrial kicks’ during different phases of diastole 
[108].
The absolute values of myofiber mechanics obtained in the AVB model were comparable with those 
described in-vitro by others [39]. Contemporary technology enables to quantify mechanics even 
at the (sub)cellular level using magnetic microbeads or carbon nanofiber arrays [12,75,90]. These 
novel approaches allow to further assess the validity of our data in experiments on (sub-)cellular 
mechanics in vitro.
Importantly, the computational models of myocardial mechanics used in this thesis assume a 
homogeneous distribution of mechanical forces within the heart, as described in Chapter 3. For 
this purpose, we used the 1-fiber model in which the heart consists of a single myocardial band 
[2,24,31,45,100,164,165]. Others reported that ventricular mechanics may vary within the LV wall, 
e.g., transmurally [7,9,103,127,171], which should be accounted for in future studies, e.g., by using 
MRI tagging. This technique allows transmural as well as a regional assessments of myocardial 
strains.
Assessment of myocardial remodeling
We described a novel approach enabling serial sampling of large LV myocardial specimens (needle 
biopsies) in a minimally-invasive way, as detailed in Chapter 4. This percutaneous closed-chest 
approach for intramural LV biopsy sampling shares many advantages with the clinically well-known 
catheter-based endomyocardial biopsy technique, but results in larger samples of good quality. The 
specimens extend from the epicardium to deep into the midmyocardium, as illustrated in Figure 
3b and 3c in Chapter 4. This novel approach is likely also suitable for other large animal models 
and potentially in anesthetized humans under very controlled conditions. The relatively large-sized 
tissue samples can be used for various cell-biological and molecular analyses, in parallel to the 
assessment of mechanical and other functional parameters.
Electrical remodeling
Applying the serial biopsy-technique, we described a profound decrease of the K+ channel subunit 
KCNQ1 that occurs within days after AVB induction and is followed by a more gradual decrease of 
ß1 AR expression. It could be concluded that the downregulation and blunted ß-adrenergic activa-
tion of the K+ channel IKs contribute to the loss of β-adrenergic-induced shortening of ventricular 
repolarization, which favors proarrhythmia. Provocation testing with isoproterenol identified 
the repolarization instability based on the acquired ion-channelopathy, as detailed in Chapter 
5. The time course of these processes had not been studied before using individual animals as 
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their own controls. Based on these findings, the mutual relation between neurohumoral alterations 
and electrophysiological changes occurring over time could now be related to other functional 
and structural changes in this model, e.g., the mechanical assessment and structural myocardial 
remodeling. Such an integrative analysis likely provides further mechanistic clues that are also 
relevant for humans with overload-induced proarrhythmia.
Structural remodeling
In the canine AVB model myocardial remodeling involves mainly the cardiomyocytes, whereas, 
based on immunohistochemical studies, the non-cardiomyocytes and the interstitium are less 
affected. Ventricular myocardial hypertrophy is largely determined by cellular lengthening [185], 
although data on the possible loss of cardiomyocytes (apoptosis, necrosis?) during AVB are lacking. 
The extracellular matrix volume and the collagen volume fraction of around 4% were found to 
be unaltered [121,174,188]. In addition, the immunoexpression of vimentin, a fibroblast marker, 
and the extracellular matrix protein laminin were not found to be altered during AVB compared 
to control dogs with sinus rhythm, as shown in Chapter 4 and Chapter 6. It should be noted that 
only one single study has reported that the volume of collagen fibers and extracellular space can 
be increased during chronic AVB [155]. Only semi-quantitative data were given based on a limited 
group comparison in beagle dogs [155].
In Chapter 6, we also studied cardiomyocyte cytoskeletal remodeling, including key proteins 
involved in mechanosensing and -transduction, in relation to increased mechanical stimuli. We 
found that acute volume overload after AVB causes a transient compromise of cytoskeletal integ-
rity, which is based, at least partly, on transcriptional downregulation. Structural reorganization 
and a strong drive to compensated hypertrophy are attended by the upregulation of melusin and 
MLP, known as procompensatory proteins in other models of hypertrophy [3,19,36,68,69,84].
In order to gain more insights into how the mechanical changes in this model are converted to 
altered gene expression, we performed experiments analyzing key regulatory proteins downstream 
of β1D-integrin and melusin, i.e., Akt (protein kinase B) and glycogen-synthase-kinase-3β (GSK3β), 
and their phosphorylated (P) forms. From the literature it is known that an increased ratio of P-Akt/
Akt stimulates the phosphorylation of GSK3β. An increased ratio of P-GSK3β/GSK3β stimulates 
hypertrophy [66]. We studied the ratiometric expression of P-Akt/Akt and P-GSK3β/GSK3β in serial 
biopsies from dogs at sinus rhythm and over time from acute to chronic AVB. Interestingly, the 
significant increase of both ratios in the second week corresponds exactly with the moment of 
peak hypertrophic growth, which suggests that the sequential interactions of β1D-integrin, melusin, 
Akt/P-Akt and GSK3β/P-GSK3β could form a central axis of hypertrophic signaling in this model.
GSK3β also stimulates the phosphorylation of glycogen synthase [32]. This enzyme promotes 
glycogen synthesis whereas the phosphorylated form inhibits it. A relative decrease of GSK3β, as 
during mechanical stimulation when the balance of GSK3β and P-GSK3β tips towards P-GSK3β, 
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may thus lead to increased glycogen synthesis and could form the basis of the glycogen data shown 
in Chapter 6.
The biological impact of the increased melusin levels is further supported by analyzing melusin-
interacting β1D-integrin in conjunction with its directly interacting extracellular matrix protein 
laminin [135]. Whereas β1D-integrin was significantly and persistently upregulated from 3 days AVB 
onward, the immunoexpression of laminin was found to be unaltered. These findings suggest that 
the cardiomyocyte protein β1D-integrin, and not the extracellular matrix protein laminin, is among 
the first upstream elements activated by mechanical stimuli.
Moreover, we studied the LIM proteins MLP and fhl2, both involved in mechanosensing and -trans-
duction in cardiac hypertrophy and failure [79,84,96]. In our study, we found a different temporal 
expression pattern for MLP and fhl2. Based on the data available in the literature we consider 
the following: both MLP and fhl2 contain a LIM-domain motif, which allows multiple protein-
protein interactions and constitutes the structural basis for functional diversity [80]. Importantly, 
the protein structures of MLP and fhl2 differ: MLP is a cysteine-rich LIM protein (a subclass of 
the LIM-only proteins), whereas fhl2 is part of the four-and-a-half LIM protein family [80]. The 
partly divergent protein structures of MLP and fhl2 are compatible with a different functional role. 
For example, in overload-induced cardiac hypertrophy MLP is considered to be prohypertrophic 
[68,69] whereas fhl2 is regarded as a repressor of hypertrophy [129]. MLP mediates anchorage 
of calcineurin to the Z-disk, thus playing an important role in the activation of the calcineurin-
NFAT pathway [69]. In contrast, fhl2 interacts with ERK2, an element of the MAP-kinase signaling 
pathway. ERK2 interacts with fhl2, but it does not interact with MLP, which underscores the 
protein-specific action of LIM proteins [129]. Hypertrophic responses induced by α-adrenergic 
stimulation with phenylephrine, and mediated via ERK2, are partially antagonized by fhl2, which 
attenuates transcription [129]. Moreover, fhl2-null mice, which exhibit a normal cardiac pheno-
type, also show increased hypertrophic growth after β-adrenergic stimulation with isoproterenol, 
supporting repressor-like activity of fhl2 in the overloaded myocardium [86].
The early transient downregulation of fhl2 coincides with enhanced adrenergic tone as evident from 
Chapter 5, and maximum hypertrophic growth in the first 10 days after AVB [44]. It could well 
be that hypertrophy is partly caused by an enhanced α- and β-adrenergic stimulation early after 
induction of AVB and mediated via MAP kinase/ERK2. The latter pathway could be incompletely 
repressed by the fhl2 reduction at this stage, promoting hypertrophy. Whether these mechanisms 
apply indeed in the canine model of AVB remains to be established.
In dogs with AVB, the mechanical stress-sensor function of MLP appears to be intact given the 
observed BNP release [84], which is known to be regulated via the calcineurin-NFAT pathway [106]. 
The steady increase of MLP protein levels parallels the increase of ventricular mass, suggesting a 
prohypertrophic action of MLP. In order to explore the mechanism underlying the actions of MLP, 
we performed experiments using immunohistochemistry to study the localization of MLP in the 
myocyte at control and in chronic AVB. At control we found a faint cytoplasmic staining pattern, 
which partly exhibited cross-striations, as described by Ecarnot-Laubriet et al. [3,46]. Immunola-
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beling of MLP in the nucleus was also faint. During chronic AVB, increased cytoplasmic labeling was 
observed (compared to control) and the nuclei exhibited strong MLP-positive labeling. These data 
showing a cytoplasmic upregulation along with a nuclear relocation of MLP during hypertrophy in 
this model suggest a dual, i.e., cytoplasmic and nuclear, functional role for MLP during mechanical 
overload in this model.
Integrating the picture - potential links between mechanical stimuli & structural, 
electrical, and contractile remodeling
In the AVB model, changes of systolic and diastolic mechanics are most pronounced in the first 
weeks of AVB. These increased mechanics likely form the basic stimuli for the coincident structural 
and functional, i.e., electrical and contractile cardiomyocyte remodeling, as illustrated in Figure 2.
In this early period, the cytoskeletal integrity is temporarily distorted. Ultimately, pro-compen-
satory mechanisms prevail and compensated hypertrophy ensues. In this context, transcriptional 
downregulation seems to be more important than posttranslational modification (at least for the 
specific processes investigated), but this issue deserves further investigation.
Based on the results from Chapter 5, cross-talk between the cytoskeleton and certain ion channels 
could be well possible in the AVB model. KCNE1, the regulatory β-subunit of the IKs channel, which 
co-assembles with the α-subunit KCNQ1, specifically interacts with the sarcomeric Z-disk protein 
T-cap (telethonin) in the Z-line region [53]. T-cap is well known to interact with the N-terminus of 
the giant protein titin [57-64,95]. This interaction might well contribute to mechanically-induced 
electrical alterations in the sense of mechano-electrical feedback [53]. Furthermore, together 
with MLP T-cap and titin form a ‘mechanosensing machinery’ [84], which appears to be intact 
in the canine AVB model as pointed out in Chapter 6. It remains to be established whether the 
KCNE1-T-cap link has any mechano-electrical function in the AVB dog to affect IKs function. In 
addition, the cardiac-enriched four-and-a-half LIM domain-containing protein (fhl2) was identi-
fied as potential KCNE1-interacting partner [88,89]. The transient decrease of fhl2 during AVB also 
parallels the electrical remodeling process, which makes fhl2 a potential mediator protein in terms 
of mechanical overload-induced electrical remodeling.
Besides potential physical links between cardiomyocyte electrical elements and the cytoskel-
eton, altered cellular Ca2+ handling is well known to play an important pathophysiological role in 
overload-induced cardiac hypertrophy and failure. In the canine AVB model, it is characterized by 
enhanced Ca2+ release from the sarcoplasmic reticulum and enhanced Na+-Ca2+ exchange [145]. 
Increased subsarcolemmal Na+ concentration may cause the Ca2+ changes [177]. These observations 
related to altered Ca2+ handling in this model all contribute to (over-) compensated contractility 
and mechanical overload, i.e., systolic strain, but also to proarrhythmia [144,146,147]. In addition, 
increased diastolic Ca2+ load may contribute to Ca2+-dependent diastolic dysfunction and might 
thereby be related to altered diastolic mechanics [117].
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Figure 2  Time course of cardiac mechanics and related remodeling in the AVB model. Schematic illustration of cardiac mechanics, 
hemodynamics and neurohumoral tone upon creation of AVB in temporal relation to different functional and structural myocardial remode-
ling processes. For full colour illustration, see page 229.
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Moreover, Ca2+ handling is important for the function of many proteins involved in hypertrophy-
mediating pathways.
Myocardial remodeling in the AVB model may also be importantly mediated by adrenergic 
mechanisms. We and others have found, as reported in Chapter 5, that norepinephrine plasma 
levels are clearly elevated during AVB, i.e., specifically in the first 2-4 weeks [159,188]. Increased 
catecholamine levels likely enhance vascular resistance and contractility, and thereby contribute to 
mechanical overload. Besides, increased adrenergic tone alters Ca2+ homeostasis in cardiomyocytes, 
e.g., β-adrenergic stimulation can dynamically enhance cellular Ca2+ entry and loading [187].
In order to identify and characterize the assumed primary stimuli for functional and structural 
myocardial remodeling in the canine AVB model in more detail a number of interventions should be 
investigated in future experiments. Restoration of the low ventricular rate by pacing is an obvious 
intervention, since the bradycardia has been shown to be an important stimulus for remodeling 
processes after AVB [121,156]. In general, cardiac pacing allows to restore a physiological heart 
rate as well as the AV-synchrony. It has been shown, that single site pacing from the RV is at least 
able to partially reverse the LV hypertrophy, whereas electrical remodeling could not be reversed 
[121]. Others have demonstrated that biventricular pacing is superior to RV pacing in the canine 
AVB model, at least in acute conditions [52]. This might also hold for the chronic setting but 
deserves further analysis. Yet, in one study 8 weeks of biventricular pacing did not reverse electrical 
remodeling after chronic AVB [120].
Recently, a more physiological restoration of the altered ventricular activation pattern was achieved 
by high-septal pacing. In this study, the paced ventricular activation is virtually physiological 
whereas the bradycardia is similar to AVB. This mode of pacing led to a reduction of ventricular 
electrical remodeling and proarrhythmia in dogs after 4 weeks of AVB, whereas the hypertrophy as 
well as the compensated contractility were comparable to non-paced AVB dogs with idioventricular 
rhythm [196]. These findings suggest that the altered ventricular activation during AVB contributes 
to electrical remodeling and proarrhythmia. In future studies, the contribution of AV dyssynchrony 
should be addressed, since it is well known to potentially alter ventricular geometry and hemody-
namics [108]. AV dyssynchrony could induce chronic mechano-electric alterations. Spatial hetero-
geneity of the mechanical stimuli may be of crucial importance for myocardial remodeling, but it 
remains to be determined whether an exaggerated spatial heterogeneity of ion-channel expression 
during cardiac overload is also the result of this. The issue of spatial heterogeneity of mechanical 
stimuli has not been addressed in this thesis due to the fact that we applied methods to assess 
global, not regionally different, LV mechanics. In order to address this aspect, techniques capable 
of assessing spatial distributions of mechanical stimuli and concomitant myocardial remodeling are 
necessary, e.g., as has been applied by Omens et al. [7]. These investigators used invasive techniques 
in normal dogs to analyze LV myocardial strain and repolarization transmurally by inserting bead 
markers in conjunction with plunge electrodes. They found that the onset of myofiber shortening 
(earliest at the endocardium) and relaxation (earliest at the epicardium) are characterized by a 
transmural dispersion of mechanics, whereas no dispersion of repolarization could be found. It 
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remains to be determined if these findings also hold for conditions of mechanical overload, as in 
the AVB model [7].
An enhanced mechanistic understanding and the identification of primary stimuli responsible for 
myocardial remodeling in the AVB model is closely related to clinical problems in cardiac pacing 
and resynchronization therapy. In this evolving field of heart-failure therapy current experimental 
and clinical studies address issues as the optimal patient selection, choice of pacing site and 
timing of pacing using myocardial deformation analysis, hemodynamic and electrocardiographic 
methods with respect to favorable structural, contractile and electrical reverse remodeling 
[14-16,18,157,168,176,179-183].
Besides ventricular pacing, as mentioned above, other interventions could be helpful to beneficially 
alter ventricular mechanics and to further unravel the underlying pathophysiology of the cardiac 
mechanomyopathy during AVB. For example, surgical techniques to obtain passive containment 
of the heart or cardiac assist devices could be applied to mechanically unload the ventricles. This 
has been shown to influence different elements of remodeling in overloaded ventricles in various 
pathologies [10,29,30,50,65,83,115,130,160]. Pharmacological interventions [140], which have also 
been shown to interfere with remodeling, could also be extended and (re-)evaluated in terms of 
mechano-structural-functional phenotyping.
Yet another method to gain more mechanistic insights in overload-induced remodeling is the use 
of computational modeling. In recent years various models have been found suitable to simulate 
complex phenomena related to ventricular electrophysiology and mechanics [6,33,34,99,162,166]. 
Yet, integrated three-dimensional models of the human heart incorporating 1) depolarizing and repo-
larizing electrophysiological properties from the level of the ion channels to electrocardiographic 
representation on the body surface, 2) regional and transmural mechanics acting throughout the 
cardiac cycle, and 3) structural and architectural elements ranging from the cellular to the organ 
level, are still under development [74].
CARDIAC mECHANomyoPATHy – Cl INICAl ImPl ICAT IoNS
Patients with cardiac mechanomyopathy
In this section, we illustrate 2 clinical cases with cardiac overload and multifaced phenotypic aspects, 
which potentially share common mechanisms. The clinical course of both patients illustrates that 
many aspects of cardiac mechanomyopathy are currently unresolved. This is mainly due to an 
incomplete mechanistic characterization of the underlying pathophysiology, which contributes to 
the shortcomings of contemporary diagnostics in clinical cardiology. Basically, the myocardium 
cannot be comprehensively characterized with regard to molecular composition (cytoskeleton, 
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myofilaments, ion-channel expression) in relation to contractile and electrical functions. More-
over, the roles of mechanical and neurohumoral factors as stimuli for remodeling remain largely 
elusive. Yet, improved mechanistic understanding in individual patients remains a prerequisite for 
the development of etiology-based therapy.
Case 1: In february 2007, a 46-year old male was transferred to the Department of Cardiology of the 
Academic Hospital Maastricht. He had been healthy before, but complained about progressively decreasing 
exercise tolerance, palpitations and (near-)collapses in the months before presentation. Clinical assessment 
revealed symptomatic ventricular extrasystoles, an episode of sustained atrial fibrillation, and most impor-
tantly a type-II atrial septal defect (ASD) with hemodynamically relevant left-to-right shunting requiring 
surgical closure. Based on the literature, this case is not exceptional at first glance, as an atrial septal defect 
can become symptomatic at late age [191].
However, as a rather exceptional additional clinical problem the patient developed monomorphic non-
sustained ventricular tachycardia (VT) originating from the right ventricular (rV) outflow tract. This was 
first documented upon introduction of anesthesia while in the operating room awaiting thoracotomy and 
surgical closure of the ASD. The procedure and the postoperative course were unremarkable. Postoperatively 
the patient felt better and had improved exercise capacity right away. Yet, frequent symptomatic episodes 
of the same monomorphic VT persisted. Oral administration of metoprolol reduced the occurrence of VT at 
rest, but did not prevent recurrences during exercise testing. Clinical work-up showed no significant coronary 
artery disease and echocardiography demonstrated a preserved LV function and a slightly diminished rV 
function (tricuspid annular plane systolic excursion was 11 mm) in the setting of enlarged rV dimensions [43 
mm). An electrophysiological study was performed using multi-site mapping, which revealed a rather large 
arrhythmogenic area. radiofrequency catheter ablation was applied, yet in the days after the procedure the 
VT persisted under β-blockade, especially during exercise testing. The family history did not reveal sudden 
death, or cardiomyopathy and cardiac MrI did not indicate arrhythmogenic rV cardiomyopathy. Given the 
persistence of symptomatic, fast VT (intermediate axis, left-bundle-branch-block configuration, cycle length 
300 ms) under β-blockade and after radiofrequency ablation, at 4 weeks after surgical closure of the ASD 
type II, it was decided to implant an internal cardioverter defibrillator (ICD). See figure 3 for the illustration 
of echo- and electrocardiographic findings.
This case illustrates the complexity of mechanical-overload-induced cardiac disease. Questions 
arise as to whether mechanical factors and related structural and functional myocardial remodeling 
could form the basis for the VT; how potential interrelations between these different aspects of 
the disease are established; and how they should be treated, preferentially based on the underlying 
mechanisms. In this sense, the clinical case underscores the need for an integrative diagnostic 
approach, which is not yet sufficiently applicable in current clinical practice.
In this case, monomorphic VT (cycle length (CL) 300ms) arises from the RV, initiating with a long 
coupling interval (CL 520ms). The VT is probably triggered by sympathetic stimulation (exercise, 
emotional stress).
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Figure 3  Cardiac mechanomyopathy - Case 1. Transesophageal echocardiography (top, left panel) demonstrating ASD type II (arrow) 
with important left-to-right shunting (insert, color Doppler flow). Ao indicates aortic valve, LA and RA indicate the left and right atrium, 
respectively. Transthoracic echocardiographic 4-chamber views after surgical correction of the ASD (top, mid and right panel) showing 
a somewhat dilated RV and a normal LV during diastole (top, mid) and systole (top, right). 12-Leads electrocardiogram (bottom) 10 days 
after surgical correction of the ASD showing SR (left) and VT (right) originating in the RV outflow tract. See text for details. For full colour 
illustration, see page 230.
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Priori et al. were among the first to provide experimental evidence for a role of triggered activity, 
i.e., delayed afterdepolarizations (DADs) occurring in vivo during a condition of cardiac overload 
[128]. In cats with aortic constriction, DADs could be induced by Ca2+ loading, digitalis, and sympa-
thetic stimulation [128]. The long-coupled initiation of the VT in Case 1 is indeed compatible with 
DADs as initiating mechanism. This is also supported by successful initiation of the clinical VT 
by programmed electrical stimulation using pacing at increasingly fast rates. Yet, the results of 
electrophysiological testing should always be interpreted with caution when searching for the 
initiating and perpetuating mechanisms of a VT [134]. Other arrhythmogenic mechanisms cannot 
be ruled out completely.
Based on the findings in this thesis, it could be that the RV myocardium of the patient in Case 1 
has undergone electrical remodeling as a consequence of the mechanical overload imposed on 
the RV due to the longstanding ASD. This could have manifested as enhanced cellular Ca2+ release 
and/or enhanced Na+-Ca2+ exchange in the setting of hypertrophy, promoting VT under adrenergic 
stimulation. Our group has previously reported that ventricular ectopy and VT are DAD-mediated 
during fast ventricular pacing and Ca2+ overload induced by digitalis [38].
In Case 1, electrical remodeling may also encompass spatial heterogeneity of electrical activation 
and repolarization between the ventricles (LV versus RV), because the mechanical overload and 
subsequent remodeling processes apply to the RV and not to the LV.
Clinical work-up in Case 1 includes the quantification of the atrial left-to-right shunt, the ventric-
ular hemodynamics, the contractile function and the cardiac dimensions. The decision whether or 
not to close the shunt is based mainly on empirical data [35,191]. A causal analysis of the relation 
between cardiac overload and ventricular proarrhythmia is hard to establish based on the limita-
tions of currently available diagnostic tests. The risks of sticking to these tests is nicely phrased in 
the following analogy:
‘If the only tool you have is a hammer, you tend to see every problem as a nail.’
Abraham Harold Maslow, clinical psychologist (* 1-4-1908 – † 8-6-1970)
Efforts should therefore be directed towards developing improved diagnostic modalities in indi-
vidual patients.
The above-mentioned case illustrates the clinical relevance of mechanical overload in the RV. In 
practice, acquired disease of the LV occurs much more frequently. Therefore, the next case illus-
trates LV mechanomyopathy:
Case 2: In May 2007, a 67-year old male was transferred to the Department of Cardiology of the Academic 
Hospital Maastricht after he had suffered an unwitnessed in-hospital cardiac arrest due to ventricular fibril-
lation. He was successfully resuscitated. five days before the resuscitation he had been admitted because of 
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dyspnea based on a combined problem of exaggerated chronic obstructive pulmonary disease (COPD) due to 
pneumonia, congestive heart failure and atrial fibrillation with a high ventricular rate. He was appropriately 
treated with antibiotics, i.e., amoxicilline/clavulanic acid, diuretics and digoxin. Adequate rate control had 
been reached before he suffered the cardiac arrest. kidney function and electrolytes were within normal 
limits. His past medical history revealed COPD, diabetes mellitus type II, a limited old inferior myocardial 
infarction and successfully revascularized 2-vessel coronary artery disease (right and circumflex coronary 
artery) as confirmed by coronary angiography. There were no any signs of a new ischemic event. Systolic LV 
function was slightly diminished (ef 45%). After resuscitation he was intubated, mechanically ventilated and 
treated with piritramide, midazolam and amiodarone intravenously to control the recurrent high ventricular 
rate during atrial fibrillation. Despite this treatment he suffered relapsing polymorphic VT (figure 4). When 
mechanical ventilation and anti-arrhythmic therapy were discontinued the polymorphic ventricular arrhyth-
mias finally stopped and no recurrences were observed during the subsequent clinical observation period.
In this case, polymorphic VT, i.e., acquired torsades-de-pointes (TdP) arrhythmias, occurred in a 
setting of LV disease with overload, i.e., slightly diminished systolic LV function in a patient with a 
limited old myocardial infarction and atrial fibrillation with a high ventricular response.
It remains unclear, which are the mechanical triggers in this case and to what extent overload-
induced electrical remodeling plays a role. From the ECG and the echocardiogram the old inferior 
wall myocardial infarction seems too small to explain major mechanical overload leading to signifi-
cant electrical remodeling. It is of course possible that longstanding atrial fibrillation caused a 
tachycardiomyopathic component contributing to impaired LV contractile function.
As in Case 1, many aspects of a cardiac mechanomyopathy apply to this case. Yet, the underlying 
mechanisms responsible for the arrhythmogenesis remained elusive, which again precluded mech-
anism-based individualized treatment. Although the phenomenon of acquired TdP is well-described 
[25,102,109,133,163,202] and many conditions (e.g., electrolyte disturbances, heart failure, drug 
effects, bradycardia, sudden changes of heart rate, etc.) are known to promote their occurrence, 
the contributing role of short- and long-term mechanical overload and structural and functional 
myocardial remodeling could not be elucidated. This lack of mechanistic insights, particularly the 
patient-specific characterization of the underlying pathophysiology, limits appropriate clinical 
decision-making.
Novel approach to the patient with cardiac mechanomyopathy
In this section, we translate the results of the thesis into an integrative diagnostic approach towards 
patients with a cardiac mechanomyopathy. Central to this approach is that myocardial mechanical 
load is characterized and mechanistically linked to remodeling.
As a first diagnostic step, cardiac mechanical load should be quantified in the individual patient. 
Ideally, the applied methodology is non-invasive, comprehensive, quick and easy-to-use, widely avail-
able, and inexpensive. As outlined in Chapter 7, CircAdapt computational modeling has the potential 
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Figure 4  Cardiac mechanomyopathy - Case 2. Serial transthoracic echocardiographic 4-chamber views during diastole and systole (left 
panels) illustrate a somewhat dilated LV (LV end-diastolic diameter 60 mm) with a slightly diminished systolic function (EF ~45%), which 
had been stable through the years. Corresponding 12-lead electrocardiograms (right panels) show signs of an old inferior myocardial 
infarction. Note the occurrence of a non-sustained polymorphic VT after a short-long-short cycle (bottom panel). See text for details.
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to meet all these criteria. In addition, the use of serum biomarkers of cardiac overload is attractive, 
as reflected by their widespread clinical use and implications [21,77,78,116,172,173,193,194]. Yet, 
currently available biomarkers are indirect markers of load and less specific than a comprehensive 
analysis of mechanical load itself, which is assumed to be a primary stimulus.
In individual patients mechanical forces acting on the myocardium vary dynamically over time, as 
shown experimentally and clinically in Chapter 3, Chapter 6 and Chapter 7. In addition, the indi-
vidual cardiac phenotype evolves gradually as the result of mutual interactions between mechanical 
stimuli, responsive remodeling and the genetic make-up. Serial analysis of cardiac mechanics is 
preferable over a single measurement. Moreover, serial mechanical phenotyping allows an assess-
ment of individual load history. The term load history suggests that the myocardium has a memory 
to store the maximum previous load in line with the strain softening property of rubber elastomeres 
[48]. The structural basis of myocardial strain softening has been demonstrated to be based on 
damaged collagen ties between interlaminar myofiber sheets caused by increased filling pressures, 
i.e., myocardial overstretch [48]. In this sense, strain softening and load history have been proposed 
as important triggers for myocardial remodeling [48].
In Chapter 3, Chapter 5 and Chapter 6 we have shown that (mal)adaptive structural and func-
tional alterations of the myocardium can be transient. Moreover, it has long been known that 
mechanical overload has time-dependent effects on the myocardium, e.g., transient overload 
may lead to beneficial alterations, whereas permanent overload is usually detrimental [104]. Thus, 
besides serial assessment of the load history, serial phenotyping of the myocardium could also 
be helpful to characterize individual patients. It is obvious that serial myocardial biopsies are not 
attractive as a general diagnostic technique for large numbers of patients, yet, non-invasive tech-
niques to characterize functional and structural aspects of the myocardium are well-suited for 
serial analyses. These non-invasive approaches would be particularly useful if clear links between 
the myocardial phenotype and the non-invasive marker could be established. In this context, the 
CircAdapt approach presented in Chapter 7 offers promising perspectives. For instance, if specific 
quantitative mechanical stimuli are closely related to well-defined aspects of adverse myocardial 
remodeling, mechanical phenotyping alone could be sufficient to monitor patients with mechanical 
overload.
To better determine the impact of mechanical load on myocardial remodeling it is unavoidable 
to analyze myocardial biopsies from individual patients. As an initial step, we investigated this 
in patients with ventricular overload due to valvular disease applying techniques and molecular 
markers that were successfully studied in experimental animals, as described in Chapter 4 and 
Chapter 6. We used LV intramural biopsies from patients undergoing valvular surgery. All patients 
had clinically compensated or slightly decompensated ventricular hypertrophy and underwent a 
routine pre-operative clinical assessment including echocardiography and coronary angiography to 
exclude significant coronary artery disease. During open-heart surgery intramural needle biopsies 
were taken from the LV free wall. All patients were electively scheduled for valvular surgery according 
to current guidelines and gave informed consent to the study. The Medical Ethics Committee of the 
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Academic Hospital Maastricht approved the experiments. The clinical characteristics of all patients 
are depicted in Table 1.
The clinical decision to perform valvular surgery is generally based on a large body of evidence. Yet, 
it remains a matter of debate whether the timing of the surgical intervention is always appropriate. 
It might well be that some patients are operated upon too late or even too early. Currently, there are 
no diagnostic tests to determine with certainty the optimal timing of surgery in individual patients. 
Also, it remains undetermined if the myocardial phenotype is characterized predominantly by 
beneficial or non-beneficial aspects of remodeling and whether and how the patient benefits from 
the intervention. On theoretical grounds, assessment of pro- and contra-compensatory myocardial 
Clinical Characteristics Echocardiography
Patient Age Gender NYHA class Valvular disease Hypertension LVEF (%) LVED (mm) LVWT (mm)
2693 56 M I AS/AR 48 64 13
8914 71 F II-III MR + 66 52 9
1597 68 F I-II AS + 70 50 12
8305 62 M II MR 49 60 12
7338 70 F II AS 70 48 11
3247 59 M II-III AR/MR 70 56 10
3169 52 F II-III AR + 63 58 11
1932 56 M II-III MR 72 62 10
3878 73 F II-III MR 67 56 10
8488 54 F I 76 43 8
8898 83 F II-III AS 59 42 15
5392 39 M I 63 44 8
1393 76 F II AS/AR 62 51 10
8066 53 M III AS 61 49 12
4108 67 M II-III MR + 54 56 8
9906 52 M II-III AS + 64 51 12
7379 36 M I AR + 50 66 10
1771 39 M I-II AS/AR 67 68 12
8549 69 F III AS 64 46 12
3471 64 M II AS/AR + 58 46 11
6982 66 F II-III MR + 60 53 8
6565 69 M II AS + 34 60 12
6537 62 M III AS/MR
Table 1  Patients characteristics. AS indicates aortic stenosis, AR, aortic regurgitation, MR, mitral regurgitation, LVEDD, LV end-diastolic 
diameter, and LVWT, LV wall thickness
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markers, as applied in Chapter 4 and Chapter 6, may aid in the clinical decision making and could 
be complimentary to currently used clinical parameters.
We characterized the LV intramural biopsy samples using light and electron microscopy to assess 
the myocardial (ultra)structure, the degree of cellular hypertrophy and the extent of extracel-
lular matrix alteration (Table 2). In addition, we studied a subset of key proteins, i.e., Akt/ P-Akt, 
GSK/ P-GSK, MLP and melusin, involved in mechanosensing- and transduction and representing 
beneficial versus non-beneficial remodeling processes in animal models and humans with cardiac 
hypertrophy [19,20,23,70,84,161,203].
Cellular Characteristics 
Patient Cardiomyocyte diameter (µm) Myofibrillarlysis (%) Extracellular matrix volume (%)
2693 31 ± 6 53 ± 0 37 ± 16
8914 28 ± 5 44 ± 0 36 ± 12
1597 22 ± 2 53 ± 16 29 ± 10
8305 41 ± 7 63 ± 10 18 ± 10
7338 31 ± 3 43 ± 10 15 ± 5
3247 31 ± 5 42 ± 9 25 ± 11
3169 28 ± 4 59 ± 24 32 ± 12
1932 23 ± 4 37 ± 12 25 ± 12
3878 31 ± 6 38 ± 0 18 ± 8
8488 20 ± 4 8 ± 4 25 ± 10
8898 31 ± 9 14 ± 9 19 ± 11
5392 23 ± 5 8 ± 3 13 ± 6
1393 33 ± 7 27 ± 6 18 ± 5
8066 35 ± 2 60 ± 20 18 ± 8
4108 28 ± 2 39 ± 30 22 ± 10
9906 30 ± 1 56 ± 28 22 ± 4
7379 35 ± 2 75 ± 19 32 ± 10
1771 33 ± 1 58 ± 37 18 ± 0
8549 28 ± 1 23 ± 2 17 ± 0
3471 24 ± 1 80 ± 0 22 ± 0
6982 28 ± 2 36 ± 16 14 ± 2
6565 27 ± 1 49 ± 22 17 ± 0
6537 29 ± 2 60 ± 6 22 ± 6
Table 2  Myocardial morphometry. Morphometric analysis of LV myocardial biopsy specimens
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In a group comparison the expression of pro-compensatory key proteins was not significantly 
different from normal controls (Figure 5). A subgroup analysis in patients with an increased LV 
end-diastolic diameter, often considered an early manifestation of detrimental remodeling and 
imminent failure, also did not show a group mean protein expression pattern different from patients 
with a normal LV end-diastolic diameter or normal controls. These results are in line with others 
reports showing that patients with compensated or slightly decompensated ventricular hyper-
trophy might exhibit a relatively normal expression profile of these pro-compensatory proteins 
Figure 5  Western blot analysis of key pro-compensatory proteins. Protein expression of Akt/ P-Akt (protein kinase B), glycogen synthase 
kinase 3ß (GSK/ P-GSK), muscle LIM protein (MLP) and melusin. See text for details.
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[19,20,23,70,84,161,203]. Additional studies in which the expression levels of the aforementioned 
proteins are investigated in patients with end-stage heart failure could be most relevant for 
comparative reasons.
In order to improve the clinical prediction of beneficial versus detrimental remodeling in indi-
vidual patients, it may be helpful to integrate mechanical and myocardial phenotyping. Practically, 
patients with cardiac overload, e.g., due to valvular heart disease with an expected progression 
requiring surgical intervention within months, should be repeatedly characterized by CircAdapt 
modeling, especially when worsening of clinical symptoms occurs. In this way, serial analyses allow 
assessment of an individual load history. At the time of surgery, cardiac biopsies should be obtained 
and analyzed as described above, selecting key proteins that represent beneficial and detrimental 
aspects of remodeling. After surgery, when cardiac loading is expected to improve, mechanical 
assessment should be continued. This approach allows to integrate key markers of myocardial 
remodeling with long-term information on cardiac (over-)load. Moreover, if such an approach 
would demonstrate clear relations between cumulative mechanical load, i.e., the individual load 
history, and unfavorable myocardial remodeling, it could finally be concluded that biopsies are not 
needed to phenotype the myocardium, but serial mechanical phenotyping would be sufficient. In 
this context it should be mentioned that many markers of myocardial remodeling, other than those 
studied in this thesis, have been described as recently reviewed [142,143]. The choice of meaningful 
markers for individual patients will critically depend on 1) the specific form of cardiac disease, 2) 
the type of mechanical overload, 3) the duration of pathological stimuli imposed on the myocar-
dium, 4) preexisting cardiac disease and relevant comorbidity and 5) the genotypic constitution of 
a patient. In the human patients analyzed in this thesis, clinical assessment did not suggest any 
known genetic defect, although this cannot be excluded. Nevertheless, it is clear that the individual 
cardiac phenotype is inseparably linked to the genotype and integrative clinical diagnostics should 
incorporate genetic testing when indicated.
The abovementioned considerations are still limiting the use of specific myocardial markers as 
valuable clinical tools to aid in patient-specific therapeutic decision making. Nevertheless, our 
results provide important insights into relevant myocardial remodeling processes present in cardiac 
overload. In order to make myocardial phenotyping practically applicable and clinically meaningful 
in patients with a cardiac mechanomyopathy, the selection of patients amenable for an integra-
tive diagnostic workup should be well-defined. We propose that these patients should fulfill the 
following selection criteria, having a:
High risk, suspicion or manifestation of cardiac disease, which likely results in life-threatening •	
(mortality) or severely disabling sequelae (morbidity)
Cardiac disease, which remains mechanistically largely unexplained, thereby preventing •	
appropriate, preferentially causal therapy
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Cardiac disease, which likely arises from multifactorial adverse myocardial remodeling, i.e., •	
structural and functional, as an important consequence of past, present or expected future 
cardiac mechanical overload
In these selected patients, the applicable approaches could range from the use of molecular and 
cell-biological techniques used in myocardial tissue samples to clinically available non-invasive 
molecular imaging techniques [142,143]. In line with the data presented in Chapter 3 to Chapter 6 
clear links between mechanical stimuli and alterations of myocardial structure and function could 
be established in individual patients by applying such an integrative diagnostic approach.
Altogether, the clinical assessment of selected patients with a cardiac mechanomyopathy should 
be adapted to incorporate mechanical, structural and functional cardiac analyses with emphasis on 
mechanistic characterization. This integrative approach of serial mechano–molecular phenotyping 
in patients should improve individualized diagnostic and therapeutic tailoring. In this sense the 
classic terminology discriminating pressure from volume overload becomes an outdated oversim-
plification. Cardiac mechanical overload and ventricular hypertrophy occurring in one individual 
patient are not comparable to those observed in another.
CoNCluDINg REmARkS
In this thesis we sought to gain novel mechanistic insights into the role of distinct mechanical 
stimuli for molecular processes relevant for structural and functional remodeling during ventricular 
hypertrophy. We developed and explored an integrative approach that allows simultaneous assess-
ment of mechanical overload and myocardial remodeling. We illustrate the opportunities and 
discuss the limitations of this mechano-structural-functional phenotyping in an animal model of 
overload-induced ventricular hypertrophy, accompanied by electrical and structural cardiomyo-
cyte remodeling. Moreover, we applied mechano-structural-functional phenotyping to individual 
patients with mechanical overload and ventricular hypertrophy due to valvular heart disease under-
going cardiac surgery.
This thesis provides novel integrative concepts to recognize, diagnose, monitor and treat individual 
patients with a cardiac mechanomyopathy in a more mechanism-based way.
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Chapter 9    PUBlICAtIoNS
SummARy
In Chapter 1, we explain the meaning of “cardiac mechanomyopathy”. We illustrate current inabili-
ties to carefully identify mechanical stimuli influencing the heart under normal conditions and 
in hemodynamic overload. Also, it is realized that molecular pathways of mechanotransduction, 
hypertrophy and mechanoelectrical coupling are often poorly resolved in individual patients with 
cardiac overload. Anno 2008, the gap between cardiac genotype and phenotype in mechanomyo-
pathy is still very large.
In Chapter 2, we address experimental and clinical evidence that mechanical forces are impor-
tant stimuli for structural and molecular-electrical alterations during cardiac overload, which can 
finally set the stage for potentially life-threatening arrhythmias. Yet, the mechanisms underlying 
the mutual interaction between mechanics, structural and electrical remodeling remain to be eluci-
dated. Recent reports suggest that cardiomyocytes are able to sense and transduce mechanical 
forces through specific cardiomyocyte Z-disk protein complexes. Moreover, physical connections 
between these protein complexes and ion channels have been suggested. These findings support 
the notion that mechano-structural links may play a role in mediating overload-induced, i.e., 
acquired, ion-channelopathies.
To investigate mechanotransduction in cardiac overload, we selected the canine model of complete 
atrioventricular block (AVB) with pronounced ventricular (and atrial) proarrhythmia. In this model 
of bradycardia-induced cardiac overload the arrhythmogenic role of impaired repolarization has 
been established, being mainly mediated by K+-channel downregulation and altered cellular Ca2+ 
handling.
As a prerequisite for further studies on mechanotransduction, we have characterized in Chapter 3 
the left ventricular (LV) myocardial mechanics acting in the AVB model. In serial acute-to-chronic 
experiments in the intact beating heart, we found that end-diastolic stress and strain as well 
as ejection strain, but not systolic stress, are significantly increased. These early increases, i.e., 
acute to 2 weeks AVB, coincided with peak hypertrophic growth, supporting the role of stress 
and strain as primary stimuli for mechanotransduction. Our approach, using echocardiography 
and invasive blood pressure measurements combined with mathematical modeling of mechanics, 
provided values of stress and strain which were similar to data obtained by others in experiments 
on isolated cardiac muscle. In this way, accurate quantification of myocardial mechanics in vivo 
allows extrapolation of data from and to in-vitro experiments, enabling comprehensive assessment 
of mechanotransduction.
In order to combine serial mechanical phenotyping described in Chapter 3 with a long-term analy sis 
of myocardial tissue remodeling, we developed a minimally-invasive transthoracic approach to 
obtain serial LV intramural biopsies, as described in Chapter 4. This technique enables repeti-
tive sampling in the same individuals yielding relatively large myocardial biopsies as compared to 
commonly-used catheter-based techniques. The tissue specimens were found to be of excellent 
quality and suitable for the use of various cell-biological and molecular analyses. Moreover, after 
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slight adaptations the technique was found to be safe, did not influence functional and structural 
characteristics of the AVB heart and could be extended to other animal models.
In Chapter 5, we applied the novel biopsy technique described in Chapter 4 to study time-related 
aspects of electrical remodeling in the AVB model. The impetus to this study was the general lack of 
temporal information on the electromolecular alterations underlying ion-channel downregulation 
in this and other arrhythmogenic models. We examined the acute-to-chronic time course of down-
regulation of the subunits KCNQ1 and KCNE1 of the slowly-activating delayed rectifier (IKs) channel 
and its β-adrenergic repolarization responsiveness. In serial apicolateral LV biopsies, mRNA and 
protein levels of the IKs pore-forming subunit KCNQ1 were significantly decreased within a few days 
after induction of AVB. This downregulation was followed by a gradual decrease of β1-adrenergic 
receptor mRNA and protein expression. In the same time interval, plasma levels of norepinephrine 
were found to be transiently elevated. Functional studies incorporating β-adrenergic provoca-
tion testing in vivo revealed repolarization instability, i.e., loss of repolarization shortening and 
increased beat-to-beat variability of repolarization. This was found to be at least partly based 
on a decreased β-adrenergic activation of IKs. These changes favor the occurrence of ventricular 
arrhythmias in this acquired form of ion-channelopathy.
As a next step, in Chapter 6, we focussed on the mechanisms of mechanotransduction in the AVB 
model by assessing ventricular mechanics (Chapter 3) and the expression of myocardial key proteins 
involved in mechanosensing- and transduction over time. During early increases of mechanical 
load, reflected by end-diastolic stress, ejection strain and brain natriuretic peptide (BNP) release 
after induction of AVB, we found a transient compromise of cytoskeletal integrity, based at least 
partly on transcriptional downregulation. A more advanced disruption of the myofibrillar apparatus 
and the desmin network did not occur and a cytoskeletal reorganization ensued, which coincided 
with the upregulation of pro-compensatory proteins such as melusin, P-Akt (protein kinase B), 
P-glycogen synthase kinase (GSK) and muscle LIM protein (MLP), indicating a strong drive towards 
compensated hypertrophy.
In order to translate our findings to human patients suffering from cardiac overload, we describe 
a novel approach in Chapter 7, which ultimately allows to quantify the mechanical forces relevant 
for myocardial remodeling, i.e., stress and strain, at the bedside. We report our first experiences 
with this completely non-invasive modality to quantify ventricular hemodynamics and mechanics in 
patients with different forms of cardiac overload. Using the CircAdapt computer model (developed 
at the Department of Biophysics, Cardiovascular Research Institute Maastricht) in combination 
with transthoracic echocardiography and armcuff blood pressure measurements, we found a high 
degree of accuracy of the CircAdapt simulation in comparison with invasive measurements of LV 
hemodynamics. Thus, accurate patient-specific modeling of LV intracardiac hemodynamics and 
myofiber mechanics is practically feasible by completely non-invasive means. The approach has 
important clinical potential as a comprehensive bedside assessment of systolic and diastolic cardiac 
function and loading conditions, i.e., pressure-volume and stress-strain relations, considered as 
triggers of cardiac remodeling and indicators of prognosis.
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In Hoofdstuk 1 wordt de betekenis van het begrip “cardiale mechanomyopathie” verklaard. Anno 
2008 is het nog steeds zeer moeilijk, zo niet onmogelijk, om de mechanische stimuli die het hart 
onder normale omstandigheden en bij hemodynamische overbelasting beïnvloeden, nauwkeurig te 
identificeren. Bovendien zijn de moleculaire processen van mechanotransductie, hypertrofie en 
mechano-elektrische koppeling zeer beperkt opgehelderd. De kloof tussen cardiaal genotype en 
fenotype bij mechanomyopathie blijkt nog steeds immens.  
In Hoofdstuk 2 wordt beschreven (op basis van experimentele en klinische onderzoeksresultaten) 
dat mechanische krachten belangrijke stimuli vormen voor structurele en moleculair-elektrische 
veranderingen tijdens cardiale overbelasting. Deze veranderingen kunnen uiteindelijk het substraat 
vormen voor het optreden van (in potentie) levensbedreigende kamerritmestoornissen. De mecha-
nismen die ten grondslag liggen aan de interactie tussen mechanica enerzijds en structurele en 
elektrische remodelering anderzijds, worden belicht. Uit recente studies komt naar voren dat 
cardiomyocyten in staat zijn om mechanische krachten te detecteren en over te brengen via 
cardiomyocyt-specifieke Z-disk eiwitcomplexen. Bovendien is aangetoond dat deze eiwitcomplexen 
in direct contact staan met ionkanalen. Deze bevindingen ondersteunen het idee dat mechano-
structurele verbanden in de myocyt een rol spelen bij het ontstaan van door overbelasting geïndu-
ceerde ionkanaalpathologie. Om mechanotransductie bij cardiale overbelasting te onderzoeken, is 
een hondenmodel gekozen met compleet atrioventriculair blok (AVB) en uitgesproken ventriculaire 
(en atriale) pro-aritmie. In dit model, met bradycardie-geïnduceerde cardiale overbelasting, is de 
aritmogene rol van een gestoorde repolarisatie van de hartkamers onmiskenbaar vast komen te 
staan. Deze wordt hoofdzakelijk veroorzaakt door downregulatie van kaliumkanalen en een veran-
derde calciumhuishouding in de cel.
Alvorens over te gaan tot verder onderzoek naar mechanotransductie worden in Hoofdstuk 3 de 
mechanische veranderingen in hartspierweefsel van de linkerventrikel beschreven die een rol spelen 
in het AVB model. In seriële acuut-chronische experimenten in het intacte kloppende hart werd 
gevonden dat eind-diastolische stress en strain, evenals ejectie-strain, significant verhoogd zijn. 
Systolische stress blijkt niet verhoogd te zijn. Deze vroege toename van mechanische krachten, 
vanaf het acute moment tot ongeveer 2 weken na AVB, gaat gepaard met een piek in de toename 
van hypertrofie. Dit ondersteunt de veronderstelling dat stress en strain een belangrijke rol spelen 
als primaire stimuli voor mechanotransductie. Onze benadering, waarbij we gebruik maken van 
echocardiografie en invasieve bloeddrukmetingen in combinatie met wiskundige modellen van 
cardiale mechanica, levert waarden op van strain en stress die vergelijkbaar zijn met die verkregen 
tijdens experimenten in geïsoleerd hartspierweefsel. Op deze manier is het extrapoleren van in-vivo 
data naar in-vitro resultaten, en vice versa, mogelijk en behoren translationele bepalingen van 
mechanotransductie tot de mogelijkheden. 
In Hoofdstuk 4 wordt een nieuwe minimaal-invasieve transthoracale methode beschreven waarmee 
myocardbiopten uit de linkerventrikelwand serieel kunnen worden verkregen. Daardoor kan de 
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moleculaire analyse van myocardiale remodelering worden gerelateerd aan seriële mechanische 
fenotyperingen, zoals ook beschreven in Hoofdstuk 4. Deze methode maakt het mogelijk om bij 
dezelfde individuen herhaalde biopten te nemen, die in vergelijking met eerdere methoden relatief 
groot zijn. De weefsels die bij biopsie werden verkregen blijken van een uitstekende kwaliteit te 
zijn en geschikt voor diverse celbiologische, moleculaire en electrofysiologische bepalingen. Verder 
blijkt deze bioptmethode na geringe aanpassingen veilig en worden de functionele en structurele 
kenmerken van het AVB-hart niet aangetast. De methode kan ook bij andere diermodellen worden 
toegepast. 
In Hoofdstuk 5 worden tijdsafhankelijke aspecten van elektrische remodelering in het AVB model 
beschreven. De reden van dit onderzoek was het algemene gebrek aan temporele informatie over 
elektromoleculaire veranderingen in dit en andere modellen van ritmestoornissen. We onderzochten 
het beloop van de afname van de subunits KCNQ1 en KCNE1 van het IKs ionkanaal (slowly-activating 
delayed rectifier K+ current) en de β-adrenerge gevoeligheid daarvan. In seriële biopten uit de 
apicolaterale linkerventrikel bleken mRNA en hoeveelheid eiwit van de kanaalsubunit KCNQ1 signi-
ficant verlaagd binnen een paar dagen na inductie van AVB. Hierna volgde een geleidelijke afname 
van mRNA en eiwitexpressie van de β1-adrenerge receptor. In hetzelfde tijdsinterval werden in 
het bloedplasma tijdelijk verhoogde concentraties noradrenaline gevonden. In-vivo studies tonen 
instabiliteit van de repolarisatie aan, te weten het verlies aan vermogen van de repolarisatie om 
te verkorten tijdens β-adrenerge stimulatie, alsmede een toename van de slag-op-slag variabiliteit 
van repolarisatieduur. Dit fenomeen blijkt ten dele gebaseerd te zijn op een afgenomen β-adrenerge 
activatie van IKs; op deze manier wordt het optreden van ventriculaire aritmieën bij deze verworven 
vorm van ionkanaalpathologie bevorderd. 
In Hoofdstuk 6 wordt aandacht besteed aan de mechanismen van mechanotransductie in het AVB 
model door middel van het bepalen van ventriculaire mechanica (Hoofdstuk 3) en de expressie 
van myocardiale sleuteleiwitten die betrokken zijn bij mechanosensing en –transductie. Gedurende 
de vroege toename van mechanische belasting, die gekenmerkt wordt door toegenomen eind-
diastolische stress, ejectie-strain en het vrijkomen van brain natriuretic peptide (BNP), zien wij een 
tijdelijk gecompromitteerde integriteit van het cytoskelet, die op zijn minst gedeeltelijk gebaseerd 
is op downregulatie van de transcriptie van bepaalde eiwitten. Een verdere verstoring van het 
myofibrillaire apparaat en het desmine-netwerk treedt niet op, maar er vindt wel een reorganisatie 
van het cytoskelet plaats, die gepaard gaat met een toename van compenserende eiwitten zoals 
melusine, P-Akt (proteine kinase B), P-glycogeen synthase kinase (GSK) en spier LIM proteine (MLP). 
Deze veranderingen duiden een sterke neiging tot gecompenseerde hypertrofie aan. 
Om de nieuwe bevindingen te kunnen vertalen naar patiënten, die lijden aan cardiale overbelasting, 
beschrijven we in Hoofdstuk 7 een benadering die ons in staat stelt om de mechanische krachten, 
relevant voor myocardiale remodeling, te kwantificeren aan het bed van de patiënt. We rappor-
teren de eerste ervaringen met dit volledig niet-invasieve model om ventriculaire hemodynamiek 
en mechanica bij patiënten met verschillende vormen van cardiale overbelasting in getal uit te 
drukken. Door gebruikmaking van het CircAdapt computer model (ontwikkeld binnen de afdeling 
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Biofysica van het Cardiovasculair Onderzoeksinstituut CARIM te Maastricht) in combinatie met 
transthoracale echocardiografie en niet-invasieve bloeddrukmeting, kon worden vastgesteld dat 
de CircAdapt simulatie de hemodynamiek van de linkerventrikel op een zeer nauwkeurige wijze 
weergeeft, te vergelijken met meetresultaten die worden verkregen tijdens invasieve procedures.
Concluderend is het in de praktijk haalbaar om op een volledig niet-invasieve manier patiënt-
specifieke intracardiale hemodynamiek en hartspiervezel-mechanica te modelleren. De benadering 
verschaft belangrijke klinische mogelijkheden om aan het bed van de patiënt de systolische en 
diastolische parameters, die betrokken zijn bij de belasting van het hart, te bepalen. Het gaat 
hier met name om druk-volume en stress-strain relaties, die beschouwd worden als triggers voor 
cardiale remodelering en prognostische factoren.
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In Kapitel 1 wird die Bedeutung des Begriffs “Kardiale Mechanomyopathie” erläutert. Anno 2008 
ist es noch immer schwierig, wenn nicht sogar unmöglich, die mechanischen Faktoren, die das Herz 
unter normalen Bedingungen aber auch bei hämodynamischer Überbelastung beeinflussen, auf eine 
exakte Art und Weise zu identifizieren. Im Übrigen sind die molekularen Prozesse der Mecha-
notransduktion, der Hypertrophie und der mechano-elektrischen Kopplung nur in begrenztem Maße 
entschlüsselt. In diesem Sinne zeigen sich bei der Mechanomyopathie auch noch große Lücken zum 
Verständnis der Zusammenhänge zwischen Genotyp und Phänotyp.
In Kapitel 2 wird beschrieben (basierend auf experimentellen und klinischen Forschungser-
gebnissen), dass mechanische Kräfte wichtige Reize für strukturelle und molekular-elektrische 
Veränderungen im Rahmen einer kardialen Überbelastung darstellen. Diese Veränderungen können 
letztendlich ein Substrat für das Auftreten von (potentiell) lebensbedrohlichen ventrikulären 
Herzrhythmusstörungen bilden. Die Mechanismen, die die Grundlage der Interaktion zwischen den 
mechanischen Kräften einerseits und den strukturellen und elektrischen Remodellierungsprozessen 
andererseits bilden, werden erläutert. In aktuellen Studien wird berichtet, dass Kardiomyozyten 
über spezifische sogenannte Z-Scheiben-Eiweißkomplexe in der Lage sind, mechanische Kräfte zu 
detektieren und weiterzuleiten. Es konnte ferner gezeigt werden, dass diese Eiweißkomplexe in 
direktem Kontakt zu Ionenkanälen stehen. Diese Ergebnisse stützen die Hypothese, dass mechano-
strukturelle Interaktionen in Kardiomyozyten beim Entstehen der durch Überbelastung induzierten 
Ionenkanalpathologie eine Rolle spielen. Um die Mechanotransduktion bei kardialer Überbelastung 
zu analysieren, wurde ein Hundemodell mit komplettem atrio-ventrikulären Block (AVB) und deut-
licher ventrikulärer (und atrialer) Pro-Arrhythmie untersucht. In diesem Modell mit Bradykardie-
induzierter kardialer Überbelastung steht die arrhythmogene Rolle der gestörten Repolarisation der 
Herzkammern unumstößlich fest. Diese wird hauptsächlich verursacht durch eine Downregulation 
von Kaliumkanälen und einen veränderten Kalziumhaushalt in der Zelle.
Bevor weitere Studien zur Mechanotransduktion dargestellt werden, werden in Kapitel 3 zuächst 
die mechanischen Veränderungen im Herzmuskelgewebe des linken Ventrikels beschrieben, die im 
AVB-Modell eine Rolle spielen. In seriellen akut-chronischen Experimenten am intakten, kontrahie-
renden Herzen konnte gezeigt werden, dass end-diastolischer Stress und Strain sowie Ejektions-
Strain signifikant erhöht sind. Systolischer Stress war nicht erhöht. Diese frühzeitige Zunahme 
mechanischer Kräfte, vom akuten Moment an bis ungefähr 2 Wochen nach AVB, wurde begleitet 
von einem Maximum des hypertrophen Wachstums des Herzmuskels. Dies unterstützt die Annahme, 
dass Stress und Strain eine wichtige Rolle als primäre Reize der Mechanotransduktion spielen. Unser 
Ansatz, bei dem wir die Echokardiographie und invasive Blutdruckmessungen mit mathematischen 
Modellen der kardialen mechanischen Kräfte kombinieren, ergibt quantitative Stress- und Strain- 
Werte, die vergleichbar sind mit experimentellen Daten aus isoliertem Herzmuskelgewebe. Somit 
ist das Extrapolieren von in-vivo Daten zu in-vitro Daten und vice versa möglich, und gehören 
translationelle Bestimmungen der Mechanotransduktion damit zu den neuen Möglichkeiten.
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In Kapitel 4 wird eine neue minimal-invasive transthorakale Methode beschrieben mit der Myokard-
biopsien in serieller Weise aus der linksventrikulären Wand entnommen werden können. So kann 
eine molekulare Analyse der myokardialen Remodellierung in Relation gesetzt werden zu seriellen 
mechanischen Phänotypisierungen, entsprechend der Beschreibung in Kapitel 3. Diese Methode 
ermöglicht es, bei denselben Individuen wiederholt Biopsien zu entnehmen, die im Vergleich zu 
früheren Methoden ein relativ großes Volumen haben. Die Gewebeproben hatten damit eine 
ausgezeichnete Qualität und waren somit brauchbar für diverse zellbiologische, molekulare und 
elektrophysiologische Bestimmungen. Im Weiteren wurde deutlich, dass diese Biopsiemethode nach 
kleinen Anpassungen ausreichend sicher war und außerdem keinerlei Einfluss auf die funktionellen 
und strukturellen Aspekte des AVB-Herzens hatte. Im Übrigen kann die Methode auch bei anderen 
Tiermodellen angewendet werden.
In Kapitel 5 werden zeitabhängige Aspekte der elektrischen Remodellierung im AVB-Modell 
beschrieben. Diese Studie wurde durchgeführt, weil allgemein unzureichende Informationen im 
Hinblick auf zeitabhängige elektro-molekulare Veränderungen in diesem und in anderen arrhyth-
mologischen Modellen vorhanden sind. Es wurde der Verlauf der Downregulation der Untereinheiten 
KCNQ1 und KCNE1 des IKs Ionenkanals (slowly-activating delayed rectifier K
+ current) und dessen 
β-adrenerge Sensibilität analysiert. In seriellen Biopsien aus der apiko-lateralen Wand des linken 
Ventrikels waren innerhalb einiger Tage nach AVB-Induktion mRNA und Eiweiß der Ionenkanalun-
tereinheit KCNQ1 signifikant vermindert. Im weiteren Verlauf folgte eine gleichmäßige Abnahme 
von mRNA und Eiweiß des β-adrenergen Rezeptors. Im selben Zeitintervall wurden im Blutplasma 
zeitweise erhöhte Konzentrationen von Noradrenalin festgestellt. In-vivo Studien zeigen eine Repo-
larisationsinstabilität, die genauer betrachtet den Verlust der Kapazität zur Repolarisationsverkür-
zung bei β-adrenerger Stimulation darstellt, wie auch eine Abnahme der Schlag-Schlag Variabilität 
der Repolarisation. Zum Teil konnte dies durch eine Abnahme der β-adrenergen Aktivität von IKs 
erklärt werden. Diese Veränderungen fördern das Auftreten ventrikulärer Arrhythmien im Rahmen 
dieser erworbenen Form der Ionenkanalpathologie.
In Kapitel 6 wird näher eingegangen auf die Mechanismen der Mechanotransduktion beim AVB- 
Modell durch quantitative Bestimmung der kardialen mechanischen Kräfte (Kapitel 3) und der 
Expression von myokardialen Schlüsseleiweißen, die eine Rolle bei der Mechanotransduktion spielen. 
Während der Phase der frühen Zunahme der mechanischen Belastung, die durch eine Zunahme des 
end-diastolischen Stresses, des Ejektions Strains und der Erhöhung van brain natriuretic peptide 
(BNP) gekennzeichnet wird, zeigt sich eine zeitweise verminderte Integrität des Zytoskeletts, die 
zumindest zum Teil ihre Ursache in der Downregulation der Transkription von spezifischen Eiweißen 
findet. Eine weitere Destruktion des myofibrillären Apparates und des Desmin-Netzwerks trat nicht 
auf, jedoch wurde eine Reorganisation des Zytoskeletts festgestellt, die von einer Zunahme soge-
nannter kompensierender Eiweiße, wie Melusin, P-Akt (Protein-Kinase B), P-Glykogen-Synthase 
Kinase (GSK) und Muskel-LIM-Protein (MLP), begleitet wird. Diese Veränderungen deuten auf eine 
starke Neigung zu einer kompensierten Form der myokardialen Hypertrophie hin.
Boek_Donker_v5.indb   219 21-7-2008   10:22:24
220
Um diese neuen Erkenntnisse umzusetzen in die klinische Situation, in der Patienten an kardialer 
Überbelastung leiden, beschreiben wir in Kapitel 7 einen Ansatz, der es uns ermöglicht die mecha-
nischen Kräfte, die für myokardiale Remodellierung relevant sind, direkt am Bett des Patienten zu 
quantifizieren. Wir berichten über die ersten Erfahrungen mit diesem vollständig nicht-invasiven 
Modell ventrikulärer Hämodynamik und mechanischer kardialer Kräfte, angewandt bei Patienten 
mit verschiedenen Formen kardialer Überbelastung. Durch die Verwendung des CircAdapt Computer 
Modells (entwickelt in der Abteilung für Biophysik des kardiovaskulären Forschungsinstituts CARIM 
in Maastricht) in Kombination mit transthorakaler Echokardiographie und nicht-invasiver Blut-
druckmessung, konnte gezeigt werden, dass die CircAdapt Simulation die Hämodynamik des linken 
Ventrikels auf eine sehr genaue Art und Weise, vergleichbar mit invasiven Messungen, wiedergibt.
Zusammenfassend ist es praktisch möglich, vollständig nicht-invasiv die jeweils patientenspezifi-
sche intrakardiale Hämodynamik und ebenfalls die mechanischen Kräfte die auf die Herzmuskelfa-
sern einwirken, modellhaft darzustellen. Dieser Ansatz bietet wichtige klinische Möglichkeiten, um 
direkt am Bett des Patienten systolische sowie diastolische Parameter, die bei der Überbelastung 
des Herzens eine Rolle spielen, zu bestimmen. Hierbei geht es vor allem um Druck-Volumen und 
Stress-Strain Beziehungen, die als wichtige Faktoren der Remodellierung und prognostischen 
Einschätzung angesehen werden.
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Figure 1  The heart. Artwork by Aaron (7 years), Eline (5 years) and Marit Donker (3 years). From left to right.
Full colour illustration chapter 1
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Figure 1  Serial percutaneous sampling of LV intra-mural biopsies. a Schematic illustration of optimal biopsy needle positioning in the 
sagittal plane in relation to the intra-thoracic location of the heart in the adult dog. b Under fluoroscopic guidance, the needle is advanced 
into the apicolateral LV wall. c Schematic illustration of optimal biopsy needle positioning in the transverse plane (caudal view) in relation to 
the intra-thoracic location of the heart. d A small incision facilitates percutaneous introduction of the biopsy needle into the left anterolateral 
inter-costal space overlying the LV apex. See text for detailed description.
Full colour illustrations chapter 4
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Figure 2  Procedural monitoring during biopsy sampling. a Electrocardiographic and hemodynamic monitoring shows ventricular extrasys-
toles (arrowhead) during intra-myocardial insertion of the biopsy needle. SR, sinus rhythm, pLV, intra-cavitary LV pressure. Ten minutes 
after sampling, the ECG and LV pressure tracings are similar to the baseline (SR). b Monitoring of heart rate and LV systolic and diastolic 
pressure trends reveals stable tracings after sequential sampling of four biopsies accompanied by multiple ventricular extra-systoles 
(arrowheads). c Trans-thoracic echocardiographic approach in the adult dog. The right parasternal transducer positions allows long axis 
(1) and, after rotation, short axis views (2), whereas left parasternal apical scanning provides four-chamber views (3). Note that besides 
B-mode also M-mode and Doppler-flow measurements (not shown) can be easily performed. Ao, ascending aorta; LA, left atrium; RA, 
right atrium.
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Figure 3  Processing of LV myocardial needle biopsies. a Biopsies can be easily lifted from the needle 
with tweezers. The specimen can be processed as a complete intra-mural cylinder or can be dissected 
into smaller pieces. After freezing, cryosections can be prepared, allowing simultaneous application 
of different analytical methods as, e.g., Histo histology, IHC immunohistochemistry, EM electron micro-
scopy, PCR polymerase chain reaction and WB Western blotting. Scale bar indicates 1 cm. b The LM 
photomicrograph illustrates the good quality of the myocardial samples using Masson’s Trichrome stai-
ning (cardiomyocytes [red]/fibrous tissue [blue]). This example of an intra-mural biopsy extends from 
the epicardium (top inset) to the endocardium (bottom inset). Scale bars indicate 1 mm. c Intra-mural 
extension of the biopsy sample can also be confirmed by visualisation of the (sub)endocardial layers 
as illustrated in the light-microscopic photograph using toluidine blue counterstained with periodic 
acid-Schiff; endocardium (pale blue), working myocardium (blue) and glycogen (magenta)containing 
Purkinje fibres. Scale bars indicate 100 µm. d At autopsy, only limited scar formation occurred at the 
sampling sites (arrowheads) after repeated biopsies. Scale bar indicates 2 mm. 
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Figure 4  Cell-biological myocardial analysis in LV needle biopsies. a Representative light-microscopic (toluidine blue counterstained with 
periodic acid Schiff) and electron-microscopic photographs showing longitudinally sectioned cardiomyocytes within a normal myocardial 
texture from a dog bioptized during SR, demonstrating the excellent tissue quality. Scale bars indicate 20 µm. b Light-microscopic and 
electron-microscopic photographs corresponding to a showing cross-sectioned cardiomyocytes. Scale bars indicate 20 µm. c Immuno-
fluorescent histochemistry in LV myocardium double-labelling the cardiomyocyte intermediate filament desmin (green), the fibroblast 
intermediate filament vimentin (red; left and middle) and alpha smooth muscle actin present in the vessel wall (red, right), in longitudinally 
(left, right) and transversally sectioned myocardium (middle). Scale bars indicate 20 µm. 
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Figure 3  Time course of structural remodeling before and after AVB. Immunofluorescent double staining for desmin (green) and laminin 
(red) A and desmin (green) and vimentin (red) B showing no differences between SR and AVB. C light microscopy (LM) photomicrographs 
of periodic acid-Schiff-/Toluidine blue-stained left ventricular (LV) myocardium from serial biopsies of one individual dog showing increased 
cytoplasmic glycogen content during AVB (asterisks), which was absent at SR. D electron microscopy photomicrographs illustrating 
ultrastructural details, as glycogen accumulation in areas with depletion of sarcomeres and remnants of myofibrils (asterisks) altered 
mitochondrial shape and size as compared with SR (arrowheads). E relative number of cardiomyocytes showing depletion of sarcomeres. 
Scale bars in A–C indicate 10 µm. *P<0.05 vs. SR; †P<0.05 vs. 10 days AVB.
Full colour illustrations chapter 6
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Figure 5  Cardiomyocyte expression pattern of MLP before and after AVB. LM photomicrographs show immunohistochemical expression 
of MLP in LV myocardium at low A and high B and C magnification, in transversely A and B and longitudinally C sectioned cardiomyocytes. 
At control (SR), a mild MLP expression was observed within the cytoplasm and the nucleus B and C; solid arrowheads. Note that noncar-
diomyocyte nuclei B and C, open arrowhead stain blue, whereas cardiomyocyte nuclei show MLP labeling B and C, solid arrowhead. In 
negative control (MLP.), both cardiomyocyte nuclei B and C, solid arrowhead and noncardiomyocyte nuclei B and C, open arrowheads stain 
blue, indicating the absence of MLP labeling. During AVB, both cardiomyocyte cytoplasmic and nuclear expression of MLP are increased 
B and C. Scale bars indicate 10 µm.
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Figure 7  Time course of desmin 
expression before and after AVB.
Serial real-time PCR a and Western 
blot analysis b show average 
values standardized to SR (n=9 
dogs). Immunofluorescent labeling 
of desmin (green) and nuclei (red) c 
and LM photomicrographs d show 
immunohistochemical expression 
of desmin in serial biopsies. Scale 
bars indicate 25mm. *P<0.05 vs. 
SR; †P<0.05 vs. 3 days AVB.
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Figure 2  Time course of cardiac mechanics and related remodeling in the AVB model. Schematic illustration of cardiac mechanics, 
hemodynamics and neurohumoral tone upon creation of AVB in temporal relation to different functional and structural myocardial remode-
ling processes. 
Full colour illustrations chapter 8
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Figure 3  Cardiac mechanomyopathy - Case 1. Transesophageal echocardiography (top, left panel) demonstrating ASD type II (arrow) 
with important left-to-right shunting (insert, color Doppler flow). Ao indicates aortic valve, LA and RA indicate the left and right atrium, 
respectively. Transthoracic echocardiographic 4-chamber views after surgical correction of the ASD (top, mid and right panel) showing a 
somewhat dilated RV and a normal LV during diastole (top, mid) and systole (top, right). 12-Leads electrocardiogram (bottom) 10 days after 
surgical correction of the ASD showing SR (left) and VT (right) originating in the RV outflow tract. See text for details.
Boek_Donker_v5.indb   230 21-7-2008   10:58:45
231
Chapter 9    DANKWooRD
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Lieve Birgit, wie kan ik meer danken voor alle steun tijdens dit beproefschrift dan jou?! Jij was in al 
die jaren mijn beste vriendin. Zonder jou was het onmogelijk geweest om het werk te combineren 
met een normaal familieleven. Aaron, Eline en Marit, vrolijke noten ... “papa, heb je het boek 
vandaag echt helemaal klaar gemaakt ?” ... toen papa ook nog erover begon hoe een hart eruit ziet 
leken jullie er helemaal niets meer van te begrijpen ... maar wat hebben jullie er mooie schilderijen 
van gemaakt. Overigens, ik maak me geen illusies. Dit hoofdstuk is voor velen het meest populaire 
stukje proefschrift. Geen probleem, ik ga jullie wel een keer vertellen waar het proefschrift zelf ook 
nog weer over ging. 
Maar nu dan het lang verwachte dankwoord. Als eerste succesvolle survivor van een AGIKO 
constructie (assistent geneeskundige in opleiding tot klinisch onderzoeker) in de Maastrichtse 
Cardiologie is het bijna niet mogelijk om iedereen te bedanken die heeft bijgedragen aan al die jaren 
in kliniek en onderzoeksland. Eén ding is zeker, ik weet wel wie ik niet wil bedanken voor de begelei-
ding van dit proefschrift en de mogelijkheden voor jonge, enthousiaste artsen om wetenschappelijk 
onderzoek met klinisch engagement te combineren, namelijk de MSRC (Medisch Specialisten Regis-
tratie Commissie). Als je naar Nederland komt en denkt de Duitse bureaucratie te zijn ontvlucht, 
vind je hem bij de MSRC meer dan driedubbel, en zeker niet gratis, terug. Prof. Hein Wellens, ik wil 
u dan ook hartelijk bedanken voor de felle, onorthodoxe strijd tegen de instanties (met en zonder 
toga). Professor Wellens, het succesvolle afronden van dit proefschrift is ook een overwinning voor 
de translatie beogende opleidingsconstructies. Nogmaals dank voor uw vertrouwen in mijn eerste 
klinische jaren, de ongelofelijke power in kliniek en wetenschap en dank voor een onvergetelijke 
en inspirerende historische tijd en vooral ook dank voor het kortste sollicitatiegesprek ooit. Sorry, 
overigens, nogmaals voor de heerlijke rode wijn op uw mooie witte bankstel. 
En dan is er Paul Volders. Paul, jongen, de Y-ruimte is al lang verleden tijd, ik zie je nog zitten aan 
je oude 486 (66 MHz); amper te geloven maar jij was vele malen sneller dan die processor. Terwijl 
hij draaide om alles op te slaan had jij al weer een nieuw idee over hoe die ene halve zin nog net 
iets strakker kon. Daar verdween ook die mooie alinea van zojuist, die mij meer dan een halve 
middag had gekost, onder die oneerbiedige Delete knop. Nadat ik naar jou was overgelopen, heb 
je mij meer dan voortreffelijk begeleid in al die jaren. Inhoudelijke steun was vanzelfsprekend en 
je hebt je uitstekende overzicht over de wetenschappelijke breedte van het vak met mij gedeeld, 
hetgeen je ook nog eens vertaalt in prachtige visies. Maar, het meest belangrijke is wellicht nog dat 
de filosofische teneur steeds dieper tot mij doorgedrongen is. Ik kon het nooit geloven, maar een 
proefschrift schrijven leidt toch echt tot een persoonlijke en professionele vorming. Ik hoop dat we 
nog veel plezier en succes zullen hebben de komende jaren ... .
Prof. Harry Crijns, beste Harry, alhoewel ik nog een van de Altlasten was, heb je mij altijd het 
gevoel gegeven dat mijn project toch werkelijk iets unieks had. In de drukte van jouw positie heb 
je veel tijd kunnen maken voor de altijd scherpe en vooral constructieve discussies waarbij jouw 
uitgesproken enthousiasme prevaleerde. Je hecht veel waarde aan integratie van de wetenschap in 
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het echte klinische werk. Als afgestudeerde AGIKO kan ik mij geen betere leermeester wensen. Ik 
loop nog steeds iedere dag fluitend naar mijn werk (en soms ook zo maar even je kamer op - dank 
voor de lage drempel) en daaraan heb jij een belangrijke bijdrage. Dank ook voor jouw visie op mijn 
Intensive Care project.
Prof. Marc Vos, beste Marc, ik heb dan toch gelukkig nog veel van jou geleerd: blijven gaan, nooit 
omvallen, geen valse bescheidenheid, op het doel af, een commerciële neus, overeind blijven staan 
in de felste discussies ... ik ken er nog wel een paar ... belangrijke bewapening voor de academische 
strijd. Marc, ik durf te wedden, jij zou zeker ook een goede bondscoach zijn ... . Ik wil je uitdrukkelijk 
danken voor je onuitputtelijke enthousiasme en steun in een bewust gekozen rampzalig risicovol 
project ... volgens mij was jij ook wel eens de kluts kwijt?!
Dr. Emile Cheriex, beste Miel, je blijft toch altijd met een glimlach wat sceptisch kijken als ik over 
mathematical modeling, myocardial remodeling en dergelijke begin. Gelukkig maar, anders was dit 
proefschrift er wellicht nooit gekomen. Dank voor je support als klinische opleider in deze altijd 
soepele AGIKO constructie. Op een gegeven moment wisten we allebei niet meer welk opleidings-
schema we nu gingen volgen ... fantastisch toch!? ... dat heeft mij de vrijheid gegeven zo veel te 
putten uit klinisch en basaal wetenschappelijk werk ... zo is het toch nog een waarlijke AGIKO 
constructie geworden. De laatste jaren ben ik diep onder de indruk geraakt van jouw succesvolle 
inzet om de klinische opleiding steeds verder te verbeteren. Ook jouw inspanningen hebben in 
belangrijke mate bijgedragen aan het fluitend naar het werk gaan.
Prof. Theo Arts, beste Theo, helemaal in het begin heb ik van jou geleerd wat er mis is met wall 
stress en toen kwam voor mij de openbaring van mathematical modeling. Ik weet nog steeds niet 
altijd wat er in jouw computer gebeurt, maar wat er uit komt is goud waard voor de clinicus 
practicus. Dank voor de vele uren op jouw kamer. Jouw jarenlange biofysische inspanningen vormen 
een belangrijke basis voor ons gezamelijk werk. Nu, op naar de kliniek ... .
Prof. Anton Gorgels, beste Ton, jij bent altijd te enthousiasmeren en nooit te beroerd om even 
je expertise te delen. Dank voor je support in de begintijd van het project en de introductie in de 
klinisch-wetenschappelijke wereld.
Dr. Luz-Maria Rodriguez en Dr. Carl Timmermans wil ik danken voor de introductie in de begin-
selen van de Maastrichtse electrofysiologie en alle support door de jaren heen. Carl, het was een 
goede tijd in Heugem en Luz-Maria, het ergste van jouw deadlines was, dat ze altijd samen vielen 
met de Amstel Gold Race.
De leden van de beoordelingscommissie Prof. Maurits Allessie, Prof. Theo Arts, Prof. Jan Glatz en 
Prof. Walter Paulus wil ik bedanken voor hun bereidheid het manuscript kritisch te beoordelen. A 
special thanks to Prof. Andrew McCulloch for his willingsness to critically evaluate the manuscript 
… and coming all the way over the ocean … I’m really looking forward to exchange views on 
integrative systems biology.
Mijn paranymfen, Roel Spätjens en Dr. Khalid Murafi. Roel, het is niet goed met woorden te 
beschrijven hoe belangrijk jouw bijdrage aan dit proefschrift is ... heb een idee ... schets vaag een 
figuur of tabel ... kijk over een half uur in je mailbox ... klaar; heb een vraag ... Roel weet de weg 
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... met (maar zeker ook zonder) internet ... binnen no time is alles opgelost. Roel, ik kon altijd op 
jou rekenen ... een rots in de experimentele Cardiologie ... creativiteit, snelheid en perfectionisme 
... bovendien nog erg kritisch ... een promovendus kan zich niet beter wensen. Khalid, bester Kalli, 
ohne Porsche geht’s nich’ ... ich bin immer mehr überzeugt. Nach TUrBOlenten Jahren kommen 
wir beide langsam wieder zu relativer Ruhe. Dein Impulstrieb und Kreativität kennen keine Grenzen 
... guter Freund in allen Lebenslagen und immer weniger Lebensfragen ... ich freue mich auf die 
kommenden Jahre. 
Voor mij was de diversiteit van dit proefschrift één van de mooiste aspecten in al die jaren. Inmid-
dels is er binnen het gebouw vrijwel geen afdeling meer waarmee ik niet op de één of andere manier 
heb samengewerkt.
Bovenaan staat de afdeling Celbiologie van en met Prof. Frans Ramaekers. Beste Frans, het cyto-
skelet breekt menig patiënt op, daar geloven we beiden heilig in ... dus, genoeg te doen de komende 
jaren ... . Prof. Marcel Borgers , beste Marcel, eigenlijk zou ik nog een rondje moeten draaien, 
want, hoe zit het nou eigenlijk met de electrofysiologische eigenschappen van de hibernerende cel? 
Ter geruststelling, ik weet nu wel dat het een lastige vraag is. Fons Verheyen en Marie-Hélène 
Lenders wil ik danken voor het vele minutieuze celbiologische werk. Sorry, Marie-Hélène, ik dacht 
echt dat het een speciaal putje was voor oplosmiddelen en ik ken nog wel iemand die dat dacht. 
En dan er is vooral nog Helma Kuijpers bij de afdeling Celbiologie ... of was het nu Cardiobiologie? 
Helma, jouw inzet heeft mij, het proefschrift en de hele groep wortels doen slaan in de moleculaire 
biologie. Western blots for Dummies ... je leert het bij Helma ... het is spannender dan koken met 
de Chef ... .
De perfecte biotechnische ondersteuning van alle experimenten heb ik te danken aan onze opera-
teurs Monique de Jong, Theo van der Nagel en Jet Beekman. Jet, je wijsvinger staat op het 
titelblad van the European Journal of Physiology – Pflügers Archiv en ook in hoofdstuk 4, figuur 
1d, dat is een mooie weergave van jouw belangrijke bijdrage aan vele proefschriften binnen de 
Experimentele Cardiologie, ... altijd een vinger aan de pols. Theo, jij bent operateur, anesthesist, 
intensivist, technische dienst en hoofd magazijn in één persoon, geweldig ... ik weet dat je geniet 
van je oude? dag. Monique, dank voor al je inspanningen ... en de eerste biopten ... ik had erg weinig 
tijd om nog eens rustig binnen te lopen ... jij bent goed op weg om met veel feeling je eigen stempel 
te drukken op de biotechnische expertise binnen onze afdeling. 
Met de oude groep Experimentele Cardiologie/ Elektrofysiologie heb ik geweldige jaren gehad, 
dank aan Chris, Cora, Jérôme, Jet, Jurren, Marc, Milan, Maaike, Marieke & Marieke, Markéta, 
Morten, Paul, Roel, en Stephan. De nieuwe groep met Annerie, Daniel, Helma, Inge, Jan, Jordi, 
Matthijs, Monique, Viola, Paul & Roel is gegroeid tot een afdeling binnen de afdeling. Bij iedere 
werkbespreking is er wel weer een nieuw gezicht bij ... . Het doet me deugd om te zien hoe het 
integratieve en translationele pionierswerk z’n vruchten afwerpt. 
En nu nog mijn klinische collega ’s. Dr. Jurren van Opstal, mijn oudste Maastrichtse vriend. Na 
onvergetelijke jaren in en buiten de Y-ruimte en op 1068 zou ik graag nog een keer willen terugkomen 
op het Ardennenoffensief en de Mirabelles. Jurren, je had altijd bemoedigende en lovende woorden 
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voor mij. Dat heeft me erg goed gedaan in tijden van veel bloed, zweet en tranen. Bewondering heb 
ik voor jouw succesvolle klinisch-academische carrière, getrouw aan de echte Jurren-stijl. Dr. Leo 
HAPPY Hofstra© ... kun je nu wel remmen ? ... ergens in de Limburgse bossen bij -20% ... eindelijk 
heb je een fatsoenlijke fiets. Nu ik weer ga trainen heb je de remmen echter niet meer nodig ... niet 
remmen ... rijden maar ... je weet, er was een tijd dat de Bemelerberg geen naam had ... wacht nog 
maar even, jongens ... straks heb ik ook een Triple ... en was het maar om jullie je beter te laten 
voelen ... Bas Bekkers en Bernard Broers dank voor de vele kilometers in en buiten het ziekenhuis, 
wij moeten weer wat meer naar extramuraal. Bas, dank voor je talrijke initiatieven, de voorbeeldige 
sollicitatie(-brieven), de privé bedside echolessen en de Intensive Cardiac Care Unit (ICCU). Bernard, 
dank voor de introductie in de Plastische Chirurg(cardiolog)ie en je (droge) humor ... ik ga wel weer 
mee fietsen.
Het team van de afdeling Cardio-Thoracale Chirurgie wil ik danken voor de inzet bij alle humane 
hartbiopten, Prof. Jos Maessen voorop. Jos, je bent altijd te porren voor goede ideeën ... en vooral 
voor de daadkrachtige omzetting daarvan ... dank voor je wetenschappelijke en chirurgisch-tech-
nische expertise.
Alle supervisoren in mijn tijd bij de niet alleen maar beschouwende afdeling Interne Geneeskunde, 
Dr. Bram Kroon, Roger Rennenberg, Evelien Pijpers, Prof. Peter de Leeuw, Dr. Wubbo Mulder, 
Dr. Pieter van Paassen en collegae wil ik bijzonder danken voor een uitstekend leerzame en vooral 
gezellige stage van één ... pardon? twee jaar! Niet te vergeten, Prof. Karl Leunissen mijn opleider 
Interne Geneeskunde, ... no worries ... de AGIKO constructie is nu echt klaar, dank voor uw inzet en 
begrip.
Natuurlijk wil ik de verpleging danken op de afdelingen binnen het Hart en Vaat Centrum Maastricht. 
Dank voor jullie begrip en flexibiliteit op onderzoeksdagen en dank voor de plezierige samenwerking 
op de klinische dagen. Een speciaal woord van dank gaat uit naar het team van afdeling C3.
Barbara Przybylski en Bianca Bastings, wat is het toch een luxe om goede secretaresses te hebben 
... en ook nog altijd goed gemutst. 
Für eine prägende Zeit im EFMT (Entwicklungs- und Forschungszentrum für Mikrotherapie) bin ich 
Dr. Peter van Leeuwen zu viel Dank verpflichtet. P(i)eter, scientist puur sang, ich hab’ noch oft an 
die vielen explorativen biomagnetic field map Stunden zurück gedacht. Die klinische Kardiologie 
hat mich inspiriert in der Augusta Kranken-Anstalt in Bochum vor allem durch Prof. Birgit Hailer 
und den Chefarzt der Abteilung, Prof. Michael Wehr. Prof. Birgit Hailer, Allround-Kardiologin der 
besonderen Art, besten Dank für gute, privilegierte Studentenjahre. Professor Wehr, bin ich froh 
dass Sie mich in die richtige Richtung weggeschickt haben.
Michael Fiegert, beste Kollegen der Spedition Pieper, in vielen Sommermonaten und Woche-
nenden war der LKW mein Zuhause. Ein Traum eines jeden Studenten um einen Mercedes Sattelzug 
über Europas Straßen zu steuern. Nach vielen tausenden Kilometern und x-mal Paris, Marseille, 
Perpignan, Provence, ... hin und her ... . Danke für’s Vertrauen. Es war in vielerlei Hinsicht eine gute 
Vorbereitung für diese Arbeit ... ich hab’ auf ’m LKW in manchen Wochen mehr Lebensweisheit 
gelernt als in vielen Jahren Studium.
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Marja en Helmut Ritterfeld, Bertine, Peter & Amélie, Thom, Marx-Jan en Sten. Het is toch 
maar goed, Helmut, dat in 1972 in München Hennie Kuiper gewonnen heeft, ansonsten wären 
wir einander nicht über den Weg gelaufen ... danke für all die Fahrten nach Stadtlohn und noch 
viel mehr. Trainer, wo weht’s denn hier … Kopf runter ... Kette rechts ... tret drauf ... fahr da hin … 
bis dir die Kniescheiben wegfliegen ... ich hab’ oft die Stoßstange und den linken Fensterholmen 
vom Passat gesehen und verflucht ... Radrennen ist ... wie das echte Leben. Marja, ik ken geen 
Nederlander die beter Duits spreekt en schrijft, volgens mij heb je wel een Duits accent ... . Familie 
Ritterfeld … what a spirit ... what a family … .
Mijn schoonouders, Mieneke en Peter Cools-Elie en schoonbroer Luc wil ik bedanken voor de 
introductie in het gezellige bourgondische Limburgse leven en vooral het avondeten ... ik lust zeker 
nog wel een goed glaasje rode wijn ... en een kopje koffie, natuurlijk ... .
An dieser Stelle gilt ein besonderer Dank meinen Eltern ... kein Weg zu weit, keine Mühe zu groß; 
liebe Oma Hildegard und Opa Gerrit ich hab gutes Rüstzeug mitbekommen; euer selbstloser 
Einsatz in all den Jahren hat mir viel ermöglicht und noch ... en nu möss ock noch moal utschäien 
... et is nu wal kloar! 
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